Hydroxyapatite Nanoparticles and Nanobiocomposite Scaffold for

Protein Adsorption and Release by Swain, Sanjaya Kumar
 
Hydroxyapatite Nanoparticles and Nanobiocomposite 
Scaffold for Protein Adsorption and Release 
 
 
 
 
 
 
 
Sanjaya Kumar Swain 
 Hydroxyapatite Nanoparticles and Nanobiocomposite Scaffold for 
Protein Adsorption and Release 
 
A THESIS SUBMITTED IN PARTIAL FULFILMENT 
OF THE REQUIREMENT FOR THE DEGREE OF 
 
 
Doctor of Philosophy  
in 
Ceramic Engineering 
 
 
 
By 
Sanjaya Kumar Swain 
(509CR102) 
 
Supervisor: 
Dr. Debasish Sarkar 
 
 
 
 
Department of Ceramic Engineering 
National Institute of Technology 
Rourkela 
January 2014 


 ii 
 
Abstract 
Spherical, rod and fibrous hydroxyapatite (HA) nanoparticles synthesize through a common 
co-precipitation technique and fabricate macroporous HA-gelatin nanobiocomposite scaffolds 
for protein adsorption/release study. Three fundamental processing parameters such as 
solution pH, temperature and Ca/P ratio synchronize the morphology and crystallinity of nano 
HA from identical precursors Ca(CH3COO)2 and KH2PO4. Dispersion study illustrates the 
HA nanoparticle suspension stability phenomenon in aqueous media. Rod shaped HA exhibits 
relatively better bovine serum albumin (BSA) protein adsorption efficacy with compare to 
other two morphologies. In aqueous media, one gram nanorod HA particle adsorb 28 mg BSA 
within a time frame of 48 h and subsequently 75 wt.% release after 96 h in phosphate buffer 
solution. Low temperature freeze casting of homogenous aqueous slurry of HA nanoparticles, 
gelatin and biocompatible polyvinyl alcohol binder develops nano HA – gelatin 
nanobiocomposite macroporous scaffolds. Freeze casted nanorod HA-gelatin macroporous 
(70 vol.%) scaffold demonstrate highest yield compressive strength of ~2 MPa compare to 
other scaffolds prepared from spherical and fibrous HA because of high surface area and the 
effective anchoring. An optimum cryogenic treatment time at 77K promotes the mechanical 
response of this low strength scaffold and designates as cryo-treated hydroxyapatite–gelatin 
macroporous scaffold (CHAMPS). CHAMPS has a high degree of interconnected pores of 
50-200 µm in size, compressive strength up to 5.6 MPa and larger strain failure up to 25%. 
L929 mouse fibroblast cell interaction supports the cytotoxicity and cell adherence behaviour 
with CHAMPS. Porous scaffold exhibits bioactivity in simulated body fluid (SBF) solution 
through preferable deposition of carbonated apatite layer around the pores. Biodegradation of 
scaffold in tris-HCl solution reveals a slow but systematic decrease in weight over incubation 
up to 7 days. Importantly, the excellent adsorption (upto 50 wt.%) and release (upto 60 wt.% 
of adsorbed protein) of BSA within 48 h has been uniquely attributed to the inherent porous 
microstructure of the CHAMPS. Protein adsorption behaviour for both of the particles and 
scaffolds follow the classical Langmuir isotherm. The extensive micro-computed tomography 
(micro-CT) analysis establishes cancellous bone-like highly interconnected and complex 
porous architecture of the protein loaded and original CHAMPS. Overall, the present study 
provides an assessment of the interaction of protein with HA nanoparticles and their 
cryotreated HA-gelatin scaffold in vitro to support as drug delivery media and tissue 
engineering, respectively.  
Keywords: Hydroxyapatite, Nanoparticle, Nanobiocomposite, Protein, Scaffold, Adsorption, 
Release. 
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Chapter 1 Introduction 
1.1 General introduction 
Now-a-days the artificial biomaterial use increases due to limited accessibility of autograft and 
significant disadvantage of allograft include the risk of induction of transmissible diseases in the 
recipient [1,2]. As a consequence, the interest shifts toward the use of synthetic implantable 
biomaterial for repair of bone defect, bone fracture repair, alveolar ridge augmentation, dental 
implant, ear implants, spine fusion that simulating the bone bonding properties and morphology of 
natural bone.  
Bone is a structure composed of hydroxyapatite (Ca10(PO4)6(OH)2) crystals deposited within 
an organic matrix collagen [3,4]. Commercial and clinical viable synthetic hydroxyapatite (HA) 
demonstrate as calcium phosphate based most potential biomaterial to be used as an efficient carrier 
for bone growth factors or drug delivery media [5]. The nano-biomaterial with an advantage of 
nanosized HA particles and compatibility with the inorganic bone crystal of the human body is 
extensively considering for tissue engineering. Nano size HA is an excellent bioactive site because 
of high surface to volume ratio, and reactivity than the same micron size material [6]. Thus, nano 
sized HA particles have arouse intensive interest and the same time high effort concentrate since the 
last decade to synthesis and understand their structure and properties. However, it is always difficult 
to synthesise HA nanoparticles with well defined size, morphology and crystallinity with respect to 
desire biological applications [7]. Moreover, nano HA has extensive market for the biocoating on 
the implants because of bioactive and biocompatible similarity with human hard tissue and 
biodegradable properties, which finally reduce the failure of the implants [8,9]. Hence, HA 
nanoscale particle and their biocomposite have direct or indirect influence as drug delivery media or 
scaffold. Nano HA ceramics has attractive ability to create direct bonding with host bone and their 
strong interface. The formation of the active interface is the result of sequence events involving 
interaction between biological fluid and cells as well as the formation of carbonated HA, which is 
similar to bone mineral [10]. Slow, localized and continuous release drug efficacy has also been 
recognized as a better choice for the treatment of many ailments. One of the potential candidate for 
such controlled drug delivery system is porous ceramic, and, therefore, much attention paid to 
fabricate biocompatible porous HA or their biocomposites [11]. For example, chronic disease or 
localized surgical intervention is relying on a continuous local drug delivery through ceramic 
capsule suitable to release drug at a controlled rate [12]. Bone drug delivery systems develop using 
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porous HA ceramic bonded with antibiotics through a biodegradable polymeric matrices. Hence, 
porous HA has extensive demand and applied for artificial bone substitutes [10,13].   
Porous HA implants have been served as bone substitute in the clinics since long [14]. 
However, lower mechanical strength of pure HA deteriorate adequate use as a bone implant 
material because of conflicting requirements of porosity and strength [4,15]. The primary purpose 
of tissue engineering need to repair, regeneration and reconstruction of lost, damaged or 
degenerative tissues by the combinations of cells, biomaterials and biologically active molecules by 
applying the principles of engineering and life science [16,17]. Most of the existing tissue 
engineering techniques based on the use of macro structured porous scaffolds, which act as 
supporting material for the initial cell attachment and subsequent tissue formation, both in vitro and 
in vivo [18,19]. Scaffolds for bone regeneration should meet certain criteria to serve this function, 
including mechanical properties similar to those of the bone repair site, biocompatibility and 
biodegradability at a rate commensurate with remodelling.  
HA and collagen are the main constituents of bone [20,21]. Collagen has a high cost and 
easily denatured during processing. However, gelatin is an irreversible hydrolysed form of collagen 
and has similar chemical composition, easy availability and low cost [22,23]. Thus, gelatin has a 
similar composition as natural collagen and consider mimicking the scaffolds [24,25]. In addition, 
gelatin has several clinical utility as temporary defect filler and wound dressing [26,27]. So, HA-
gelatin biocomposite scaffolds has significant attention for tissue engineering [28]. Moreover, as the 
cryogenic engineering attracts more attention owing to its extensive applications in superconducting 
fields, nuclear fusion and so on. There is an urgent need of researchers to study and enhance the 
mechanical properties of nanobiocomposites at cryogenic temperature due to their favourable 
plasticity, gelation properties of gelatin which could meet the demand of cryogenic engineering 
[29,30].    
Protein is the first living entity to interact with the surface of the biomaterial during contact in 
the host environment [31,32]. Thus, the surface of the material gets covered by a layer of proteins 
momentarily, after implantation in a competitive process. Protein layer adsorb first onto the foreign 
material surface to interact with the cell receptors towards cell membrane surface, since cells do not 
have any interaction capacity with bare biomaterial surface [33]. Hence, the presence of protein 
molecules is mandatory for a suitable attachment and proliferation of cells onto the surface of a 
given substrate [34,35]. Proteins are the key elements creating a bridge between the implant 
materials surface and cells. Furthermore, the adsorption behaviour of proteins is highly dependent 
on surface area, crystallinity, size and morphology of nanoscale biomaterials [36,37]. These 
parameters of the implant‟s surface will determine not only the amount of proteins adsorb but also 
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their type and confirmation [38,39]. Osteobleast cell and mesenchymal cell attachment and 
proliferation solely depend upon the concentration of the serum protein in culture media [40]. 
Serum albumin is important constituents for cell culture, and it supports the cell growth factor, 
attachment factor and provide nutrients to cell [41]. The adsorbed serum proteins consider 
promoting better adhesion of cells than other peptides. Therefore, the rate of adsorption and release 
of serum albumin affect the in vitro study of the composite biomaterials.  
In this backdrop, HA nanoparticle synthesis and fabrication of their nanobiocomposite porous 
scaffold with sufficient mechanical properties will encounter to develop a reliable and tailor made 
protein bearing media for biological application.  
1.2 Hydroxyapatite ceramics  
Hydroxyapatite is calcium phosphate based ceramics and known to be one of the most important 
implantable biomaterials due to its biocompatibility and osteoconductive properties [42,43]. Natural 
bone made of hydroxyapatite (~70 wt%), organic substances such as collagen, proteins and water. 
Bone skeleton has HA nanocrystals with an average size less than 50 nm and collagen through the 
formation of an interconnected net like open porous structure. Hydroxyapatite is one of the most 
biocompatible ceramic because of its significant chemical and physical resemblance to the mineral 
constituents of human bones and teeth [10]. It is a bioactive ceramic and widely use as powder or in 
particulate forms in various bone repairs, and as coatings for metallic prostheses to improve their 
biological properties [44]. HA is a thermodynamically stable calcium phosphate ceramic compound 
nearest to the pH, temperature and composition of the physiological fluid. Recently, HA has been 
used for a variety of biomedical applications, including matrices for drug release control [45]. 
Synthetic HA exhibits strong affinity to host hard tissues because of the chemical similarity 
between HA and mineralized bone of human tissue. Formation of the chemical bond with the host 
tissue offers a greater advantage in clinical applications over most other bone substitutes, such as 
allograft or metallic implants [46]. However, despite chemical similarities, mechanical performance 
of synthetic HA is very poor compared to bone. In addition, the bone mineral present a higher 
bioactivity compared to synthetic HA [47].  
Many researchers have observed that the mechanical strength and fracture toughness of HA 
ceramic can be improved by the use of different sintering techniques or incorporation of the second 
phase which include, incorporation of sintering additives and use of nanoscale ceramic powders 
influenced by large surface area to volume ratio [48]. The preparation of HA bioceramic materials 
have been carried out using different approaches like sol–gel, hydrothermal processing, microwave 
route, wet chemical route, emulsion system and sonochemical synthesis. Most of the researcher 
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follows the wet chemical route due to the ease of handling, environment friendly and simple to 
optimise the process parameters.  
1.3 Porous hydroxyapatite scaffold  
Bone is a complex structure with micro, macro and the interconnected pores useful to allow body 
fluid to carry nutrients and provide a medium where interfacial reactions between hard tissue and 
soft tissue can occur. Two types of bone structures have been described: cancellous and cortical 
structures. Cancellous bone differs from cortical bone consist of sponge-like highly open 
macroporous structure and high surface area. Currently, natural materials have been selected as 
bone substitute for bone grafting surgery. These include auto- or allograft, bovine and coral blocks 
but their source is limited. Therefore, the fabrication of the grafting material for bone tissue 
application takes more attraction. Porous HA has been applied for cell loading, drug releasing 
media, chromatography analysis and most extensively for hard tissue scaffolds [49]. Various cell 
products have therapeutically significance including hormones, enzymes, vaccines and nucleic acids 
which improves the diagnosis and treatment of human diseases. Mammalian cells can be grown and 
maintained in vitro, but anchorage-dependent which means, it needs solid substrate for growth 
[50,51]. Since, porous HA is more resorbable and osteoconductive than dense HA, there is an 
increasing interest in the development of synthetic porous HA bone replacement materials for the 
filling of both load-bearing and non-load-bearing osseous defects [52]. 
Scaffolds are the three dimensional templates that serve as supporting material for repair, 
reconstruct of a musculoskeletal system. It guides the cell to grow and facilitate grow of new bones. 
Ideal scaffold has several criteria for bone regeneration, which include bioactivity (ability to bond 
to bone), osteogenic (stimulation of bone growth), biocompatible (induce minimal toxic or immune 
response), resorb safely and effectively in the body, similar mechanical properties to bone (such as 
load absorption), ability to shape to a wide range of defect geometries and meet all regulatory 
requirements for clinical application [53,54]. In terms of the osteogenic material, the material 
should be osteoinductive (capable of promoting the differentiation of cells), osteoconductive 
(support bone growth and encourage the ingrowth of surrounding bone) and osteointegrate 
(integrative to the surrounding bone) [55]. Furthermore, mechanical conditioning often has a direct 
effect on cellular behaviour such as differentiation, extracellular matrix production, migration and 
proliferation. Recently, the regeneration of tissues in biomedical application is taking place using 
synthetic implants and tissue grafts applying tissue engineering approach, where degradable porous 
material scaffolds integrated with protein molecules or living biological cells. Mass transports 
balance the tissue regeneration and their temporary mechanical response. Since, bone tissue is the 
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most commonly replaced organ of the body, the necessity to engineer the proper scaffold material is 
of a growing need. Synthetic bone graft substitute require to repair large bone defects associated 
with trauma, malignancy and congenital diseases [56]. In particular, the replacement of structural 
bone loss remains a challenging clinical problem. Millions of patients in the worldwide suffer each 
year from considerable bone loss resulting from trauma, osteoporosis, osteomyelitis, malignancy 
and congenital diseases and this number is expected to increase substantially with the doubling of 
the population over the age of 65 years [57]. 
1.4 Bovine serum albumin  
Albumin is a soluble monomeric protein, which comprises about half of serum proteins. It is a 
carrier material for steroids, fatty acids and thyroid hormones and stabilizes extracellular fluid 
volume. Bovine serum albumin (BSA) is a serum albumin protein produced from cows. It is used as 
a protein concentration standard. The full-length BSA precursor protein consists of 607 amino acids 
in length with a molecular weight of 66.5 kDa. BSA is the most abundant plasma protein 
accounting of 55-60% of the measured serum protein. The chain is characterized by having no 
carbohydrate moiety, scarcity of tryptophane and methionine residue such as lysine, arginine, 
glutamic acid and aspartic acid. The mature circulating molecule is arranged in a series of α-helices 
folded and held by 17 disulphide bridges. The folding creates sub-domains of three continuous α-
helices in parallel. It can be seen as cylindrical structures with polar outer walls and a hydrophobic 
central core. The tertiary structure of human albumin crystal has been isolated by X-ray 
crystallography. The molecule is very flexible and changes shape rapidly with variation in 
environmental conditions and binding of ligands. Denaturation occurs only with dramatic and non-
physiological changes in temperature, pH and the ionic or chemical environment. BSA has 
numerous biochemical applications including ELISAs (Enzyme-Linked Immuno sorbent Assay), 
immune blots and immune histochemistry [58]. It is also used as a nutrient in cell and microbial 
culture. BSA is used to stabilize some enzymes during digestion of DNA and need further 
stabilization [59]. BSA has a common use to quantify other proteins, by comparing an unknown 
quantity of protein to known amounts of BSA. BSA is considered as standard protein because of its 
stability, lack of effect in many biochemical reactions and low cost. Large quantities of BSA can be 
readily purified from bovine blood, a by-product of the cattle industry.  
BSA is usually used as a supplement to cell culture media [60]. It supports cell growth and 
product formation by providing a broad spectrum of macromolecules [61], attachment factors, 
nutrients, hormones and growth factors [62,63]. The most commonly used animal serum 
supplement is fetal bovine serum, FBS (or alternatively called FCS, fetal calf serum). However, a 
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well defined structure of serum such as BSA over FBS is used prior to cell culture. Bovine Serum 
Albumin (BSA) is cheaper than human serum albumin (HSA) and has potential use in clinical 
research.  
 High soluble albumin protein is present in human plasma at normal concentration between 
35 and 50 g/l [64]. Albumin has several important physiological and pharmacological functions, 
which transport metals, fatty acids, cholesterol, bile pigments and drugs. It is a key element in the 
regulation of osmotic pressure and distribution of fluid between different compartments [65]. In 
general, albumin represents the significant and predominant antioxidant in plasma, a body 
compartment is known to be exposed in constant oxidative stress. A large proportion of total serum 
antioxidant properties can be attributed to albumin. Research report has been revealed that more 
than 70% of the free radical-trapping activity of serum is due to HSA [66]. Usually, albumin 
concentrations remain very low in cerebrospinal, aqueous humor, synovial and lung 
bronchoalveolar lining fluids in comparison with plasma [67]. A beneficial effect albumin 
concentrations could be found in sites of inflammation, for the protein to exert its multiple 
antioxidant properties [68]. Physiological or pathological functions modifying the antioxidant 
properties of albumin are also reported. 
1.5 Biomaterials protein interaction  
Protein–biomaterials surface interaction has significance importance to develop a new class of 
biomaterials, specifically in the field of pharmaceuticals and tissue engineering. When a solid 
material (e.g., a catheter, stent, hip joint replacement or tissue engineering substrate) comes in 
contact with a fluid that contains soluble proteins (e.g., blood, interstitial fluid, cell culture media), 
which rapidly adsorb onto the surface of the material [6,69]. Similarly, living cells does not 
fascinate direct interaction with molecular structure of the material itself, but prefers to adsorb  
protein molecular layer as discussed earlier [32,70]. The type and amount of adsorb proteins refer 
the type and surface density of bioactive sites that may be available for cell interactions and 
orientation, confirmation and packing density of the adsorbed proteins. Accordingly, it is important 
to know that how surface chemistry and topology affect the formation of the adsorbed protein layer 
and the available bioactive sites by this layer to control the cellular response [71]. Recent advances 
in biotechnology demonstrate that peptides and proteins are the basis of a new generation of drugs 
[72]. A deficiency of protein in the body causes the diseases like thrombosis, colon cancer, breast 
cancer, diabetes and osteoporosis. Proteins are transported orally or through injection. High 
molecular weight, structural fragility and their hydrophilicity does not support to transport of 
proteins towards the targeted site [9]. Hence, the proper sustained and targeted delivery of 
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pharmaceutical offers several advantages in compare with classic administration through increment 
of drug amount towards the targeted area, improve the transportation mechanism, and protect the 
drug against inactivation, degradation and metabolization phenomena. In recent, HA nanoparticles 
has been elucidated to be an efficient carrier for bone growth factors or drug deliver [73]. High 
molecular weight proteins will tend to be more tightly adsorb on HA, but protein charge also plays a 
critical role [74]. Instead, the goal here is to provide an overview of the basic understanding of 
protein interaction with biomaterials, surface properties, adsorption kinetics and driving force for 
interactions.  
Cells are not adhering without the presence of intermediate protein layer within foreign host 
biomaterial, and cell molecules [75]. The protein properties like hydrophobicity and surface charge 
attribute the most effective contribution towards the adsorption of protein on biomaterials [76]. The 
described features are needed to encounter to understand the protein adsorption phenomena  
(Table 1.1).  
  
Table 1.1 Effect of protein properties on the adsorption phenomenon [76].  
Properties Effect  
Size Large molecules have more sites for surface contact 
Charge  Molecules near their isoelectric point adsorb more readily 
Hydrophobicity More hydrophobic molecules adsorb more readily on hydrophobic surface 
Stability Less stable proteins form more surface contact points 
Unfolding rate Molecules that rapidly unfold can form surface contacts more quickly 
   
Mutual protein interaction depends on both protein and biomaterial surface properties. The most 
effective surface properties of the biomaterial on the protein adsorption are represented in Table 1.2. 
Relative bulk concentration of each protein and intrinsic surface activity has two driving forces of 
protein adsorption. Along with two major contribution, van der Waals force of interaction and 
electrostatic force of attraction plays an important role in protein interaction [77]. Surface behaviour 
has a significant impact on protein adsorption phenomenon. It has been seen that neutral, 
hydrophilic material surface shows little adsorption, whereas hydrophobic surface has strong 
adsorption in an aqueous environment. A charged surface has variable adsorption depending on the 
electrostatic interaction of protein and surface [78]. The adsorption of biomaterials on different 
surface is represented in Figure1.1.   
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Table 1.2 Biomaterial surface that affect protein adsorption [76]. 
Feature  Effect  
Topography  Greater texture exposes more surface area for interaction with protein  
Composition  Chemical makeup of a surface will determine the type of intermolecular 
forces governing interaction with proteins  
Hydrophobicity  Hydrophobic surfaces tend to bind more proteins  
Heterogeneity  Non-uniformity of surface characteristic results in domains that can interact 
differently with proteins  
Potential  Surface potential will influence the distribution of ions in solution and 
interaction with proteins  
 
 
Figure1.1 Schematic for the adsorption of biomaterials on different biomaterial surfaces [79].   
 
In addition, the protein adsorption kinetics on the biomaterial surface study is also essential to 
develop new class of materials. Let us consider a reaction between protein (P) in solution and the 
biomaterial unoccupied surface site (A). Hence, the existing equilibrium between the protein 
occupied surface site (PA) and unoccupied surface site can be represented as: 
PAAP   
According to Langmuir, 
 
][1
]][[
][
PK
APK
PA T


 
 
Where, AT = Maximum amount of protein adsorbed (mg/g) 
 K = Affinity constant (ml/g)  
The adsorption isotherm of protein on the surface of biomaterial is represented in Figure 1.2.  
Figure 1.2 (A) reveals that very rapid initial phase of adsorption proteins has been arrived quickly to 
an empty surface [80]. Slower phase is approaching towards a steady-state value. Protein molecule 
covers the entire surface and difficult to identify of any empty spots (Figure 1.2 (B)). 
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Figure 1.2 Adsorption isotherm (A) and monolayer of protein adsorption (B).  
1.6 Protein delivery  
Protein delivery is the method or process of administering a protein compound to achieve a 
therapeutic effect in humans or animals [81]. This acute process is effective to modify drug release 
profile, absorption, distribution and elimination for the benefit to improve drug efficacy and safety, 
as well as patient convenience and compliance [82]. Most common routes of administration 
includes the preferred non-invasive peroral (through the mouth), topical (skin), transmucosal (nasal, 
buccal/sublingual, vaginal, ocular and rectal) and inhalation routes [83]. Many medications such as 
peptide and protein, antibody, vaccine and gene based drugs, in general may not be delivered using 
these routes because they might be susceptible to enzymatic degradation or cannot be absorbed into 
the systemic circulation efficiently due to molecular size. Thus, much protein and peptide drugs 
have to be delivered by injection or a nanoneedle array. For example, many immunizations are 
based on the delivery of protein drugs and are often done by injection. However, the current efforts 
concentrate on the development of targeted delivery media which can release the drug overtime in a 
controlled manner. In order to achieve efficient targeted delivery, the designed system must avoid 
the host's defence mechanism and circulate to its intended site of action [84]. Different drug release 
media formulation are available include liposomes, drug loaded biodegradable microspheres and 
drug polymer conjugates.   
1.7 Thesis structure  
On the basis of the above findings, the entire structure of the dissertation elaborates in different 
chapters. Introduction on the essential background about the existing field is discussed in Chapter 1. 
The literature reviews related to the HA nanoparticle synthesis, BSA adsorption and release on HA 
nanoparticle, fabrication of HA scaffold, cryogenic treatment of the scaffold, biocompatibility, 
cytotoxicity and protein adsorption/release phenomena on scaffold describes in Chapter 2. This 
chapter includes the aim and objectives of this investigation and also reviews recent reports by other 
investigators in different aspects. Preparation of different morphologies of HA scaffolds (spherical, 
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rod and fiber), low temperature treatment of scaffold (77K), protein adsorption/release, in vitro 
cytotoxicity and their relevant characterizations illustrates in Chapter 3. Results and discussion part 
of the dissertation is represented in Chapter 4. This section has seven subsections, which illustrate 
as follows. Preparation of different morphologies of HA nanoparticles with respect to three 
important parameters such as temperature, pH and Ca:P ratio has been discussed and optimized 
their preparation conditions. The process of homogeneous and stable dispersion of the HA 
nanoparticles in aqueous media has illustrated through complexomatric reaction. BSA protein 
interaction phenomenon, and their adsorption and release kinetics on the synthesized nanoparticles 
are also discussed. Porous HA-gelatin scaffold has fabricated through freeze casting technique and 
attempted to enhance mechanical properties of optimized scaffold at liquid nitrogen temperature. 
Bioactivity and biodegradation of cryotreated HA-gelatin macroporous scaffold (CHAMPS) has 
investigated in vitro. The cytotoxicity and L929 mouse fibroblast cell adherence of CHAMPS 
demonstrates in chronologic sense. BSA protein adsorption and release is also studied on 
CHAMPS. Protein concentration determination and characteristic bonding behaviour of amides of 
scaffolds are also reported systematically. Micro-CT analysis illustrates the fractal dimension, 
degree of anisotropy and pore interconnectivity before and after protein adsorbed CHAMPS.  In the 
beginning of Chapter 5, all the results are summarized of the present research finding along with the 
possible direction for future works. A complete list of references has provided at the end of the 
dissertation.  
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Chapter 2 Literature Review 
2.1 Hydroxyapatite  
Synthetic hydroxyapatite (HA) is one of the most foreign implantable materials among other 
calcium phosphate based ceramics because of similar biocompatibility and bioactivity properties 
with bone. HA has a high degree of in vivo stability in compare with other calcium phosphates. 
Elliott et al. [85] reported that bone and teeth mineral are an inorganic composite of HA in which 
Ca/P molar ratio varies from 1.6 to 1.7 along with a few percent of carbonate and water. The 
mineral is preferable crystalline with hexagonal crystal structure for adult bone and semicrystalline 
for fetus [86]. Typically, the crystals appear as 400 Å long and 150 Å wide in bone, whereas 400 Å 
wide and 1000 Å long in dental enamel [87]. The basic crystal structure of apatite is reported by 
Naray-Szabo [88] and  Mehmel [89] in 1930 and represented in Figure 2.1. HA possesses a 
hexagonal structure with a P63/m space group and cell dimensions a = b = 9.42 Å, and c=6.88 Å, 
where P63/m as space group has six-fold symmetry axis and three-fold helix structure [90]. It has an 
exact stoichiometric Ca/P ratio of 1.67 and chemically very similar to the mineralized human bone 
[91].  
 
 
Figure 2.1 Crystal structure of hydroxyapatite [92].  
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Day –to –day clinical demand insists on preparing synthetic HA by a number of methods in 
preference solid state, sol-gel, microwave irradiation, wet-chemical precipitation, hydrothermal 
technique etc [93,94]. Researchers, academician, clinician and manufacturer are trying to find out 
the best choice of HA material with respect to purity, morphology, size, crystallinity and Ca/P ratio. 
Generally, solid state technique is relatively needed less effort, but difficult to control the pure HA 
phase and particle size similar to original HA crystal for bone and dental applications. On the other 
hand, low temperature chemical techniques are preferably suitable to produce different morphology 
of HA through control over the processing parameters such as precursor concentration, temperature, 
pH, structure directing agent and Ca:P ratio. Therefore, it is important to understand and need 
elaborate discussion on the different processing methods and parameters to achieve desire 
morphology with purity and crystallinity of HA phase.  
2.2 Preparation techniques of HA nanoparticles   
Extensive literature data suggests the availability of versatile HA particle processing techniques to 
achieve different morphologies followed by either low or high temperature process. Most relevant 
synthesis process and their details analysis related with the project objective are discussed as 
follows.   
 
Feng et al. [95] synthesized spherical HA nanoparticles through sol-gel method with starting of 
P2O5 and Ca(NO3)2.4H2O as precursor material. It has been seen that the degree of crystallinity and 
morphology of synthesized HA nanoparticles are depended on the calcination temperature and 
aging time. The obtained HA particles exhibit low temperature stability and gradually destabilized 
beyond 800 
o
C through decomposition of β-tricalcium phosphate (β-TCP). The crystal size of the 
HA nanoparticle increases along with aging time. Near spherical morphology 10-15 nm dimension 
is found after calcination at 700 
o
C for 4 h.  
 
Qui et al. [96] prepared spherical nano-HA by biomimetic method using Ca(NO3)2.4H2O, 
(NH4)3PO4.3H2O precursors and 2-6 wt.% polyethylene glycol (PEG) as morphology and 
crystallinity manipulator, respectively. Effect of PEG concentration on the HA morphologies is also 
reported in this research work. Synthesized HA powder is more crystalline in presence of PEG 
higher than without content of any PEG. High concentration PEG favours formation of spherical 
and isotropic growth of crystalline HA. The prepared HA nanoparticle persists spherical 
morphology in the size range of 30–50 nm. 
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Zhang et al. [97] prepared spherical and crystalline nano HA through wet chemical precipitation at 
low temperature from inorganic precursors Ca(NO3)2 4H2O and (NH4)2HPO4. It has been observed 
that the reaction temperature influences the phase formation, crystallinity, grain size and 
morphologies of HA. Rapid mixing mode develops spherical HA nanoparticle at 40 
o
C with an 
average diameter of 20–50 nm.  
 
Mejoo et al. [98] employed microwave heating module to achieve pure and thermally stable 
nanocrystalline HA phase. The received ceramic powder possesses needle-shaped nanocrystals with 
dimension about 50 nm diameter and 200 nm in length. Phase stability and microstructure evolution 
are discussed in terms of the formation of secondary phase at 700 
o
C.   
 
Wang et al. [99] synthesized and controlled the HA nanorod size through chemical precipitation of  
Ca(NO3)2 4H2O and H3PO4 precursors in the presence of organic modifier dodecyl sulphate and 
sodium dodecylbenzene sulphonate at low synthetic temperature range from 100 to 200 
o
C. The 
crystallinity of the prepared HA increases with increasing autoclave temperature, whereas HA 
nanorod size influences by different structure organic modifiers and synthesis temperature. 
Interaction between anions of the modifiers and HA nuclei controls the ultimate growth pattern. 
Strong adhesion prefers to form small-sized HA nanorods. HA nanorod size 12 nm diameter and 
aspect ratio ~2 results at lower autoclave temperature (100 
o
C), but HA nanorod 18 nm diameter 
and aspect ratio ~ 2.73 forms at relatively higher temperature (200 
o
C) in the presence of sodium 
dodecyl sulphate and sodium dodecylbenzene sulphonate.  
 
Liu et al. [100]  synthesized HA nanorods through wet chemical method at low temperature and 
suitable surfactant. Common precursors CaCl2, NH4NO3 and Na3PO4 with addition to PEG-400 and 
cetyl trimethyl ammonium bromide (CTAB) as surfactant are used for this study. Synthesized 
nanorods have a diameter of 50–80 nm and length of 0.5-1.2 µm under condition of solution pH-4.5 
and temperature 85 
o
C. PEG-400 and CTAB surfactant directs the formation of classic needle like 
structure of HA. 
 
Suzuki et al. [101] prepared needle like HA through wet chemical method using (CH3COO)2Ca and 
K2HPO4 with adjustment of stoichiometric ratio of Ca:P ~ 1.67 at 100 
o
C. The study investigates 
that HA is grown to long needle-like shape with Ca-deficient HA in the weak acidic regions. The 
developed needle-like HA has near to ~18.6 (mean length: 5.8 µm) aspect ratio, Ca:P ~ 1.59 and  
92 wt.% yield. This needle-like HA particle has Ca:P ratio of 1.59, which is less than the 
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stoichiometric ratio of 1.67. Aspect ratio below 3.6 or less does not favour formation of 
stoichiometric HA.  
 
Feruichi et al. [102] prepared fibrous morphologies of nano HA through wet chemical process using 
the starting materials Ca(NO3)24H2O, NH4H2PO4 and organic additive gelatin at a temperature of 
95
o
C and solution pH ~ 10. Nanotextured and nanofibrous HA are produced through topotactic 
transition of dicalcium phosphate dihydrate (DCPD) containing gelatin molecules. Resultant 
nanoscale effects due to the formation of dicalcium phosphate (DCP) through dehydration of 
DCPD. High hydrolysis rate of DCP favours formation of 20 nm spherical nanoparticles whereas 
moderate hydrolysis by ammonia produces elongated nanorods with diameter of 50 nm. 
Hierarchical nanostructured HA results of organic molecule assisted phase transformation with the 
existence of high surface area (100 m
2
/g). 
   
Zhang et al. [103] prepared HA multiform morphologies like nanowire, nanorods, microspheres, 
microflowers and microsheets through hydrothermal process using water as reaction medium. 
Ca(NO3)24H2O and (NH4)2HPO4 are considered as common precursor in addition of structure 
directing agent hexadecyl trimethyl ammonium bromide and organic additive trisodium citrate. 
Hydrothermal process at the temperature of 180 
o
C has been studied to understand the effect of 
solution pH in the range of 4–9 and organic additive (trisodium citrate) on different morphologies 
of HA. Different hydrothermal treatments in absence of trisodium citrate at 180 °C (pH–7.0) 
influence the formation of one dimensional nanostructure HA. However, average diameter 25 nm 
and 50–70 nm in length nanoparticle obtain at solution pH–9, whereas low solution pH~ 7 forms 
longer with average length~120 nm and diameter of about 25 nm. Bur-like 7–9 μm HA microsphere 
develops in the range of solution pH–5 and 10 micron flower-like architecture in pH–4.  
 
Li et al. [104] demonstrated the effect of surfactant citric acid on resultant size of the HA 
nanoparticles when coprecipitated CaCl2 and Na3PO4 precursors in the solution pH range of 9 – 11 
and aging 24h. Rod like morphology 10-20 nm width and 50–70 nm length HA develops in the 
presence of surfactant citric acid, but it become 1µm diameter and 100 µm length HA nanoparticles 
in absence of citric acid. However, in the oil-in-water emulsion method favours HA ellipse-like 
nano-HA particles of 20–40 nm width and 50–60 nm in length.  
  
Zhang et al. [105] reported the formation mechanism of nano and micro scale fluorinated HA 
(FHA) prickly spheres, whisk brooms, flowers, dandelions, nanofibers and nanoribbons through 
Chapter 2 – Literature Review 
15 
 
adjusting reaction conditions and content of glutamic acid. The precursors Ca(NO3)2 4H2O, 
K2HPO4, NaF and glutamic acid are used for the preparation of different morphologies of FHA at 
60 
o
C. FHA crystals are found in a non-equilibrium growth process. The processes are influenced 
by the interaction with glutamate ions and precipitates surfaces related to the formation of FHA. 
Processing parameter and glutamic acid concentration have a significant contribution to develop 
spheroidal nanoparticles to anisotropic growth of fibers and flower like aggregates. Low 
concentration glutamic acid favours 80 nm spheroidal, whereas intermediate and large quantity 
transforms to 80 nm fibers and 2 µm flower like morphology, respectively.   
 
Neira et al. [106] prepared different morphology of HA through urea-assisted hydrothermal reaction 
between Ca(NO3)2 4H2O and (NH4)2HPO4 at low temperature of 90 °C. Particle morphology of the 
prepared HA crystals has been controlled by varying the decomposition kinetics of urea and 
concentration of the precursor components in the course of hydrothermal process. Hexagonal prism 
and needle like morphologies of HA particles preferentially grows along the c-axis of HA crystal. 
The hydrothermally prepared HA powder contains CO3
2-
 ions in the crystal lattice and exhibits AB-
type carbonated HA. AB-type carbonated HA is formed through partial substitution of CO3
2- 
on 
OH
–
 and PO4
3-
 of apatite crystals.   
 
Brown et al. [107] illustrated on the effect of synthesis temperature on morphology of HA. The 
study investigates the impact of temperature on the kinetics of calcium-deficient HA (CDHA) by an 
acid-base reaction. The kinetics of HA formation are initially controlled by surface area of reactant, 
and their rate of reaction is found as diffusion controlled. Diffusion control mechanism experiences 
the epitaxial formation of HA on the surface of dicalcium phosphate reactant. The study reveals that 
seeding with HA initiate and accelerates the response, but it has not long-term effect on the 
fractional degree of reaction or microstructural development.  
 
Thorough literature survey depicts; no trial has been conducted to prepare different aspect 
ratio of spherical, rod and fibrous morphology through co-precipitation route from identical 
precursors control over their concentration, solution pH and temperature. This selective nano HA 
morphologies will be utilized for fabrication of nanobiocomposite scaffold and protein adsorption – 
release study. Hence, this challenging task has been considered as one of the objectives in this 
research work.   
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2.3 Dispersion of hydroxyapatite   
Nano scale HA is a classic bioactive and biocompatible material, which on rationale simulate both 
of the bone and dental mineral compartments. Nanoparticles are needed to disperse to investigate  
in vitro cell interaction and in vivo circulation/ reciprocation phenomena. Preparation of well-
dispersed HA nanoparticles are required not only for protein delivery but also facilitating as the 
drug carrier. Therefore, brief literature reports are discussed as future work reference.  
 
Tan et al. [108] prepared nano HA rods using Ca(NO3)2 4H2O and (NH4)3PO4 as precursor material 
and followed by aqueous dispersion through sodium citrate and sodium hexametaphosphate. 
Primarily, the dispersion of HA nanoparticles is an attribute to the ion exchange reaction between 
sodium citrate and sodium hexametaphosphate which improves the colloid stability of HA and their 
complexometric reaction with citrate ions. Sodium hexametaphosphate addition to the dispersed HA 
increases the stability of a dispersion as well as increases the zeta potential value from –30 mV to  
– 44 mV.  
 
Han et al. [109] prepared stable nano HA suspension through ultrasound assisted precipitation 
technique in presence of glycosaminoglycans (GAGs). HA nanoparticles suspension has been 
prepared by using the precursor materials Ca(H2PO4)2 and Ca(OH)2 in a solution state. Suspension 
is primly composed of both 20–50 nm short rod-like and 10–30 nm spherical HA nanoparticles. The 
average particle size of a stable suspension predicts as 30 nm at the zeta potential (ζ) of –60.9 mV. 
Stability of HA nanoparticles suspension mainly depends on the electrostatic and steric effect of 
GAGs. It is also discussed that prepared HA nanoparticles suspension has easy mode of transport 
into the cancer cells and exhibit good potential as gene or drug carrier system.  
 
Borum-Nicholas et al. [110] studied the colloidal stability of nanophase hydroxyapatite both in 
water as well as ethyl alcohol at 115 
o
C. An increase in colloid stability has been observed for HA 
just by altering the solvent from water to ethyl alcohol. The study demonstrate that the 
sedimentation time for HA is 3 h in water and 7 days in ethyl alcohol. The origin of the enhanced 
stability of HA in ethyl alcohol is because of electrostatic effect that is influenced by Lewis acid–
base interaction. Ethyl alcohol readily accepts more electrons from the HA surface than water 
resulting in enhanced colloid stability. The colloidal stability of HA in water is dictated by Lewis 
acid–base interactions (electron donor–electron acceptor interactions), in addition to the traditional 
electric, double layer repulsion and van der Waals interactions.  
  
Chapter 2 – Literature Review 
17 
 
Li et al. [111] prepared hydrocolloids of HA using aqueous ammonium phosphate and calcium 
nitrate in the presence of citrate ions. A hydrocolloid of HA formation mechanism is proposed 
based on the interaction of citrate ions with the calcium ions on HA surface. During the low-
temperature (30 
o
C) reaction stage, the HA primary particles are like to link together by 
carboxylate–calcium bridges, which results relatively large aggregates. These aggregates have 
broken into small colloidal particles at the higher temperatures (90 
o
C) of aging stage due to the 
disassociation of the carboxylate–calcium links imparting negative charges to the HA, forming 
stabilized colloidal particles by surface charge. Citrate ions and temperature are the two key factors 
for stability of the HA colloids.   
 
Sadat-shojai et al. [112] studied the colloidal stability of synthesized hydroxyapatite nanorods in the 
dental adhesive solution. Homogenous dispersion is obtained through preparation of 0.2 wt.% HA 
nanorods incorporated into the adhesive solution and homogenized by ultra-sonication using a 
probe sonicator apparatus. The prepared HA nanorod colloid exhibits a low tendency to 
agglomerate and stabilized for 60h, which might be result for the surface charge of the nanorods.  
 
In this context, the dispersion study of proposed particles will be carried out to fulfil our 
objective.   
2.4 BSA adsorption and release on HA nanoparticles 
This study is essential to understand the importance of such study and future development as 
delivery media of HA nanoparticles. Brief classic examples with relevant data are described as 
reported by a different group of researchers.  
 
Kandori et al.[78] studied the adsorption of BSA on HA particle of 50 nm size with respect to Ca/P 
molar ratio variation from 1.55 to 1.70. Prior to such study, the HA surface has been modified by 
silicate and fluoride ions at pH ~6.0 and 288 K. Adsorption isotherm of BSA on HA particle 
follows Langmuir type and adsorption of BSA develops a negative charge on HA. However, 
unmodified HA particles exhibit high Ca/P molar ratio, which results larger electrically positive 
zeta potential because of their electrostatic attractive force and turns to high saturation BSA 
adsorption. Surface modification by silicate ion increase surface acidity and made surface more 
electrically negative to yield lesser amount of adsorbed BSA. Fluoride ions assisted surface 
modification and increases two-fold adsorption of BSA over that on the unmodified surface. 
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Calcium fluoride facilitates to adsorb high amount of BSA on the HA surface. Hydrophobic silica 
surface adsorbs higher amount of BSA than a hydrophilic surface.  
 
Macritochie et al. [113] studied adsorption isotherm of BSA on the solid-water interface. 
Hydrophilic surface has weak adsorption efficiency and high electrical factors sensitivity. Large 
adsorption energy is required for the adsorption at hydrophobic surface end as compared to 
hydrophilic silica surface. However, air-water interface adsorption isotherm for both of the two 
surfaces is similar in nature. The role of interfacial coagulation and slow desorption has been 
discussed in relation to the reversibility of adsorption. Colloidal silica both in its natural state and 
with methylated surface groups is used in order to compare the effects of hydrophilic and 
hydrophobic surfaces. The protein adsorption at solid-liquid interface follows monomolecular 
behaviour.  
 
Boonsongrit et al. [114] studied the desorption behaviour of protein BSA on commercial HA 
microspheres and their control delivery phenomenon. Desorption behaviour is carried out in 
phosphate buffer solution (PBS). The result shows that desorbed BSA concentration increases with 
an increase in the amount of phosphate. BSA protein desorption phenomenon is related to PBS 
concentration and time, for e.g. a rapid and larger amount (70%) BSA protein desorption is obtained  
after 30 min in 10 mM phosphate buffer solution, whereas a low release profile is recorded in 
deionized water (DI) only. The release rate of BSA-loaded HA microspheres is controlled in 
physiological condition, through encapsulate with a biodegradable polymer, poly (lactic acid-co-
glycolic acid) (PLGA).  
 
Shirkhanzadeh et al. [115] studied on the adsorption and release of L-lysine on HA. Controlled 
release of osteoinductive proteins from HA has been discussed in this work. An investigation on the 
nature of interfacial interaction between L-lysine and HA is reported in point of the formation of 
hydrogen bonding between C=O groups of L-lysine and polar –OH groups of HA. This incident 
phenomenon has significance influence on the chemical intermolecular attractions. The rate of 
release of biomolecules from HA in simulated physiological solution depends on the number of 
polar groups and molecular weight of these compounds. Proteins of high molecular weight 
particularly, phosphoproteins are strongly adhered by HA coatings, which is because of multi 
attachment of their polar groups to HA crystals.  
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Wu et al. [116] studied the BSA protein adsorption and release on semi-crystalline mesoporous 
nano-hydroxyapatite. The BSA loading increases with the specific surface area and the pore volume 
of nano HA. The release rates of BSA are different due to their different pore sizes and pore 
structures. The synthesized nano HA demonstrates the capacity of 20 mg of BSA adsorption and 
75% release in 24h. Nano HA sample reveals an initial burst release of about 40% BSA within 2h 
and following 75% in 24h. The adsorbed amount of BSA protein on nano HA has a high correlation 
with the specific surface area and pore volume of nano HA.  
 
Iafisco et al. [117] studied on the interaction mechanism of BSA with biomimetic carbonated HA 
nanocrystals. Smaller size (20 nm) and the lower crystallinity degree with the high surface area  
(120 m
2
/g) of carbonated nanocrystals facilitate to adsorb 25 mg of BSA in 12h. Protein adsorption 
follows the Langmuir adsorption isotherm pattern. The reaction mechanism between protein BSA 
and carbonated HA crystals surface is due to hydrophobic and electrostatic interactions.   
 
Literature data suggests the HA-BSA adsorption and release study have significance 
importance in view of the development of a delivery media, which will be considered another 
important aspect for current research topic. This study will also assist to identify a particular HA 
nanoparticle morphology with respect to BSA protein adsorption/release efficiency.   
2.5 Fabrication of porous HA scaffolds 
Since the last decade, different group of researchers are concentrated to fabricate different class of 
HA porous bioceramics by adopting different processes and their utility for tissue engineering. 
Herein, several pioneer works are discussed to understand the basic physical properties of pure HA 
porous scaffold characteristics prior to fabricate nanoHA-biocomposite scaffold. 
 
Hou et al. [118] fabricated porous scaffold for tissue engineering application through coagulation, 
compression moulding and particulate leaching technique. High molecular weight polymer–salt 
composite is processed at 115 
o
C. Porosities of scaffolds are varied between 70 % and 95 vol.% by 
adjusting the polymer to salt ratio, whereas the size of leachable particles control the pore size of 
scaffold. The resulted scaffold exhibit homogeneous pore morphology with pore diameter ~ 300 µm 
along with compressive modulus ~ 1.5 MPa.   
 
Li et al. [119] prepared porous HA scaffold by approaching a dual phase mixing technique. 
Combination of HA and polymehtylmethacrylate (PMMA) slurry technique has been adapted to 
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fabricate the scaffold. Naphthalene particles are used to enhance the porosity (> 50%) of such 
scaffold. Majority of pores are located within the range of 200–300 µm with 50% porosity, and 
average compressive strength ~ 8.9 MPa. Ultimate pore volume, porosity, pore size and 
interconnectivity of the scaffold are adjusted through controlling over the process parameters such 
as viscosity of HA slurry and HA/PMMA mixing time.  
 
Potoczek et al. [120] prepared HA foams through gel casting via agarose as gelling agent and 
control over rheological behaviour of suspensions. The viscosity of slurries has been adjusted by 
agarose concentration and HA solid loading. The study demonstrate that a pore size of HA foams 
depend on the slurry concentration. HA solid loading (24–29 vol.%) and agarose concentration 
(1.1–1.5 wt.% with regard to water) in the starting slurry controls the mean pore size in the range of 
130 to 380 μm. Porosity of HA foam has found to be in the range 73–92 % and the compressive 
strength ~ 0.8–5.9 MPa.  
 
Tadic et al. [121] prepared carbonated porous HA by mixing polyvinyl alcohol fibres (PVA) and 
sodium chloride as porogens. The mixture is compacted by cold isostatic pressing (CIP) followed 
by dissolution of porogens and develop interconnecting porosity with pore diameter in the range of 
250–400 µm. The invented method is applicable to prepare macroscopic porous scaffold through 
any kind of water-insoluble ceramic materials compacted without sintering.  
 
Ramay et al. [122] prepared calcium phosphate biphasic porous scaffold for tissue engineering 
application. Biodegradable nanocomposite porous scaffold comprises of β-tricalcium phosphate  
(β-TCP) matrix and HA nanofibers. Composite scaffolds are fabricated by combined gel casting 
and polymer sponge techniques, where nanofiber has a dramatic effect to improve the mechanical 
properties. Porous scaffold exhibits a compressive strength of 9 MPa with porosity 73 %. 
Toughness of the scaffold increases from 1.0 × 10
-3
 to 1.7 × 10
-3
 MPa.m
1/2 
when concentration of 
HA nanofiber increases from 0 to 5 wt. %.   
 
Kwon et al. [123] developed a large range of porous bioceramics using polyurethane sponge replica 
technique. The volume porosity has controlled by the number of coating on the sponge struts. 
Complete interconnected pores are observed after single coating of HA with porosity content of  
~ 90%. However, the porosity of a sintered specimen is drastically reduced to 65 vol.% after 5 times 
coating of the scaffold and subsequent sintering at 1250 
o
C. Compressive strength primly depends 
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on the porosity volume. Maximum strength ~3 MPa could be achieved for 65 vol.% porous 
scaffold. 
 
In a recent article preparation of macroporous scaffold using polymeric sponge technique has been 
discussed [124]. Interconnected macroporous microstructure is obtained starting with near spherical 
HA powder and PVA used as binder and subsequent sintering at 1250 
o
C. The prepared scaffold 
appears a significant fraction of pore diameter in the range ~50–125 μm and 60 vol.% porosity. The 
pore content, pore morphology, pore interconnectivity of scaffold and their compressive strength 
depend on the solid loading and binder content. Low compressive strength ~1.8 MPa is observed 
after sintering at 1250 
o
C. Scaffold pore morphology, pore distribution, pore interconnectivity and 
compressive strength consider the prime factors to optimum the solid loading in around 40 wt.%.   
  
Koc et al. [125] studied the fabrication and characterization of porous tricalcium phosphate (TCP) 
scaffold using a modified slip casting technique. The prepared slip exhibit stability when TCP 
powder and PMMA beads are suspended in an aqueous medium and stabilized with an acrylic 
deflocculant. Porous TCP ceramics is produced by sintering the polymer-free preform for 2 h at 
1000 
o
C. It is observed that prepared slurry has 70 wt.% polymer beads in the size range 210–250 
µm with porosity of 65 vol.%. The average pore size in the sintered ceramic is around 190 µm. Pore 
size in the slip casted porous TCP scaffold has a restriction because of polymeric bead size. Porous 
scaffold wall thickness and degree of porosity depends on the content of polymer beads. As the 
amount of polymer beads increased, the dimension of interconnect passage increases 
proportionately.   
 
Lin et al. [126] prepared macroporous calcium silicate ceramics by using PEG as pore former. 
Sintered porosity varies in the range of 40-75 vol.% influenced by ceramic solid loading, volume of 
PEG particles and sintering temperature 900 to 1200 
o
C. The work is preciously focused on the 
effect of molecular weight of PEG, which assists to achieve desire morphology, pore structure and 
pore size of the macroporous calcium silicate. The PEG particle size directs the macropore 
formation mechanism.  
 
Ebaretonbofa et al. [127] prepared high porous HA scaffold through low silica polyurethane as the 
organic vehicle and coarsening agent n-heptane. High temperature 1225 
o
C fabrication process 
develops 90 vol.% porosity and ~100 μm pore diameter. However, the sintered scaffold retain the 
HA phase but compressive strength exhibits a dramatic lower value ~ 0.2 MPa.  
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Huang et al. [128] prepared porous HA scaffold by a combination of H2O2 foam with polyurethane 
sponge and modified with PLGA for achieving high mechanical properties to mimic bone tissue 
engineering scaffold. Micropores are seen in the HA scaffold due to infiltration of PLGA. HA 
scaffold exhibits the porosity in the range of around 61-65% and micro pore size of 200–600 µm. It 
has been seen that use of PLGA infiltration improves compressive strength of the scaffold from  
1.5-1.8 MPa to 4.0-5.8 MPa. PLGA has vital role for the development of micropores and obvious 
their compressive strength.  
 
Deville et al. [129] developed porous HA scaffold through another different freeze casting method 
for bone tissue engineering. Both porosity and pore size are manipulated by altering the freezing 
rate of slurries and slurry concentration. Freeze casted porous scaffold exhibits 56 vol.% porosity 
and gradation of pore in the range ~50–500 µm. The developed open pore has unidirectional 
lamellar morphology. Pore formation mechanism in the freeze casted body follows by the basic 
principle of physics of ice formation. Lamellar pore architecture and pore shape anisotropy are 
associated for the enhancement of compressive strength of scaffolds. The phase change of liquid 
vehicle during freeze drying is shown in Figure 2.2 (A). Details freeze casting principle has been 
described in next section 2.6. Different zone of porosities that developed in the direction of ice 
crystal formed is represented in Figure 2.2 (B).   
 
 
Figure 2.2 Phase change of the liquid vehicle (A)  and ice growth direction during freeze  
casting (B)[129]. 
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Fu et al. [130] prepared porous HA scaffold through freeze casting technique followed by sintering 
process. The study demonstrates the effect of sintering conditions on the microstructure and the 
mechanical behaviour of freeze-cast HA. The freeze casted scaffold dramatically enhances 50% 
compressive strength when porosity reduced to < 5% at prerequisite temperature. The scaffold with 
a porosity of 52 vol.% has compressive strengths of 12 MPa and 5 MPa in the directions parallel 
and perpendicular to the freezing direction, respectively. Compressive strength of freeze-casted HA 
scaffold strictly depends on the sintering temperature. Mechanical response reveals high strain 
tolerance at the yield stress (5–10 %) and the strain at the failure high (> 20 %) as represented in 
Figure 2.3. Microstructure and mechanical properties of the fabricated scaffold alters by adding 
glycerol and 1,4- dioxane to an aqueous suspension. Optimum strength could be observed after 
sintering for 3h at 1350 
o
C. The fabricated scaffold exhibits porosity of around 52% and pore size 
5–30 µm. The scaffold prepared from aqueous suspensions with 20 wt.% glycerol has higher 
strength, but lower porosity with finer pores. Whereas, HA scaffold prepared from aqueous 
suspensions (10 wt.% particles) with 60 wt.% dioxane has compressive strength of 7.5 MPa, strain 
to failure of 60 % and favourable microstructure with porosity ~ 65 % and pore size~ 100 µm.   
 
 
Figure 2.3 Stress-strain behaviour in compression testing parallel and perpendicular to the freezing 
direction of freeze casted scaffold [130].  
 
Several porous scaffold fabrication techniques such as immediate combination of HA and 
organics, dissolving porogens, gel casting, salt leaching, high temperature replica method, freeze 
casting, combine freeze casting/sintering has been adopted to improve and achieve different pore 
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structure and compressive strength. However, direct macroporous hydroxyapatite-gelatin 
nanobiocomposite scaffold fabrication from suggested HA nanoparticles is limited.     
2.6 Freeze casted porous nanobiocomposite scaffolds 
The freeze-casting of porous materials in particular has received a great attention during the past 
few years, because of simplicity; fabrication of tailor made shapes and desirable properties. In 
freeze casting, a material suspension is simply frozen at solvent triple point, and their sublimation 
provides a unique porous architecture. The triple point of a substance is the temperature and 
pressure at which the three phases (gas, liquid, and solid) of that substance coexist in equilibrium. 
The porosity produced is almost a direct replica of the frozen solvent crystals. Proper control of the 
freezing condition yields elongated and continuous porosity along the solidification management, 
which form indigenous morphology from other methods.  
Importance of freeze drying  
Freeze casting method has excellent and attractive features to make different class of implantable 
materials for biomedical applications because of:   
a) All class of materials, such as polymers, ceramics, metals and their composites can be 
shaped without alteration of morphology, chemical composition and in-situ reaction within 
organic matrix.  
b) Freeze casting permits to manufacture tailor made complex, hybrid materials through 
excellent control of structural and mechanical properties.  
c) The processing can be carried out with biocompatible liquid carriers such as water; the 
hierarchical microstructure can be carefully controlled by the physical and chemical 
properties of the components used and processing parameters such as freezing temperature,  
rate of freezing etc.  
d) Porosity gradient obtained at different zone.   
This characteristic attracts more towards the fabrication of ceramic – polymer scaffold through 
freeze casting process although it is limited to laboratory only. Few interesting literature results are 
incorporated as references.   
 
Kang et al. [24] fabricated porous HA-gelatin scaffold through freeze drying method to understand 
the effect of freezing temperature on scaffold microstructure. Hydrogels are prepared in aqueous 
solution through glutaraldehyde crosslinker of gelatin. Water and their ice crystal acts as a porogen 
to develop porous structure. Freeze-drying favours to form ice within a hydrogel and develop 
porous network structure through sublimation. Different porous microstructure is achieved by 
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varying the freezing temperature from –20 oC to –80 oC. Porous scaffold prepared at –20 oC results 
an interconnected porous structure. Porosity and pore size of dried hydrogels are controlled by the 
size of ice crystals formed during freezing. Different microstructures of the gelatin scaffold are 
obtained by changing freezing rate. The scaffold has average pore diameter ~250 µm with very 
weak mechanical properties.  
 
Landi et al. [131] fabricated HA/gelatin composite porous scaffold with ice-designed channel-like 
porosity through freeze casting method. The fabricated scaffold exhibits lamellar morphology with 
aligned channel-like pores. With changing the process parameters, lamellar ice crystals with 
different thickness grows throughout the sample from bottom to top of HA scaffold as represented 
in Figure 2.4. The scaffold results 45–55 vol.% of porosity with pore diameter in the range  
~100 µm and compressive strength ~ 4 MPa. Compressive strength and elastic modulus of lamellar 
scaffold increase with the addition of gelatin.  
 
 
Figure 2.4 Different gradient of porosity in the direction of freezing [131]. 
  
Panzavolta et al. [132] prepared porous composite scaffolds of gelatin and tricalcium phosphate  
(40 wt.%) through freeze casting for 24 h at –50 oC. Mean pore dimension decreases from 350 to 
170 µm with increment of inorganic phase content, which finally enhances the compressive strength 
and Young‟s modulus. A wide range of pore dimensions can be obtained by varying the relative 
amount of gelatin and inorganic components. However, the pore wall seams as microporous with 
mean dimension micropores of 2–4 µm. The scaffold represents a porous interconnected 
microstructure with 85 vol.% porosity, ~ 200–400 µm pore diameter and compressive strength  
0.3 MPa.      
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Zhang et al. [133] fabricated HA-gelatin porous biocomposite scaffold by freeze casting technique 
to evaluate the effect of gelatin addition on the microstructure of scaffold. Pore morphology and 
microstructure of the porous composite has been synchronized by gelatin content. Gelatin addition 
changes the viscosity of slurry and pore morphologies of composite scaffold from the large and non 
interconnected lamellar pores into small and interconnected cellular pores.   
 
Zuo et al. [134] prepared HA-poly vinyl alcohol (PVA) porous composite scaffold by freeze casting 
process to explore the effect of PVA on microstructure of scaffold. The composite morphologies are 
modified by adjusting the concentration of PVA additive in the HA slurries. The resulting 
composite without PVA additive has non interconnected macroscopic lamellar pores and porous 
ceramic walls, whereas with PVA (10%) additive made up of small lamellar pores or three-
dimensional reticulate pores and porous ceramic walls. PVA additive has no effect on the phase 
composition of HA. The HA solid loading of slurry and the concentration of PVA additive have 
great effects on the process of PVA gelation and manners of ice crystals growth, resulting in 
different morphologies.  
 
Azami et al. [135] prepared HA-gelatin nanocomposite scaffold to mimic the mineral and an 
organic component of natural bone using glutaraldehyde as crosslinking through freeze casting 
method. Composite scaffolds are prepared with 10 wt.% gelatin and 30 wt.% HA. The compressive 
strength of composite has improved up to 2.5 MPa with increase in the gelatin concentration. HA-
gelatin nanocomposite exhibits macroporous connected structure with pore size in the range of  
200–400 µm and the thickness of pore inter wall is about 6–20 µm.  
 
Kim et al. [136] fabricated HA-gelatin composite scaffold through freeze drying technique for 
tissue engineering. HA powder up to 30 wt.% is found as effective solid content during freeze 
casting of HA-gelatin slurry. The pure gelatin foam has a well-developed pore configuration with 
porosity and pore size of ~90 vol.% and 400–500 µm, respectively. Pore volume 85 vol.% and pore 
size (200–400 µm) decreases with an increment of HA powder content but pore shape irregularity 
increases for the same. The HA foams experience as high as compressive stress ~0.6 MPa with HA 
content and exhibits elastic modulus of ~ 4 MPa.    
 
Yook et al. [137] studied on the improvement of compressive strength of porous HA scaffolds by 
adding polystyrene polymer as a binder to HA/camphene slurries. The compressive strength is 
significantly increased from 1.1 to 2.3 MPa, with increase in polystyrene content (0 to 20 vol.%), 
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which is an attribute to minimization of pore size from 277 to 170 μm. The study investigates the 
improvement of compressive strength because of the prevention of microcrack on the green body by 
addition of polystyrene during freeze drying.  
 
Heinemann et al. [138] prepared hydroxyapatite-collagen nanobiocomposite scaffold followed by 
freeze drying method.  Freeze dried (–20 oC) nanobiocomposite macroporous scaffold has open and 
interconnected porosity with pore size varying in the range of 100–200 µm. Compressive strength 
of the biocomposite scaffold increases with addition of the mineral HA volume content. The 
Young‟s modulus of the nanocomposite scaffold exhibits about 0.4 MPa, whereas compressive 
strength is found as 0.085 MPa, only.   
 
Asefnejad et al. [139] prepared nano-fluoro-hydroxyapatite (nFHA)/polyurethane composite 
scaffolds through freeze drying technique. The study demonstrates that composite scaffold has 
interconnected and homogeneously distributed pores along with 80 vol.% porosity. The scaffold has 
a pore size in the range of 50–250 μm. Compressive strength and modulus increases with increase 
content of nFHA. Highest compressive strength 0.6 MPa and their modulus 0.8 MPa are reported 
for 20 wt.% nFHA.  
  
Kane et al. [140] studied the effect of hydroxyapatite reinforcement on the architecture and 
mechanical properties of freeze dried collagen scaffold. The scaffold exhibits elongated linear pore 
structure with 90 vol.% of porosity and pore width of 50 µm. The compressive modulus of 
composite scaffold at 60 vol.% HA content is 0.2 MPa, whereas  30 vol.% HA exhibits 0.02 MPa. 
High aspect ratio elongated morphology (length-18 and aspect ratio-8) of HA whiskers has a low 
level of reinforcing effect compare to conventional equiaxed 1.3 µm HA powder.   
 
Several study demonstrate the fabrication of nanobiocomposite scaffold has significant 
influence on HA solid content, HA morphology and freeze casting conditions. In this backdrop, 
suggested different morphologies of nano HA will be considered to achieve high level of 
compressive strength for porous nanobiocomposite scaffold with variation of HA solid content.          
2.7 Materials at cryogenic temperature  
Coefficient of thermal expansion is generally reduced bellow 273K and enhanced above it. This 
basic philosophy would be encountered to enhance the mechanical response of freeze casted 
nanobiocomposite. Brief literatures as relevance with proposed work are discussed as follows.   
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Yang et al. [141] studied on the improvement of mechanical properties of polymer in cryogenic 
temperature. Mechanical properties improvement after low temperature treatment is seen for epoxy 
resins such as di-glycidyl ether of bis-phenol A (DGEBA). The study demonstrate that hydroxyl 
functionalized hyperbranched polymer (H30) is introduced to improve the mechanical properties of 
DGEBA epoxy resin at liquid nitrogen temperature (77 K). Tensile strength, failure strain (ductility) 
and impact strength at 77 K are also simultaneously improved by the addition of H30. The 
maximum tensile strength at 77 K has increased by 17.7% from 98.2 MPa of pure epoxy resin to 
115.6 MPa at 10 wt.% H30 content. Failure strain at 77 K increases consistently with the increase of 
H30 content. The maximum impact strength at 77 K is observed by incorporation of 10 wt.% H30 
with an improvement of 26.3% over that of pure epoxy resin. The achieved maximum tensile 
strength at 77 K is attribute to optimum content of 10 wt.% H30.  
 
Chen et al. [142] studied on the reinforcement of multi-walled carbon nanotubes (CNT) in epoxy 
resin matrix to enhance the cryogenic mechanical properties. The study represents that when the 
temperature decreases from room temperature to liquid nitrogen temperature (77 K). A strong 
CNT–epoxy interfacial bonding exhibits stronger interaction at 77 K compared to room temperature 
due to coefficient of thermal expansion minimization from 5.1×10
-5
 K
-1 
to 0.73–1.49×10-5 K-1. 
Cryogenic tensile strength, Young‟s modulus and failure strain and impact strength at 77 K all are 
enhanced by the appropriate concentration of CNT. 
 
Yang et al. [29] studied on enhancement of mechanical properties of montmorillonite/epoxy 
(MMT/epoxy) nanocomposites at cryogenic conditions. The comparative study reveals the 
mechanical behaviour of MMT/epoxy nanocomposites both at room temperature (RT) as well as 
liquid nitrogen temperature (77 K). The strength and modulus of nanocomposites are significantly 
higher at 77 K than at RT, and these observations are explained in terms of interfacial adhesion and 
constituent properties at 77 K and RT. Cryogenic treatment enhances the room temperature tensile 
strength of MMT/epoxy nanocomposites from 3.1% and 13.2%. Tensile modulus of 
nanocomposites at 77 K almost linearly increases with increase of organo-MMT content. The 
notched impact strength at RT increases from 4.0 kJ/m
2
 for the epoxy matrix to 5.0 kJ/m
2
 for 
nanocomposite with 1 wt.% organo-MMT content.  
 
Yamaoka et al. [143] studied on the mechanical and chemical properties of plastic film at cryogenic 
temperature, where tensile strength and elongation of plastic film at 77 K are found to decrease with 
an increase in the degree of crystallinity. Since, the polymers include those whose main chains are 
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composed of oxygen, sulphur or various heterocyclic linkages only. The study focuses on chemical 
behaviour of polymers which able to change bond angles of the main chain seem to excel in the 
cryogenic environment. This is due to their segmental motion frozen out at cryogenic temperature 
and subsequent polymer deformation.  
 
Polymer based HA composite exhibits better mechanical properties in the cryogenic 
conditions and, hence the cryogenic process optimization for enhancement of mechanical properties 
of the proposed freeze casted HA-gelatin scaffold are needed to explore.  
2.8 In vitro bioactivity and biodegradation  
Utilization of HA based biomaterial preferably depends on its bioactivity and biodegradation during 
in vivo application. In this aspect, in vitro assessment is mandatory prior to clinical use and 
therefore, different classical research is pointed out to understand these phenomena. 
  
Kim et al. [144] studied the bioactivity of HA scaffold as a function of soaking time in simulated 
body fluid (SBF). The mechanism of bone like apatite formation has been examined and described 
on the surface of HA. After soaking in SBF, HA form a Ca-rich amorphous calcium phosphate 
(ACP) and Ca-deficit ACP and finally crystallizes to bonelike apatite. HA surface reveals negative 
surface charge during exposure to SBF, thereby interacting with the positive calcium ions in the 
fluid to form Ca-rich ACP, which ultimately gains positive surface charge and described in  
Figure 2.5. The Ca-rich ACP on HA then interacts with negative phosphate ions in the fluid to form 
Ca-deficient ACP, which finally stabilize and crystallized into bonelike apatite with a low solubility 
in the SBF. However, this exposure time retards the bone like apatite formation on high crystalline 
HA compared with less crystalline HA. This phenomenon is attributing to initial lower negative 
surface charge of the higher crystalline HA to scarcity in surface hydroxyl and phosphate ions. 
 
 
Figure 2.5 Schematic presentations of the origin of negative charge on the HA surface and the 
process of bone like apatite formation [144].  
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Takadama et al. [145] demonstrated in vitro mechanism of biomineralization of apatite on Na2O-
SiO2 glass as a function of soaking time in SBF. First stage of soaking, favours the Na
+
 ions 
exchange with H3O
+
 ions in SBF to form silanol (Si-OH) groups on its surface. Calcium ions prefer 
to incorporate within Si-OH group during immersion condition and forms amorphous calcium 
silicate. Following that, phosphorous ion insertion is observed within calcium silicate to form 
amorphous calcium phosphate with a low Ca:P atomic ratio of 1.43. The amorphous calcium 
phosphate is gradually transformed into crystalline apatite, which contains small amounts of Na, 
Mg, and Cl with Ca/P ratio of 1.65, similar to bone mineral. This work also illustrates the 
spontaneous bone like apatite growth phenomenon by consuming the remaining calcium and 
phosphate ions in the fluid. In brief, the original formation of calcium silicate is a consequence of 
an electrostatic interaction of negatively charged -Si-O- units which formed by dissociation of Si-
OH groups and positive charged calcium ions in the fluid. Calcium silicate is postulated to gain a 
positive charge and interact with negatively charged phosphate ions in the fluid to form an 
amorphous calcium phosphate. 
 
Kokubo et al. [146] studied the apatite formation on the surface of ceramic, polymer and metal. 
Bioactive ceramics bond to the living bone through a bonelike apatite layer formed at an optimum 
condition. The apatite is nucleated by -Si-OH groups on their surfaces and grows by consuming the 
calcium and phosphate ions from the body fluid. Bonelike apatite layer formed even on metal 
surfaces such as silicon, titanium and its alloys, tantalum as well as organic polymers such as 
poly(ethylene terephthalate), polyether sulfone and polyethylene in a simulated body fluid with ion 
concentration nearly equal to those of human blood plasma. Ti-OH and Ta-OH groups can also 
induce an apatite nucleation in SBF. The study demonstrates the mechanism of formation of 
bonelike apatite layer on the surfaces of bioactive ceramics.  
 
Tas et al. [147] prepared  biomimetic HA powders at 37 
o
C in synthetic body fluids. Nano HA 
powder is prepared from Ca(NO3)2 4H2O and (NH4)2HPO4 salts dissolved in modified synthetic 
SBF solutions at 37 
o
C and pH of 7.4 through chemical precipitation technique. The prepared HA 
powder is spherical in morphology with average particle size in the range of 30–50 nm and 
stabilized up to 1600 
o
C an air atmosphere. The as-synthesized biomimetic HA powder has near to 
96% densification characteristic. 
 
Okazaki et al. [148] studied on dissolution behaviour of fluoridated HA. The dissolution rate of 
synthetic fluoridated apatite pellets with different fluoride content is measured in acetate buffer 
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solution at pH~ 4. The observed dissolution rate depends on degree of fluoridation, interestingly 
lowest at low fluoride levels. The experimental data are analysed by means of a diffusion-controlled 
model in which initial dissolution rate is greatly affected by both the solubility and the overall mass 
transfer resistance. Overall mass transfer resistance is influenced by fluoride content in HA. The 
study has discussed that the solubility of fluoridated apatite is more strongly affected by fluoride 
content than by crystallinity and morphology.  
 
Xu et al. [149] studied the biodegradation behaviour of porous scaffolds. Composite scaffolds of 
poly( D,L-lactide)(PDLLA) bioactive wollastonite powders are prepared through a salt-leaching 
method using NH4HCO3 as a porogen. The in vitro bioactivity of composite scaffold is evaluated in 
SBF solution and reported the apatite layer formation mechanism on its surface. In vitro 
degradation behaviour of these scaffolds is systematically monitored at varying time schedule in the 
presence of tris-HCl buffer solution at 37 
o
C. Apatite formation on the surface of scaffolds is seen 
after 7 days of immersion in SBF. The measurement of weight loss, pH and molecular weight of the 
samples indicates that PDLLA/wollastonite composite scaffold degrades slower than the pure 
PDLLA scaffolds. The wollastonite addition enhances the mechanical properties of the composite 
scaffolds.    
  
Martinez-Valencia et al. [150] studied in vitro bioactivity and biodegradability on polyurethane HA 
composite scaffold. Biodegradability and bioactivity studies are carried out by immersion into 
phosphate buffer saline (PBS) and SBF solutions, respectively. Biodegradation rate increases with 
the content of nano HA content. The study reveals 3 wt.% loss in the composite contains 10 wt.% 
nano  HA, where as 4 wt.% loss is seen for 40 wt.% nano HA content composite during 56 days of 
study. In vitro bioactivity shows that the composite exhibit advantages over polyurethane, although 
the bone-like apatite formation is regulated both in composite as well as in polyurethane. 
  
Similarly, bioactivity and biodegradation assessment of HA-gelatin biocomposite porous 
scaffold will be carried out after optimization of pore morphology and mechanical strength.   
2.9  In vitro cytotoxicity and cell viability  
Cell viability and cytotoxicity assessment will support to understand the in vivo cell compatibility 
and level of toxicity of the synthetic biocomposite scaffold for clinical application. Therefore, 
different schools are continuously evaluated and reported this phenomenon for the future 
development of a new class of biomaterials.  
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Filho et al. [151] studied on the cell attachment, cellular interactions and modulation of osteoblast 
cells on biocompatible materials such as porous HA scaffold. Biocompatibility of material has been 
studied through consideration of human osteoblast (HOB) cells on the fibronectin coated glass 
surface and mono layers formation of HOB observed. The cellular adhesion to material interaction 
includes two phenomena: (a) physico-chemical properties of the interacting surface and (b) 
molecular properties of both surfaces and also the interaction medium. The study pointed out that 
cell attachment is a property which depends on physical and topological features of both biomaterial 
and cell surfaces.  
 
Oliveira et al. [152] studied the cytocompatibility and cell viability on porous HA scaffold using 
mouse fibroblast cells (L929 cells). Fibroblast cells partially proliferated and covered scaffold 
surface, after prolong 72h seeding. The scaffold extract fluid is investigated by carrying out a 
cellular viability assay (MTT {3-(4,5-diamethyl thiazol-2-yl)-2,5- diphenyltetrazolium bromide} 
test) using mouse fibroblastic-like cells. L929 cells percentage relative viability determine for each 
extract concentration and compare to tissue culture polystyrene. Cells morphology, proliferation 
and monolayer formation are observed through inverted microscope. The study reveals that 
materials do not have any cytotoxic effect. 
 
Kim et al. [153] studied in vitro cellular response and attachment on freeze dried HA–gelatin 
composites. Osteoblast-like human osteosarcoma cells are spreading and actively proliferate on 
composite scaffold. The cell proliferation rate is calculated indirectly on the cells cultured on Ti 
discs coated with gelatin and HA–gelatin composites using MTT assay. The alkaline phosphate 
activities express by the cell culture on composites and HA coatings on Ti discs enhances 
significantly compared with those on pure gelatin. This finding suggests that HA–gelatin composite 
has great potential for use as hard tissue regeneration scaffolds. 
 
Silvio et al [154] studied in vitro effect of surface composition of human osteoblast (HOB) cell 
behaviour on different content of HA reinforced polyethylene (PE) composite. HOBs are cultured in 
direct contact with test materials containing 20% and 40 vol.% HA. The study reveals that 40% 
HA/PE enhanced cellular activity by increasing proliferation rate and differentiation compared to  
20 vol.% HA composite. HOBs cultured on 40% HA/PE is flatter, enhanced rate of cytoskeletal 
organisation and an increase in focal contact points compared to 20% HA/PE. Here, the surface 
topography has importance for cell attachment, where cellular response enhances with increasing 
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HA volume. Cytoskeletal studies have suggested that HA particle provides anchorage for 
osteoblastic cells and reveals a favourable surface for cell attachment.  
 
Dalby et al. [155] studied the original attachment of osteoblast like cells on HA reinforced 
polyethylene composite (HAPE), which is designated as a second-generation orthopaedic 
biomaterial with suitable mechanical and biological characteristics for bone augmentation. 
Optimisation of the material features like mechanical properties enhancement has important role for 
effective attachment of osteoblasts cells. Polishing followed by roughening the surface of HAPE 
enhances osteoblast proliferation.  
 
Gou et al. [156] studied cytotoxicity and ostioconductive properties of Ca-deficient HA (CDHA) 
scaffold using MSCs (Mesenchymal stem cell). MSCs are cultured, expanded and seeded on the 
scaffold surface. Proliferation and differentiation of MSCs on scaffold is evaluated through MTT 
assay. CDHA scaffolds are biocompatible and have no negative effect on the MSCs in vitro. The  
in vivo biocompatibility and osteogenicity of the scaffolds are also investigated and is implanted in 
rabbit mandibles. It exhibits good biocompatibility and osteoconductivity. Biodegradation up to 
36% of CDHA scaffolds are degraded after 12 weeks in Tris–HCl solution. Effective new bone 
formation could be seen after implantation of MSCs into the scaffold within 2–4 weeks.  
  
In this perspective, it is important to assess the cytotoxicity and cell viability of developed 
scaffold.  
2.10 Protein loaded porous scaffold   
Cell attachment on the biomaterial interface and their proliferation is only possible when protein 
molecule make bridge within these two moieties. Several pioneer works has been carried out to 
understand the cell viability and attachment with synthetic biocomposite scaffolds through the 
protein adsorption and release.   
 
Jaklenec et al. [157] discussed a novel method for incorporating proteins in 3D biodegradable 
scaffolds by utilizing protein-loaded microspheres as the building blocks for scaffold formation. 
Poly(L,D-lactic-co-glycolic acid) (PLGA) microspheres containing BSA are combined with 
scaffolds using a dichloromethane vapor for different time intervals. The microspheres are loaded 
with 0.4, 1.5 and 4.3 wt.% BSA protein. The protein release study has been quantified in vitro and 
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demonstrate a slight lower (up to 20%) release over 10 days. Well spread and attachment of 
fibroblast cells observed on the protein loaded scaffold after 4 h of incubation.   
 
Mohan et al. [158] fabricated biodegradable egg albumin based gelatin porous scaffold. Gelatin is 
functioning as promoter for good cell adhesion due to its hydrophilic nature. Hydrophobic–
hydrophilic balance has been controlled by egg albumin. Monolayer fibroblast and chondrocyte 
calls are cultured in the fabricated scaffold and also examined on the stem cell differentiation to 
chondrocytes. Proliferation and differentiation of mesenchymal stem cells to chondrocytes is 
studied in presence of growth factors. Chondrocyte culture on the porous scaffold shows the 
deposition of cartilage specific matrix molecules.  
 
Lyu et al. [159] developed polyethylene oxide/chitin/chitosan porous scaffolds grafted with albumin 
and applied for the neocartilage formation. The albumin grafted porous scaffold is cultured with 
porcine knee chondrocytes cells to understand the regeneration of articular cartilage. Albumin 
coating on the pore surface of a scaffold accelerates the proliferation of porcine knee chondrocytes, 
secretion of glycosaminoglycans, which favours generation of collagen and formation of 
cartilaginous components. 
 
Sawyer et al. [160] studied the effect of adsorbed serum protein on adhesion of mesenchymal stem 
cells (MSC). RGD (Arg-Gly-Asp) and proteoglycan-binding peptide combination do not have 
remarkable enhancement of MSC attachment spreading on HA surface. The study reveals that 
peptide-modiﬁed surfaces are not able to stimulate the same degree of cell attachment and to spread 
as that seen on serum-coated HA. The results suggest that the possibility of optimal cell-material 
interaction insist by native HA exposed to blood in vivo, instead of surface functionalization with 
RGD/proteoglycan-binding peptides. 
 
Kou et al. [161] studied the formation of neocartilage by cultivating chondrocytes in elastin and 
poly-l-lysine modified scaffolds. Bovine knee chondrocytes are seeded on the scaffolds and 
cultured in a spinner-flask bioreactor over 4 weeks. Surface elastin reveals a better efficiency in the 
adhesion and proliferation of bovine knee chondrocytes in the scaffolds than surface poly-l-lysine. 
Elastin and poly-l-lysine grafted scaffolds are found to be effective in producing cartilaginous 
components to generate neocartilage by cultivating chondrocytes in elastin and poly-l-lysine 
modified scaffolds. The study illustrates that elastin and poly-l-lysine graft enhance the peptide rich 
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surroundings for chondrocyte growth. The effect of surface elastin and poly-l-lysine improves cell 
adhesion, viability and chondrogenesis in the scaffolds.  
 
Kilpadi et al. [162] investigated that HA binds more serum proteins, purified integrins and 
osteoblast precursor cells than pure titanium or 316L stainless steel. The implant material HA 
exposed to the patient‟s blood during surgery adsorbs known cell adhesive proteins such as 
fibronectin and vitronectin from the serum. The study shows that an osteoblast precursor prefers to 
adhere of these proteins through integrin-mediated mechanisms. The enzyme-linked 
immunosorbent assay (ELISA) and cell adhesion assay test suggests that  the increased protein 
adsorption would lead to better binding of fibronectin, vitronectin and osteoblast precursor cells to 
HA than to the metals. It has been suggested that osteoblast attachment is one of the potential 
targets for clinical improvement of bone formation at implant surfaces. 
  
Literature suggests a protein interaction behaviour is an important issue and need to explore 
when development of a new scaffold is concern. Hence, optimized scaffold will be considered to 
understand the common and easy available BSA protein adsorption-release phenomena.    
2.11  Micro-CT analysis of scaffold  
The quantitative analysis of pore interconnectivity, pore volume content and pore wall thickness of 
the adsorbed protein layer are effective information for in vivo assessment of biomaterial composite 
scaffold. Till to date, selective work has only been carried out to accumulate this information which 
are summarized for future reference. 
  
Segvich et al. [163] studied the deposition of protein incorporated calcium phosphate mineral layer 
on three dimensional porous polymer scaffold through micro-CT analysis. Micro-CT analysis 
illustrate the mineral volume percent (MV%) (7.86 ± 3.25 MV) increment and the uniform 
distribution of BSA protein on polymer scaffold. Near to 10-fold increase of BSA incorporation is 
observed in polymer scaffold. The 3D mineralization is observed through the thickness of porous 
material and provides the option of inclusion of co-precipitated biomolecules within the mineral 
layers.      
 
Simon et al. [164] studied the micro-CT analysis of HA bone repair scaffold to evaluate the scaffold 
architecture on bone ingrowth. Bone volume ingrowth with respect to the total region of interest, 
bone volume ingrowth with respect to available ingrowth volume and soft tissue volume are 
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analysed. The study illustrates that factorial analysis is the greatest determinant factor for soft tissue 
ingrowth, whereas pore volume is the greatest determinant of bone volume ingrowth. Pore 
interconnectivity, thickness of pore wall and pore size distribution also analysed. 
  
Henslee at al. [165] studied the micro-CT analysis of biodegradable composite scaffold for bone 
morphogenic protein deliver and bone regeneration in segmental long bone defects. The work 
describe a 3D micro-CT and pore partitioning study to derive pore scale parameters including pore 
radius distribution, accessible radius, throat radius and connectivity over the pore space of a tissue 
engineered constructs. The amount of bone formed within the defect is evaluated both qualitatively 
and quantitatively only after at 12 weeks with micro-CT. Tissue response is evaluated for the bone-
rod interface, bone sleeve interface and within the pores of the sleeve for 12 weeks.   
  
However, no trial has been conducted to get detail quantification data for the internal 
architecture, pore interconnectivity and pore wall thickness of scaffold and their protein loaded 
scaffold. 
2.12 Summary of contribution 
The extensive literature survey shows that no trial has been conducted to make different aspect ratio 
particles such as spherical, rod and fibrous morphology co-precipitation route and control over 
identical precursor concentration, solution pH and temperature. Stable aqueous homogeneous 
dispersion of such developed three different morphologies of HA nanoparticles in physiological 
temperature and solution pH is obvious not reported. Moreover, no trial has been conducted to 
study the effect of HA nanoparticle morphologies and their aspect ratio on the adsorption and 
release of protein. The assessment of macroporous hydroxyapatite-gelatin scaffold with connected 
pore architecture, optimized compressive strength, and effect of HA solid content on porosity and 
strength at low temperature are also needed to explore. Consideration of cryogenic temperature 
(77K) and effect of curing time for the enhancement of compressive strength and bonding 
behaviour on HA-gelatin macroporous scaffold is limited. Understanding on the apatite nucleation 
in simulated body fluid, cytotoxicity, cell viability and rate of biodegradation on the cryotreated 
nanocomposite scaffold is essential for the development of such scaffold. Protein adsorption 
capacity and efficient release kinetic for both particles and cryotreated HA-gelatin macroporous 
scaffold have not been found, which may assist to understand the efficiency of protein interaction 
activity. The study of scaffold internal architecture, pore interconnectivity and pore wall thickness 
in cryotreated macroporous HA-gelatin scaffold and their protein loaded scaffold is also not 
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documented. Based upon the above findings the objective of the present investigation has been 
summarized.   
2.13 Thesis objective  
a) To pursue low temperature synthesis of different spherical, rod shaped and fibroid morphologies 
of hydroxyapatite nanoparticles and study of their dispersion phenomenon.  
b) To prepare HA nanoparticle – protein (bovine serum albumin) conjugate and study of their 
adsorption and release. 
c) To fabricate freeze casted nanobiocomposite (HA-gelatin) scaffolds and evaluation of their 
compressive strength.  
d) To improve and optimization of compressive strength through cryogenic treatment of scaffold. 
e) To study bioactivity and biodegradability of developed and optimized porous scaffolds. 
f) To evaluate cytotoxicity and cytocompatibility of nanobiocomposite scaffolds.  
g) To prepare nanobiocomposite scaffold – protein conjugate and evaluation of their adsorption 
and release. 
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Chapter 3 Methods 
3.1 Preparation of HA nanoparticles  
A simple wet chemical process and systematic design of experiment were conducted to synthesis 
and achieved specific properties of HA spherical nanoparticles, nanorods and nanofibers. Three 
different morphologies of HA nanoparticles were prepared from two common precursors; 
(CH3COO)2Ca and KH2PO4. A representative microsturcture of calcium acetate was taken and 
discussed later. In aqueous media, two inorganic salt solutions were separately prepared and slowly 
mixed to maintain the Ca:P molar ratio of 1.67 in HA. Both of the solutions ((CH3COO)2 Ca = 
0.1M and KH2PO4 = 0.06M) were separately added at a constant rate of 0.5 lh
-1
 and stirred within 
one litre of water. Solution pH were controlled through NH4OH and tris-buffer (Tri-methylhydroxy 
aminomethane) solution for spherical and rod morphology, respectively. A specific tailor-made 
temperature sensor attached glass vessel was used to measure accurate reaction vessel temperature 
during synthesis of these nanoparticles. Different 35 sets of experiment were conducted in account 
of Ca/P ratio, solution pH and temperature, wherein 22 numbers of data found as HA phase with 
desired morphology; i.e. spherical, rod and fibroid shape. However, five numbers of experiment 
supported the formation of Ca:P near to 1.67. Calcium (Ca) and phosphorus (P) was determined by 
complexometric titration with EDTA and gravimetric method through ammonium molybdate, 
respectively [166]. The entire experimental setup for the preparation of nano HA powder 
represented in Figure 3.1. However, three optimized conditions were chosen to achieve the desired 
morphology and Ca:P ratio of pure HA nanoparticles. A typical flow diagram for the preparation of 
HA nanofibers described in Figure 3.2. Spherical HA nanoparticles (NHS), rod HA nanoparticles 
(NHR) and fibroid HA nanoparticles (NHF) were developed at pH = 12.25, temperature = 298K; 
pH = 9.5, temperature = 303K and pH = 5.25, temperature = 353K, respectively. The individual 
precipitates were washed with de-ionised water followed by isopropyl alcohol and separated 
through centrifuge at 14,000 rpm. Semi dried particles were freeze dried at 220 K and 77 torr 
pressure and finally obtained 12 gram of nanoparticles. Similarly, bulk quantity (60 gms) 
nanoparticles were prepared to carry forward their characterizations, preparation of nanocolloids 
and making scaffolds from all morphologies. 
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Figure 3.1 Experimental setup for the preparation of HA nanoparticles through precipitation 
method.   
 
 
 
Figure 3.2 A typical flow diagram for the preparation of HA nanofibers.    
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3.2 Characterizations of HA nanoparticles 
3.2.1 Phase analysis of HA nanoparticles  
Phase and crystallinity of HA powders were analysed using room temperature powder X-ray 
diffraction (Philips PAN analytical, Netherland) with an attachment of Ni-filter 0.154 nm and Cu K- 
α radiation as source. The diffractometer was operated at 35 kV and 30A. All powder samples were 
scanned in a continuous mode over a 2θ range from 20 to 80 with a scanning rate of 0.02 
degree/sec. The peak position, phase purity, peaks of different atomic planes and the relative 
intensities of the powder pattern were identified in comparison with the reference powder 
diffraction data (JCPDS). The average crystallite size of all nano HA samples were calculated using 
Scherrer‟s formula [167,168].  
                                               
βcosθ
0.9λ
D  ................................................ (i) 
Where, D = Average crystallite size  
  λ = Wavelength of X-ray 
  β = Wavelength of the full-width at half-maximum 
  θ = Diffraction angle  
3.2.2 Rietveld refinement of calcined HA nanoparticles  
All three different powders were calcined to evaluate their probable crystal pattern, crystal 
structure, lattice parameter, cell volume as for reference. FullProf.2k program was used for Rietveld 
refinement of X-ray diffraction powder patterns. As synthesized three different grade of HA 
nanopartiles were calcined at predetermined temperature 700 
o
C with isothermal soaking of 2h. HA 
nanoparticles were analysed using room temperature X-ray diffraction with Ni-filtered using Cu  
K-α radiation source, and data were collected in continuous mode from 20 to 80o 2θ with a scanning 
rate of 0.02
o
/sec [169]. Apatite starting atomic parameters from the refinement based on X-ray 
diffraction data in P63/m space group. Rietveld structure refinement method was corresponded to 
the general guideline as adopted by the International Union of Crystallography Commission on 
Powder Diffraction. Scale factors, zero shift, line profile parameters, lattice parameters, preferential 
orientations and asymmetry parameters were refined at first step. Atomic displacement factors, as 
well as atomic coordinates from the HA structure, were refined in a second step. Site occupancies of 
cations, phosphate and hydroxyl anions were also systematically checked in the last run.   
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3.2.3 FT- IR study of HA nanoparticles 
The phase purity and presence of major functional groups were analysed through Fourier 
Transmission Infrared (FT-IR) spectra method (Perkin Elmer RXI, Spectrum, USA) in the wave 
number 4000 – 400 cm-1 and KBr as reference. The discs were prepared by pressing the mixture of 
5 mg of HA nanoparticles with 100 mg of KBr at pressure of 3 ton.   
3.2.4 Determination of Ca:P ratio of HA 
Calcium to phosphate ratio for as-synthesized HA nanoparticles were estimated through chemical 
analysis. Calcium was estimated by complexometric titration technique with EDTA 
(Ethylenediaminetetraacetic acid), whereas phosphorus was estimated by gravimetric method 
through ammonium molybdate precipitation method. 
Preparation of stock solutions: 
(a) Preparation of HA solution: Spherical (NHS), rod (NHR) and fibroid (NHF) HA stock 
solutions were prepared by taking 0.1g of each sample in 250 ml volumetric flask and made 
complete solution by the addition of few drops of nitric acid. Volume of each flask was 
adjusted up to the mark by distilled water. 
(b) Preparation of 0.01M EDTA solution: EDTA (0.9306 gm) was taken in 500 ml volumetric 
flask and prepared homogeneous solution by distilled water and considered as primary 
solution. 
(c) Preparation of 0.01M CaCO3 solution: CaCO3 (0.1gm) was taken in 100 ml volumetric flask, 
added HCl to dissolve and volume marked up through distilled water.  
(d) Preparation of ammonium molybdate reagent: Initially, solid 125 gm ammonium nitrate was 
dissolved in 125 ml water and added 175 ml nitric acid (sp.gr. 1.42) to prepare their nitrate 
solution. Solid ammonium molybdate (12.5 gm) was dissolved in 75 ml water and subsequent 
slowly added into ammonium nitrate solution through constant stirring. Mixture solution 
further diluted to 500 ml, heated the flask in a water bath at 60 
o
C for 30 minute and finally 
filtered the precipitate. The resultant filtrate (heptamolybdate) was further used for the 
estimation of phosphorus atom concentration of hydroxyapatite nanoparticles.  
Standardization of EDTA: 
10 ml of 0.01M CaCO3 solution was taken in 250 ml conical flask, added 10 ml of ACC 
(ammonium acetate) buffer (pH~10) and 2-3 drops of Eriochrome Black-T indicator followed by 
titration with 0.01M EDTA solution. The end point detected when solution was changed from wine 
red to blue in colour. The experiment was repeated 2-3 times to get concordant value. 
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Estimation of Ca
2+
 in HA: 
As similar with EDTA standardization, 10 ml of HA [Ca10(PO4)6(OH)2] solution was taken in 250 
ml conical flask, followed by added 10 ml ACC buffer solution to maintain pH~12 and 2-3 drops of 
Eriochrome Black-T indicator and subsequently titrated with standard EDTA solution. The end 
point was reached when colour of the solution changed wine red to blue. Similar experiment was 
carried out for all HA solutions as obtained from three different grade nanoparticles. The 
experiment was also repeated 2-3 times as earlier. 
Determination of phosphate in HA: 
The as prepared 15 ml ammonium molybdate reagent (heptamolybdate) was added to 10 ml of HA 
solution into a conical flask and heated at 60 
o
C for an hour through constant stirring. The resultant 
yellow precipitate was separated by filtration and washed with 2 wt.% ammonium nitrate solution. 
The precipitate was calcined at 825 
o
C and develop P2O524MoO3, which was gravimetrically 
estimated the content of phosphate ions and thereof concentration of phosphorous atom [166]. The 
equation is leading to phosphate determination through the molybdate reagent as:  
 ....(ii) 
 
352
C8253
4012 24MoOOP]O2[PMo
o
               ....(iii) 
3.2.5 Transmission electron microscopy of HA nanoparticles  
Transmission electron microscopy (TEM) is a technique to study the high resolution morphology, 
lattice fringe and crystallinity of materials, in which a beam of electrons is needed to transmit 
through the specimen. An image is developed from interaction of electrons transmitted through the 
specimen. The particle size and morphology of as synthesized HA powder were studied by TEM, 
whereas lattice parameters and crystallinity was estimated by TEM and SAED (Selected Area 
Electron Diffraction) pattern, respectively. The TEM samples were prepared by dispersing a small 
amount of powder in acetone using 20 kHz and 500W ultrasonic energy for 30 minute. A well-
dispersed suspension was dropped on a carbon coated copper grid and dried to evaporate the 
solvent. The powder morphology was observed under bright field mode transmission electron 
microscope (JEOL JEM-2100, TEM).  
3.2.6 BET surface area study of HA nanoparticles  
BET technique was coined according to inventor Stephen Brunauer, Paul Emmett and Edward 
Teller, who scrutinized the surface phenomena of a powder or porous body by help of gas 
adsorption method. The approach assumes each gas molecule occupy a specific surface area. Low 
pressure adsorption isotherm provides a mean to take the mass of adsorption corresponding to a 
  O12HOPMoPO12MoO24H 2
3
4012
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4
2
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single gas molecule layer and calculated the surface area from it. BET surface area is then 
calculated from adsorption behaviour under a range of partial pressures. The BET equation [170] is 
represented as: 
       







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P
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1
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 .............................(iv) 
Where, 
P = Measured partial pressure of adsorbate.  
Po = Saturation or equilibrium pressure of adsorbate, which depends on the gas and temperature.  
X = Mass of the gas adsorbed at pressure P.  
Xm = Adsorption capacity of the powder (the mass of gas necessary to form a saturated surface 
coating one atomic layer thick). 
C = Constant relating to the adsorption enthalpy. „C‟ is calculated from the exponential of the    
difference in adsorption enthalpy for the outer surface layer versus an inner layer.  
 
BET equation is a linear equation and valid for measuring the surface area of a powder when the 
pressure range P/Po varies from 0.05 to about 0.35. The SBET equation can be represented in a 
general form as:  
 
WM
ANX
S oomBET  .......................(v) 
 Where,  
M = Molecular weight of the adsorbate,  
Ao = Average occupational area of an adsorbate molecule (nitrogen is the most popular adsorbate 
gas and it has an average occupational area of 16  10-20 m2)  
No = Avogadro‟s number 
W = Mass of the sample 
BET specific surface area could be demonstrated with consideration of equivalent spherical 
diameter of monosized spheres. The BET equivalent spherical particle diameter is generally, 
calculated from surface area as follows [171].  
BETt
BET
sρ
6
D

 ..............................................(vi) 
 Where,  
SBET = Specific surface area of the powder measured in m
2
/g  
ρt = Theoretical density of the powder  
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DBET = Particle size measured in micrometer.  
In this form the proportionality factor of 6 reflects an assumed spherical shape. 
 
The BET specific surface area and BET isotherms of synthesized powders were taken at 
nitrogen adsorbate, using BET (Quantachrome Autosorb, USA). The HA powder was degassed at 
200 
o
C and measurement was performed at five different points for specific surface area. The N2 
gas adsorption-desorption isotherms of the samples were conducted at liquid nitrogen temperature 
(77K). Approximately 40 mgs of powder was taken to remove contaminant water vapour and 
adsorbed gases from the samples at 200 
o
C in nitrogen atmosphere. BET isotherms (40 points) 
measurement were done in liquid nitrogen environment and represented as the amount of nitrogen 
adsorption or desorption on the material as a function of pressure (P/Po = 0.025 – 0.999). The 
sample cell pressure altered until equilibrium established during adsorption or desorption. Average 
pore diameter and Barrett, Joyner & Halenda (BJH) adsorption pore distribution curves of the 
samples were estimated according to BJH model.   
3.2.7 Scanning electron microscopy of HA precursor  
Scanning electron microscope (SEM) is a typical electron microscope that images formed by simply 
scanning it with a beam of electrons. The electrons (secondary electrons, back-scattered electrons 
(BSE), characteristic X-rays) interact with the surface atoms which initiate to develop relevant 
information about the sample's microstructure, morphology and elemental composition. The 
microstructure of calcium acetate precursor was elucidated using scanning electron microscope 
(JEOL JSM 6480LV) after platinum coating in secondary electron mode at 15KV source. Several 
SEM images were taken similarly in later stage of the experiment.   
3.3 Dispersion of HA nanoparticles in aqueous media   
Different three grade HA nanoparticles were dispersed in aqueous media at optimum solution pH 
separately. The dispersion of 50 mg HA nanoparticle was executed in 400 ml double distilled water 
by the addition of (2 ml) 0.1M citric acid and (2.5 ml) 0.1M NaOH solutions. The solid – liquid 
mixture solution was treated at 348 K and 350 rpm for 30 minute. The synthesized HA 
nanoparticles and colloidal HA-citrate complex was analysed through FT-IR technique to 
understand the moiety adhesion phenomenon. Zeta potential at different step was measured during 
preparation of these homogenous suspensions.   
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3.4 Characterizations of dispersed HA  
3.4.1 Zeta potential measurement of dispersed HA  
Zeta potential provides the information about the magnitude of the electrical charge at the double 
layer in a colloidal system. Usually, it describes the potential difference between the dispersed 
medium and the stationary layer of fluid attached with the dispersed particles. The zeta potential 
value has significance to achieve and maintain the stability of colloidal dispersions. It indicates the 
degree of repulsion between adjacent, similarly charged particles in dispersion phase. Zeta potential 
(ζ) was measured through the zetasizer nano analyser (Zetasizer nano ZS, Malvern) by 
Smoluchowski's theory at room temperature and calculated by following equation-vii. 



4
 .........................(vii) 
Where, 
ξ = Dielectric constant  
η = Viscosity of the solution  
υ = Electrophoretic mobility of ions  
3.4.2 Particle size analysis of dispersed HA  
The particle size and its distribution were estimated through zetasizer nano analyser (Zetasizer nano 
ZS, Malvern). The most important parameter for the dynamic light scattering is refractive index, 
and absorption of the particles and medium. Refractive index for both of the HA and water was 
considered as 1.5 and 1.33, respectively and absorption of HA powder was 0.01 [172]. The 
dispersed HA nanoparticles were used for the particle size analysis.   
3.4.3 FT- IR study of dispersed HA  
The dispersed HA nanoparticles were centrifuged at 800 rpm and freeze dried at 220 K and 120 torr 
pressure. The dried HA-citrate complex was analysed through FT-IR technique as discussed in 
section 3.2.3.  
3.5 HA nanoparticle protein conjugates  
3.5.1 SEM of BSA Protein  
The morphology of BSA protein was studied through SEM analysis. Pt coated samples were 
analysed at 15KV through secondary electron mode. The detailed procedure was represented in 
section 3.2.7.   
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3.5.2 Measurement of BSA concentration through UV-visible  
UV-vis spectroscopy technique was used to determine the absorbance of samples at visible region 
(400-800 nm). The concentration of an absorbing species in solution was quantitatively calculated 
by applying Beer-Lambert law. The Beer-Lambert law states that absorbance of a solution is 
directly proportional to the concentration of the absorbing species in the solution and their path 
length [173]. The mathematical relation is represented in equation (viii). Thus, for a fixed path 
length and wavelength, UV-vis spectroscopy was used to determine the concentration of the 
absorber in a solution. The schematic for the beer-Lambert‟s law is shown in Figure 3.3.  
 
Figure 3.3 Schematic for the Beer-Lambert‟s law  
 
Where,      ........(viii) 
Io = Intensity of the incident light  
I = Intensity of the transmitted light  
A = Absorbance  
b = Path length in cm (the distance that light pass through the material)   
c = Concentration of the solution  
a = Absorption coefficient (Lmol
-1
cm
-1
)  
UV-vis spectroscopy (Perkin Elmer, Lambada 35) at 562 nm was used to characterize the 
absorbance peaks and estimation of BSA concentration through the use of a predetermined standard 
concentration – intensity calibration curve.  
3.5.3 Dilution of standard BSA  
One ample of standard BSA contains 1 ml of concentration 2.0 mg/ml.  A set of diluted standards 
with different ion concentration was prepared with the help of digital micropipette by taking one 
ample of standard BSA. BSA standard samples were prepared according to the following Table 3.1.  
 
 
Aabc
I
I
 0log   
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Table 3.1  BSA standard ion concentration for test tube protocol working range (20-2000 µg/ml).  
No. Vial Volume of 
diluents (µl) 
Volume of BSA(µl) Final BSA 
Concentration (µg/ml) 
A 0 300 of stock 2000 
B 125 375 of stock 1500 
C 325 325 of stock 1000 
D 175 175 of vial B 750 
E 325 325 of vial C 500 
F 325 325 of vial E 250 
G 325 325 of vial F 125 
H 400 100 of vial G 25 
I 400 0 0 
 
3.5.4 Preparation of BCA working reagent  
BCA (bicinchoninic acid) working reagent was prepared by adding 50 parts of BCA reagent A with 
1 part of BCA reagent B (50 : 1, reagent A : B). Reagent A composed of  Sodium carbonate (0.1M), 
Sodium bicarbonate (0.1M), Bicinchoninic acid (0.02M) and Sodium tartrate (0.1M) in 0.1M 
Sodium hydroxide in solution  pH – 11.25,  whereas reagent B contains 4% CuSO4.5H2O ( 0.25M) 
only. A clear green working reagent prepared with addition of reagent B. The prepared working 
reagent was stored in a closed container at room temperature of 25 
o
C.  
3.5.5 Test tube procedure for protein concentration determination  
Test tube procedure was adapted for the protein concentration determination through UV-vis 
spectroscopy. In the beginning, BCA working reagent (2 ml) was added within 0.1 ml of each 
diluted standard BSA protein and mixed thoroughly. The small liquid volume estimation was 
maintained by micropipette. Each tube was fitted tightly with a cover and then incubated at 37 
o
C 
for 30 minutes. Incubated tube was cooled down to room temperature say 25 
o
C. Intensity of the 
developed colour was measured through UV-vis spectrometer. The spectrometer was fixed at  
562 nm and base line correction was done through de-ionized water. All the measurements were 
completed within 10 minute. The detailed test tube procedure for the estimation of protein 
concentration through UV-vis spectroscopy is shown in Figure 3.4. 
 
Chapter 3 – Methods 
48 
 
 
Figure 3.4  Schematic for the protein concentration determination through UV-spectrometers.   
3.5.6 BSA adsorption/release on HA nanoparticles 
Commercial grade crystallized and lyophilized BSA (Grade A9418, Sigma Chemical Co.) protein 
with molecular weight of 69 KDa and isoelectric point ~ 4.74 was used for the protein 
adsorption/release study. BSA protein was dissolved in deionized water. Nano HA particles 
(0.1gms) was separately added in 10 ml BSA solution of 5 mg/ml concentration and kept in an 
incubator at 37 
o
C for different time schedule from 6 h to 240 h. The supernatant solutions were 
collected after formation of each BSA–HA conjugate specimens through a centrifuge at 800 rpm 
and temperature 4 
o
C. BSA-HA conjugated residue product was freeze dried and further used for 
the release study. Identical procedure was followed for all three spherical, rod and fibroid HA 
nanoparticles. The amount of BSA protein uptake was quantified by taking 0.1 ml of supernatant 
from each specimens and mixing 2 ml of bicinchoninic acid solution (Thermo Pierce, Bicinchoninic 
acid protein assay kit, BCA-1 and 10N8010904) as discussed in the previous section. Similarly, 
BSA release study was also conducted in contact of HA-BSA conjugate and 20 ml of phosphate 
buffer solution (PBS) at pH 7.4 and temperature 37 
o
C. Detail schematic for release study has been 
represented in section 3.13.3. 
3.5.7 Determination of peptide bond through FT- IR  
FT-IR technique was employed for the determination of protein purity and the attachment 
feasibility of protein conjugate with HA nanoparticles. The protein samples were scanned in the 
wavenumber range 400-4000 cm
-1
 by following the KBr pellet technique. The detailed procedure 
was represented in section 3.2.3. The secondary structure and denaturation of protein was 
characterized through FT-IR analysis. However, circular dichroism (CD) spectroscopy is more 
apposite technique to determine the secondary structure and denaturation of protein [174].    
3.5.8 Thermal analysis of HA-BSA conjugate  
Thermal analysis technique is an excellent approach to determine decomposition behaviour, 
crystallization temperature, glass transition temperature, phase transition and reaction kinetic of 
materials which depends on the resultant heat content of sample with respect to temperature. 
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Thermo Gravimetric (TG) and Differential Scanning Calorimetry (DSC) (Netzsch STA/409 C) 
analysis of BSA and BSA adsorbed HA nanoparticles were carried out in an ambient atmosphere 
with the heating rate of 10 
oC per minute, using α-Al2O3 as reference material. This experiment will 
predict the indirect organic protein molecule attachment efficacy with ceramic HA nanoparticles.  
3.6 Fabrication of porous HA scaffold  
HA-gelatin scaffolds were prepared from all three morphologies (NHS, NHR and NHF) of freeze 
dried HA nanopowders with adjustment of different solid loading 30, 40 and 50 wt. %. A slurry was 
prepared by addition of HA nanopowders, biocompatible 10 wt.% polyvinyl alcohol (PVA), 15  
wt. % gelatin and rest amount of water. An optimum amount of gelatin was calculated on the basis 
of organic matrix content in bone [136]. Gelatin (Gelatin granules, Fisher Scientific Qualigens) was 
added in transparent PVA solution and mixed till homogenization. Highly dispersed HA 
nanoparticles were slowly added within the mixed solution of gelatin and PVA through continuous 
magnetic stirring. The solid–liquid mixture was gradually turned into high viscous slurry at 60 oC. 
The slurry was poured in a cylindrical glass mold and refrigerated at 268 K for 12 h to avoid sudden 
liquid solidification and evaporation. Semi–dried mass was then freeze dried at 221 K and 77 torr 
pressure. The detail process flow diagram is represented in Figure 3.5.  
 
 
Figure 3.5 Flow diagram for the preparation of freeze dried HA scaffold.   
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Here it is necessary to mention that only gelatin-PVA composite without HA nanopowder was 
prepared to differentiate the effect of HA nanoparticles, but unfortunately high porous scaffold did 
not sustain any particular shape and easily scrambled at very low load. Because of this reason no 
further study was conducted for gelatin-PVA composite only.  
3.7 Characterization of fabricated scaffold  
3.7.1 Scanning electron microscopy of the scaffold  
Surface morphology, microstructure, pore shape and pore size distribution of HA scaffolds were 
studied by SEM (JEOL JSM 6480LV). The SEM images of platinum coated scaffolds were seen in 
secondary electron mode at 15KV. Average pore diameter was estimated considering five different 
micrographs of identical scaffold. High resolution FESEM (NOVA NANO SEM-450) image was 
taken to illustrate the particle dispersion in the scaffold matrix. 
3.7.2 Apparent porosity measurement  
Porosity of HA-gelatin scaffold was measured by applying Archimedes‟ principle using ethanol as 
solvent [175]. Dry weights of all the freeze dried HA samples were taken accurately using a digital 
balance. HA samples were kept inside a beaker filled with ethanol and kept inside a vacuum 
desiccator for half an hour to remove entrapped air present inside the scaffold. Suspended as well as 
soaked weights of the samples were taken using four digit accuracy electronic balance. Apparent 
porosity and density of sample was estimated as:                                            
                           100
H-S
D-S
porosityApparent  ................................(ix) 
 
H-S
 D
densityBulk 

  .......................................(x)  
 
100
density lTheoretica
densityBulk 
density Relative  ...........................(xi) 
                       Porosity = 1- Relative density ....................................(xii)    
  
   Where, D = Dry weight of HA scaffold  
    H = Suspended weight of HA scaffold 
    S = Soaked weight of HA scaffold  
ρ = Density of ethanol (0.789 cc/g) 
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3.7.3 Mercury intrusion porosimetry   
Mercury intrusion porosimetry is generally used for the quantification of volume porosity, nature of 
pores, pore volume and pore size distribution for specifically porous materials. Bulk density and 
sample weight are important parameters for this measurement because mercury intruded volume 
depends upon sample volume. Nature of pores and pore size distribution was evaluated through 
porosimetry (Poremaster-33, Quantachrome, USA). The freeze dried HA scaffold samples were 
placed in a penetrometer and infused with mercury under increasing pressure. The pore morphology 
behaviour was measured on the approached theory by Washburn, which defined as “pressure 
required to force a non-wetting liquid to enter a capillary of circular cross section is inversely 
proportional to the diameter of the capillary and directly proportional to the surface tension of the 
liquid and the angle of contact with the solid surface” [176]. Mathematically Washburn equation is 
given as:  
 
               
r
cos 2σ
 P

 ..................................................(xiii) 
Where, 
P = Pressure of Hg   
r = Radius of the pore 
б = Surface tension of mercury   
θ = Contact angle.  
As the pressure (P) increase, the radius of pores (r) that can be filled decrease according to the 
Washburn equation. The open porosity л (porosity accessible to mercury intrusion) is given as  
 
   ScaffoldIntrusion VV  π     ......................................................................  (xiv) 
 
Where, VIntrusion was the total intrusion volume of mercury and VScaffold is the volume of the scaffold.  
The closed porosity ω is not accessible to mercury and can be determined as:                                     
                                    πΠω   ...................................................  (xv) 
Where, П = Total porosity of scaffold. The applied pressure during mercury intrusion porosimeter 
measurement was varied slightly higher than 0.5 to 60,000 psi.  
3.7.4 Compressive strength measurement  
Compressive strength of the material is that value of uniaxial compressive stress reached when the 
material tend to reduce size or fails completely. It is usually obtained experimentally by means of a 
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specimen under compression at constant load. Compressive strength of the cylindrical (14 mm 
diameter and 15 mm thickness) porous scaffolds was measured by universal testing machine (H10 
KS, Tinius Olsen) using the load cell of 10 KN with a cross head speed of 2 mm/minute and 
determined by the following formula: 
 
              
A
P
 Strength  eCompressiv  ....................(xvi) 
     Where,  
                        P = Load in KN                    
                        A = Cross sectional area of the cylindrical sample 
3.7.5 Elastic modulus of scaffold  
Modulus of elasticity is the mathematical representation of a substance that tends to deform 
elastically when a force applied and is defined as the slope of its stress–strain curve in the elastic 
deformation region [177]. Elastic modulus of the HA scaffolds was determined through the stress-
strain curve that obtained during compression measurement. The elastic modulus of an object is 
represented as:  
Strain
Stress
E   ...........................................................(xvii)  
 
Where, E is the elastic modulus; stress is the restoring force caused due to the deformation divided 
by the area to which the force is applied and strain is the ratio of the change caused by the stress to 
the original state of the object.   
3.8 Scaffold at cryogenic temperature  
The freeze dried HA-gelatin scaffold sample was treated in liquid nitrogen at 77 K for different time 
schedule say 2, 5, 8 and 11 hours inside a cryochember. Original HA-gelatin scaffold as well as 
liquid nitrogen treated scaffolds were further characterized specifically porosity measurement, 
compressive strength, XRD and FT-IR analysis. 
3.9 Characterization of cryo-treated scaffold  
3.9.1 Morphologies of cryo-treated scaffold  
Surface morphology, microstructure, pore shape and variation of pore size of liquid nitrogen treated 
HA-gelatin scaffolds with varying the soaking time were analysed through SEM (JEOL JSM 
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6480LV). The SEM images of platinum coated scaffolds were observed in secondary electron mode 
at 15 KV.  
3.9.2 Room temperature phase analysis  
Phase analysis of the liquid nitrogen treated HA scaffold was studied through XRD analysis (as 
represented in section 3.2.1) to understand the effect of low temperature on crystallization 
behaviour polymer matrix. The scaffold samples were scanned in the range of 2θ from 20-80 in a 
continuous mode with a rate of 0.02 degrees/sec.   
3.9.3 Porosity measurement  
Porosity of the N2 treated scaffold was characterized through mercury porosimetry. Pore size and 
size distribution was characterized though intrusion porosimetry. The detailed procedure was 
represented in section 3.7.3.     
3.9.4 Compressive strength measurement  
The room temperature compressive strength of the liquid nitrogen treated scaffold samples were 
measured by universal testing machine (H10 KS, Tinius Olsen). The detailed procedure was 
represented in section 3.7.4. Surface morphology, microstructure, pore shape and pore size 
distribution of HA scaffolds were studied by SEM (JEOL JSM 6480LV). The SEM images of 
platinum coated scaffolds were observed in secondary electron mode at 15 KV.  
 
Nano rod HA based scaffold exhibited highest compressive strength after optimum cryo-
treatment and designated as cryo-treated HA-gelatin macroporous scaffold (CHAMPS),  which was 
further considered for bioactivity, biodegradability, cytotoxicity, cell viability, protein 
adsorption/release and micro-CT scan study.     
3.10 Bioactivity of the cryo-treated HA-gelatin macroporous scaffold 
(CHAMPS)  
In vitro bioactivity test of the scaffold materials evaluate the ability of apatite formation, soaking in 
simulated body fluid (SBF) solution [178]. The SBF solution is known to be a metastable buffer 
solution and even a small, undesired variance in both of the preparation steps and the storage 
temperature may drastically affect the final nucleation of apatite phase. SBF solution was prepared 
in accordance with the chemical ion concentration nearly equal to those of the inorganic 
constituents of human blood plasma and were used by A. Cuneyt Tas et al. [147]. Analytical grade 
pure NaCl (99.5%), NaHCO3 (99.5%), KCl (99.0%), Na2HPO4 2H2O (99.5%), MgCl2 6H2O 
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(99.0%), Na2SO4, (CH2OH)3CNH2 (99.5%), CaCl2 H2O (99.0%) and HCl (37 vol.%) were used in 
the preparation of SBF solution for this study. Fresh 1000 ml SBF solution was prepared by 
dissolving the required amount chemical reagents into a 2000 ml polystyrene (Tarson) beaker as 
mentioned in Table 3.2. In the beginning, reagents were added to 700 ml deionised water 
continuously one by one in the sequence only after the previous reagent has completely dissolved. 
During the preparation of SBF solution, pH ~7 was maintained by addition of 1M HCl in each step 
and temperature 33 
o
C. Finally, volume of the solution was adjusted up to 1000 ml by deionised 
water with maintaining solution pH~7.4 and temperature 37 
o
C. The resulting solution was stored in 
air tight polystyrene (Tarson) container at 5 
o
C.  
  
Table 3.2 Chemical composition of SBF [147].  
Order Reagent Amount (gpl) 
1 NaCl   6.547 
2 NaHCO3 2.268 
3 KCl 0.373 
4 Na2HPO42H2O 0.178 
5 MgCl2 6H2O 0.305 
6 CaCl2 2H2O 0.368 
7 Na2SO4 0.071 
8 (CH2OH)3CNH2 6.057 
 
 
Table 3.3 Ion concentration of SBF solution and human blood plasma[146,147]  
Order Ion Kokubo et al. 
(mM) 
Cuneyt Tas et al. 
(mM) 
Human plasma 
(mM) 
1 Na
+
 142.0 142 142.0 
2 Cl
-
 147.8 125 103.0 
3 HCO3
-
 34.2 27 27.0 
4 K
+
 5.0 5.0 5.0 
5 Mg2
+
 1.5 1.5 1.5 
6 Ca2
+
 2.5 2.5 2.5 
7 HPO4
2-
 1.0 1.0 1.0 
8 SO4
2-
 0.5 0.5 0.5 
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The ion concentrations of the SBF solutions used in this study were more closely similar with 
those of human plasma than reported by Kokubo et al [179]. The difference between the ion 
concentrations of SBF solutions and those of human plasma are represented in Table 3.3. 
Bioactivity test was conducted by taking SBF solution at pH ~ 7.4 and temperature 37 
o
C. The HA 
porous scaffolds (0.5 gm, 3 × 6 × 10 mm
3
) were soaked in 20 ml of SBF solution inside a closed 
polystyrene (Tarson) Petridis and kept in an incubator with adjust of solution pH ~ 7.4 and 
temperature 37 
o
C. The SBF soaked sample was repeatedly cleaned by de-ionized water and dried at 
40 
o
C for 12 h. Feasibility of the apatite nucleation was demonstrated through SEM microstructure 
attached with EDX.   
3.11 Biodegradation of CHAMPS  
In vitro biodegradation was carried out in 0.05M Tris-HCl buffer solution at 37 
o
C and pH ~ 7.4. 
HA scaffolds were taken in a sealed polystyrene (Tarson) Petridis followed that soaked in Tris – 
HCl buffer solution for different time interval inside an incubator at 37 
o
C and pH ~ 7.4. The tris-
HCl soaked samples were repeatedly washed with deionised water and dried at 100 
o
C. The final 
weight of the sample was taken through digital weighing balance. The weight loss was correlated 
with biodegradability of scaffold. The percentage of weight loss was estimated as:  
                           
0
0t
W
WW
  loss Weight %

  .............................................(xviii) 
Where,  
Wt = Weight of sample at time„t‟  
W0 = Weight of sample before Tris- HCl treatment  
3.12 In vitro cytotoxicity and cell viability of CHAMPS  
3.12.1 Cytotoxicity Test 
An in vitro cytotoxicity test of steam sterilized cryo-treated HA-gelatin macroporous scaffold 
(CHAMPS)  was performed using mammalian mouse fibroblast cell line L929 by direct contact 
method as per ISO-10993-5 guideline [180]. L929 cells were used in the present study because it 
can be easily cultured in a reproducible manner and also this cell line is widely used for basic 
biocompatibility. It has ease rate of proliferation and adheration with most of the biomaterial 
surface. In the beginning, guide line L929 cells were subcultured, trypsinized and seeded on to 
multiwall tissue culture plates. The L929 fibroblast cells were cultured with DMEM (Dulbecco's 
Modified Eagle Medium), 10% FBS (Fetal Bovine Serum) and incubated at 37 
o
C in 5% CO2 
atmosphere till formation of a cell monolayer. The test specimen (CHAMPS) was incubated with 
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monolayer cells at 37 
o
C for 24 h to 26 h. The CHAMPS was examined using a fluorescence 
microscope for cellular response after the requisite incubation. In vitro cytotoxicity of the test 
specimen was also compared with the negative control (high density polyethylene) nontoxic 
material and positive control (stabilized poly vinyl chloride disc) toxic material. Cell monolayer 
was examined microscopically for the response around the test specimens. 
3.12.2 Cell viability study with scaffold  
 The MTT assay was performed to measure the metabolic activity of cells and assessed through 
„color-change‟ phenomenon from yellow colored tetrazolium salt, MTT {3-(4,5-diamethyl thiazol-
2-yl)-2,5- diphenyltetrazolium bromide} to purple colored formazan. Fresh test specimens 
(CHAMPS) were sterilized by steam sterilization at 121 
o
C for 20 minute and extract was prepared 
after 24–26 h incubation at 37 ± 1 oC in 1 ml culture medium with containing of serum protein. The 
extract solution was further diluted to 50, 25 and 12.5% in same culture medium. Equal volume 
(100 µl) of extract as obtained from CHAMPS, negative control (high density polyethylene), 
positive control (dilute phenol) and cells were placed on a subconfluent monolayer of L929 cells 
and incubated for 24 ± 2 h at 37 ± 1 
o
C. The cultured cells were treated with 50 µl of MTT and 
further incubated at 37 ± 1 
o
C for 4 h in humidified and 5% CO2 atmosphere. The excess amount of 
MTT was removed by aspiration, and subsequently 100 µl of isopropanol was added in order to 
dissolve the formazan crystals. Cytotoxicity tests were performed in triplicate. The colour exchange 
was quantified by measuring absorbance at 570 nm using a spectrophotometer.  
3.13 BSA protein CHAMPS conjugate 
3.13.1 BSA protein adsorption on CHAMPS  
BSA protein solution was prepared as described in section 3.5.6. In the beginning, the identical 
shaped eight different small pieces of CHAMPS (0.5 gm, Ø–14 mm and thickness–2.5 mm,  
volume – 0.38 cm3) was sliced down by steel blade and immersed in 10 ml BSA solution of 5 
mg/ml initial concentration and kept in an incubator at 37 
o
C for different time scale from 6 h to 240 
h. The supernatant solutions were collected from individual BSA – CHAMPS conjugate specimens 
through centrifuge at 100 rpm for 4 
o
C. The adsorbed BSA protein amount was quantified by taking 
0.1 ml of supernatant from each specimen and mixed 2 ml of bicinchoninic acid solution (Thermo 
Pierce, Bicinchoninic acid protein assay kit, BCA-1 and 10N8010904). The detailed flow diagram 
for protein adsorption was represented in Figure 3.6. UV-vis spectroscopy (Perkin Elmer, Lambada 
35) at 562 nm was used to characterize the absorbance peaks and to estimate of BSA concentration 
through the use of a predetermined standard concentration – intensity calibration curve. SEM 
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(JEOL JSM 6480LV) and FT-IR (Perkin Elmer RXI, Spectrum, USA) analysis were carried out to 
understand the protein adsorption and surface bonding of CHAMPS, respectively.  
 
 
Figure 3.6 Flow diagram for the preparation HA-BSA conjugates.    
3.13.2 Micro-CT analysis of protein adsorbed CHAMPS  
Micro-CT system is an effective tool, where micro-focal X-ray projections rotated through multiple 
viewing directions in order to obtain 3D reconstructed images, spatial distribution maps of linear 
attenuation coefficients and scaffold composition [165]. The as-fabricated nanorod HA/gelatin 
scaffold as well as their protein loaded scaffold were first fixed in 10% neutral buffered formalin 
and thoroughly washed with PBS (phosphate buffer saline). Subsequently, the test samples (as-
synthesized scaffold and protein loaded scaffold) were analyzed using high resolution X-ray micro-
computed tomography (Skyscan 1172, Bruker micro CT, Kontich, Belgium). The scanning 
parameters include, X-ray beam energy = 40 kV and current = 250 μA. Under the operating 
conditions, the pixel size was around 4 μm and typically the scaffold length of 5-6 mm is sectioned 
into 600-700 parallel slices of equal height during the micro-CT analysis. While analyzing the test 
scaffolds, the rotation step was 0.25 degrees and 30 degree rotation was completed. Typical 
timescale for scanning a test sample was around 4.5 hours. The reconstruction of the selected region 
was made using the commercial NRecon reconstruction program (cone beam convergence/back 
projection algorithm-based software). Based on the density variation of various regions of the test 
scaffold, the 3D image of the scaffold was extracted on the basis of the distinction between ROI 
(region of interest) and VOI (volume of interest). Also, various views (side view, top view, front 
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view) of the 3D images are studied in order to realize the pore interconnectivity or pore distribution 
along the entire volume of the scaffold and this aspect can only be studied using micro CT 
technique. From the experimentally measured CT database, multiple 2D slices were analysed to 
quantify the distribution of the pore size, pore volume as well as strut thickness for the entire 
scaffold volume.  
3.13.3 BSA release study on CHAMPS 
BSA release study was also carried out for the same BSA protein loaded CHAMPS after immersion 
in 20 ml of phosphate buffer solution at pH 7.4 and temperature 37 
o
C. UV-vis spectroscopy (Perkin 
Elmer, Lambada 35) at 562 nm was used to characterize the absorbance peaks and to estimate BSA 
concentration through the use of a predetermined standard concentration–intensity calibration 
curve. Flow diagram for the release of loaded BSA from HA scaffold is represented in Figure 3.7.     
  
 
Figure 3.7 Flow diagram for release of BSA from loaded scaffold.  
3.14 Statistical analysis of experimental data   
Statistical analysis was conducted to understand the variation of experimental data for mechanical 
properties, protein adsorption and release on both nanoparticles and scaffolds. Each data point was 
taken from the mean of three repeated experiments. Data were represented as the mean ± standard 
deviation (SD) (n=3) through Origin Pro8. Numerical data were analysed statistically using 
standard analysis of variance (ANOVA) considering statistical significance at p < 0.05 [181,182].  
 
  
 
 
           
   
Chapter-4 
Results and Discussion 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 4 – Results and Discussion  
59 
 
 
Chapter 4 Results and Discussion  
 
Morphology, crystallinity and Ca/P ratio are prime factors to simulate the surface characteristic and 
bioresorption of hydroxyapatite nanoparticles. Moreover, the pore interconnectivity of 
hydroxyapatite-gelatin nanobiocomposite porous scaffold has a significant effect on mechanical 
properties and binding affinity of foreign molecules like BSA protein. In this context, necessary 
explanation for the above findings has been discussed in a different section as follows. Section 4.1 
illustrates a systematic synthesis technique of different morphologies such as spherical, rod and 
fibroid HA nanoparticles and their relevant characterizations. The dispersion of HA nanoparticles 
needs to consider for the delivery media and hence discussed in section 4.2. Section 4.3 describes 
on the detailed analysis of protein adsorption and release behaviour on all three different grades HA 
nanoparticles. Fabrication of freeze casted micro/macro porous nanobiocomposite scaffolds and 
their different characterizations has been discussed in section 4.4. Low grade mechanical properties 
of freeze casted scaffolds are further enhanced through optimum cryogenic treatment and discussed 
their mechanical properties with respect to microstructure in adjacent section 4.5. A particular 
scaffold has been optimized with respect to adsorption-release phenomena of HA particle/protein 
conjugate and mechanical strength of nanobiocomposites for relevant in vitro characterization. 
Bioactivity, biodegradability and cytotoxicity of developed cryotreated hydroxyapatite macroporous 
scaffold (CHAMPS) have discussed in next section 4.6. Finally, section 4.7 illustrates the improved 
protein adsorption and release efficacy of developed scaffold through FT-IR, UV-spectroscopy and 
micro computed tomography.           
4.1 Synthesis and characterization of hydroxyapatite nanoparticles   
Synthetic nano scale hydroxyapatite has classic bioactive and biocompatible properties to simulate 
bone minerals and binding affinity with foreign molecules, which specifically depends on Ca:P 
ratio, crystallinity and their morphology [103,183]. For example, semi-crystalline hydroxyapatite 
has a high level of bioresorption capability compared to high crystalline HA; moreover, high aspect 
ratio nanoparticle exhibit low binding affinity with protein molecules compare to the low aspect 
ratio nanoparticles [184,185,186]. Therefore, control over the size, morphology, degree of 
crystallization and composition of HA phase has significant importance for bio-applications, which 
could be synchronized through temperature gradient, structure directing reagent, solution pH and an 
atomic ratio of Ca/P [187,188]. Thus, a common strategy has been adapted to the synthesis three 
different morphologies such as; spherical, rod and fibroid with control over the size and 
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crystallinity, from common precursors for the fabrication of nanobiocomposite scaffold and their 
protein adsorption-release study.  
4.1.1 Process optimization and formation mechanism of HA nanoparticles 
The entire set of experimental conditions and their outcome has been represented in Figure 4.1. 
However, three optimized conditions are chosen to achieve the desired morphology, crystallinity 
and Ca/P ratio of pure HA nanoparticles. Spherical HA nanoparticles (NHS), rod HA nanoparticles 
(NHR) and fibroid HA nanoparticles (NHF) develops at pH = 12.25, temperature = 298K; pH = 9.5, 
temperature = 303K and pH = 5.25, temperature = 353K, respectively. A ternary diagram is 
sketched out on the support of the process conditions temperature, pH and Ca:P ratio in Figure 4.1. 
Crystalline and desired morphologies are achieved only for 22 sets of data, which is projected as 
hatched region. Beyond these hatched regions most of the particles appear to be calcium phosphate 
which deviates from an elemental composition of HA.  
 
 
 Figure 4.1 Hatched area of ternary diagram indicates the projected region for the formation  
of spherical (NHS), rod (NHR) and fibroid (NHF) morphology. Coloured circular point  
represents the optimum conditions to achieve Ca:P ~ 1.67 for diversified morphologies.   
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Ca-acetate SEM image provides the precursor morphology, which exhibits flower like 
structure influenced by individual fibrous Ca-acetate crystals as shown in Figure 4.2. However, 
such morphology develops different spherical, rod and fibrous hydroxyapatite nanoparticles in 
particular reaction condition. This observation indicates that starting precursor morphology has no 
significant effect when it completely dissolves in aqueous media; whereas HA morphology is 
predominately governed by the solution pH and temperature. 
  
 
Figure 4.2 SEM microstructure of calcium acetate that used as precursor material for the 
preparation of HA nanoparticles.  
 
A probable HA morphology formation mechanism are represented in Figure 4.3. High 
concentration of hydroxide (12.25 ≥ pH ≥ 10.5) ion and low temperature (298 K) favours isotropic 
growth of spherical shape, medium concentration (9.5 ≥ pH ≥ 7.75) and low temperature (303K) 
initiates the anisotropic growth of rod and finally low concentration (7 ≥ pH ≥ 5.25) with high 
temperature (353 K) accelerates the confined growth to fibroid morphology as confirmed by 
microscopic analysis. High concentration hydroxide ions are expected to present when pH solution 
is 12.25, which adsorbs on HA nuclei surface and favours non-confined three-dimensional growth 
to spherical morphology [103]. However, at intermediate solution pH, a small amount of hydroxide 
ions release from tris-buffer is likely to adsorb on selective site of HA nuclei, which results in a 
weak isotropic growth with the formation of nano rods. Hence, minimization of OH
–
 concentration 
has benefit to restricted and directional growth of HA nanoparticles. At low solution pH and high 
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temperature (353 K) the probability of OH
–
 ion adsorption from alkali on HA nuclei is decreasing 
and favours anisotropic growth of HA nuclei to fibroid morphology, which enhances one directional 
growth as a similar mechanism proposed by Bu et. al [189].  The optimized process parameters for 
the synthesis of HA nanoparticles are represented in Table 4.1.  
 
 
Figure 4.3 Schematic representation for the mechanism of different morphologies of HA. 
 
Table 4.1 Optimised parameters for the synthesis of HA nanoparticles. 
Sample Temperature (
o
C) Ca:P pH 
NHS 25 1.655 10.5-12.25 
NHR 30 1.66 7.75-9.5 
NHF 80 1.64 5.25-7 
 
4.1.2 Phase content and crystallinity of different morphologies  
Phase content, purity and crystallinity of these HA nanoparticles are assessed by XRD and plotted 
in Figure 4.4. The diffraction peaks are indexed as HA hexagonal phase with a = b = 9.4180,  
c = 6.8840 and space group P63/m (JCPDS No. 09-0432). It has been clearly seen that NHS and 
NHR appears to be poorly crystalline while NHF is well crystalline. The crystallinity of pure phase 
is increasing with aspect ratio; highest for fibroid morphology. The calculated crystallite size as 
preferred (211) plane for NHS, NHR and NHF samples are 7 nm, 15 nm and 50 nm, respectively. 
Bonding behaviour of the characteristic functional groups and Ca/P ratio has been determined 
through FT-IR and chemical method, respectively.  
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Figure 4.4 Room temperature XRD pattern of (a) NHS, (b) NHR and (c) NHF after freeze drying at 
220 K and 120 tor pressure.   
4.1.3 Rietveld refinement of HA  
X-ray diffraction patterns of as synthesized HA nanoparticles have low crystallinity along with pure 
HA phase. In order to study of their crystal structure behaviour, lattice parameter, cell volume and 
phase purity of different morphologies of as synthesized HA nanoparticles, powders were calcined 
at a predetermined temperature 700 
o
C and studied their Rietveld refinement analysis. The 
background of selection temperature is attribute to the phase and morphology stability of HA 
nanoparticles irrespective of morphologies up to 700 
o
C only [190]. Figure 4.5 represents the 
Rietveld refinement results of three different morphologies of HA nanoparticles. It is clearly seen 
from the figure that all the morphologies show the pure phase of HA with no impurities on the 
P63/m space group. The observed patterns of three morphologies of HA nanoparticles have good 
agreement with the calculated patterns with χ2 (goodness of fit) are 1.39, 1.41 and 1.31 for NHS, 
NHR and NHF, respectively. The refinement is carried out taking account on the lattice parameter, 
scale factor while the background is modelled by six co-efficient polynomials for different 
morphologies. It is to be noted that there is a change in peak shape, position and broadening which 
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is reflected in terms of lattice parameter as shown in Table 4.2. The refine parameter is found as 
similar in previous literature [191,192].  
 
 
Figure 4.5 Rietveld refinement fit to powder XRD spectra of HA (a) NHS, (b) NHR and (c) NHF. 
 
Table 4.2 Unit cell constants of HA from XRD Rietveld refinement against space group P63/m. 
Parameters NHS NHR NHF 
a =b (Å) 9.4351 (05) 9.4247 (03) 9.4223 (04) 
c (Å) 6.8748 (06) 6.8840 (04) 6.8833 (05) 
Volume (Å)
3
 530.017 (20) 529.563 (18) 529.235 (16) 
 
 
 
 
Atomic 
Positions 
 
 
 
 
4f 
 
Ca
+2
 
x 
0.6666 
y 
0.3333 
z 
0.0007 
6h Ca
+2
 0.2426 0.9904 0.2500 
6h P
5+
 0.3948 0.3657 0.2500 
6h O
2-
 0.3270 0.4849 0.2500 
6h O
2-
 0.5791 0.4618 0.2500 
12i O
2-
 0.3417 0.2578 0.0711 
2a O
2-
 0.0000 0.0000 0.1837 
2b H
1+
 0.0000 0.0000 0.0608 
Rp 17.6 % 15.1 % 15.0 % 
Rwp 23.6 % 22.3 % 21.4 % 
χ2 1.39 1.41 1.31 
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In order to get a better fit, atomic position and site occupancy are also refined. The reliable 
parameters Rp (Profile residue), Rwp (weighted profile residue) and χ
2
 are well fitted within the 
accepted values [193]. A small change in lattice parameter due to may be the different 
morphologies, which is obvious since different shapes have different strains [194]. It is also being 
pointed out that volume of cell decreases from spherical to fibroid. 
4.1.4 Vibrational spectra of HA nanoparticles 
Functional group and bond behavior of different class of HA nanoparticle confirms through FT-IR 
analysis. FT-IR spectrum of NHS, NHR and NHF powders are shown in Figure 4.6. The absorption 
bands are detected at wavenumbers 3435, 1040, 605, and 570 cm
-1
 for the synthesized HA 
nanoparticles. The absorption band at 1430 cm
-1 
is detected in the spectrum of NHS due to the 
partial absorption of atmospheric CO2 on the surface of NHS. HA has more affinity towards the 
absorption of CO2 at basic media during synthesis but that corresponding peak is absence in NHR 
and NHF since both are synthesized at low solution pH. The bands at wavenumber 1040 and 570 
cm
-1
 are associated with the characteristics of PO4
3-
 group but bands at 3435 and 605 cm
-1
 
represents the characteristic stretching and bending modes for OH
–
 group, respectively [195]. Thus, 
the low temperature synthesized HA nanoparticles are composed of PO4
3-
 and OH
–
 anions and free 
from other impurities.  
 
 
Figure 4.6 FT-IR spectrum of (a) NHS, (b) NHR and (c) NHF as synthesized nanoparticles.  
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4.1.5 Ca:P ratio of HA nanoparticles  
The amount of calcium (Ca) and phosphorous (P) present in HA nanoparticles is estimated by 
complexometric titration with EDTA (Ethylenediaminetetraacetic acid) and gravimetric method 
with ammonium molybdite, respectively [166]. EDTA makes complex reaction with the content of 
Ca
2+
 in HA at 25 
o
C and solution pH~12. The amount of Ca
2+
 consumed by EDTA is estimated with 
the use of ACC (Ammonium Acetate) buffer and Eriochrome Black-T indicator. The Ca- EDTA 
complex is shown in Figure 4.7 as:  
 
HO N
OH
O
N
OH
O
OH
O
O
EDTA
Ca
O N
O
O
N
O
O
O
O
O
Ca-EDTA Complex
Ca
2
pH~12
25oC
 
Figure 4.7 Schematic representation of the reaction between Ca
2+
 and EDTA.  
 
Phosphate reacts with ammonium molybdate in warm nitric acid solution and precipitates yellowish 
ammonium 12-molybdophosphate [(NH4)3(PMo12O40)] after drying at 200-400 
o
C or molybdenum 
oxide phosphate (P2O524MoO3) at 800-825 
o
C for 30 minute [166]. XRD pattern represents the 
identity of P2O524MoO3 complex after reaction within ammonium molybdate and hydroxyapatite 
nanoparticles (Figure 4.8). The amount of phosphorus is estimated from the yield of the final 
complex. XRD represents the phase of ammonium phosphomolybdate. Ca:P ratio for spherical, rod 
and fibroids are found as 1.656, 1.66 and 1.64, respectively. The Ca:P ratio plays an important 
factor to control the surface reactivity of nano HA particles. The result shows that the calculated 
Ca:P ratios for the synthesized HA has a lower value as compared to the stoichiometric HA (Ca:P 
ratio ~ 1.67). Thus synthesized HAs could be considered as calcium deficient HA with relatively 
low crystallinity. 
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Figure 4.8 XRD pattern of ammonium phosphomolybdate at 825 
o
C. 
4.1.6 Transmission microscopy of HA nanoparticles  
Morphology, crystallinity and particle size are investigated through TEM and SAED techniques. 
TEM images of these HA powders and their SAED patterns are represented in Figure 4.9. A close 
look reveals the formation of spherical particles near to 10 nm diameter with a consist of strong 
concentric ring pattern for (002), (211), (112) and (300) plane of polycrystalline HA [196]. Rod 
shaped morphology exhibits near to 7 nm diameter with aspect ratio of ~5. The dotted SAED 
pattern is also well matched with ring, which confirms a better crystallinity of rod morphology 
compare to spherical powder. High crystallinity and purity of fibrous morphology as defined by 
XRD pattern are well matched with represented SAED pattern. Average diameter is gradual 
increament up to 30 – 40 nm with very high aspect ratio for fibroid morphology.   
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 Figure 4.9 HRTEM and SAED represent the morphology and crystal pattern of NHS, NHR and 
NHF. 
4.1.7 BET isotherm of HA nanoparticles  
BET specific surface area plots for the prepared HA nanoparticles are represented in Figure 4.10. 
The measured specific surface area of NHS, NHR and NHF are 256 m
2
/g, 217 m
2
/g and 47 m
2
/g 
and calculated crystallite sizes (DBET) are found as 7, 9 and 40 nm in diameter, respectively [197]. 
BET isotherm with BJH (Barrett, Joyner and Halenda) pore size distribution of the synthesized HA 
powders are shown in Figure 4.11. All particles exhibit type – IV isotherm. A characteristic feature 
of the type–IV isotherm is represented by hysteresis loop and occurs due to capillary condensation 
taking place in micropores over a range of high p/p
o
 [198]. The initial part of the type–IV isotherm 
is an attribute to monolayer-multilayer adsorption phenomenon. Enhance pore volume and decrease 
relative pressure depend on low surface area as well as high aspect ratio of HA nanoparticles. 
Identical nature of pore diameter is observed for all three morphologies. However, difference in the 
adsorption hysteresis curve for the synthesized HA nanoparticles are observed with varying the 
saturation pressure due to the presence of different levels of nano scale pores. Detailed properties of 
BET isotherm and the size of the observed micro pores of the synthesized HA powders are 
represented in Table 4.3. The adsorption hysteresis curves for the synthesized HA nanoparticles are 
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varying with the saturation pressure due to the presence of different levels of nano scale pore.  A 
large extent of surface area and insignificant pore diameter variation has been found with respect to 
morphologies.  
 
 
Figure 4.10 BET plots for (a) NHS, (b) NHR and (c) NHF. 
 
 
Figure 4.11 BET adsorption and desorption isotherms (a), (c) and (e) and BJH pore size 
distribution (b), (d) and (f) for HNS, HNR and HNF respectively.  
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Table 4.3 BET surface area and micro pore properties of HA. 
Sample 
ID 
BET surface 
area in  m
2
/g 
(SBET) 
Average 
particle size 
in nm 
(DBET) 
Pore 
volume in 
cc/g VBJH 
Pore 
diameter 
in Å 
(BJH) 
NHS 256 7 0.788 17.9 
NHR 217 9 0.821 18.01 
NHF 47 70 0.903 19.3 
  
4.1.8 Conclusion  
HA nanoparticles are successfully prepared through chemical precipitation method using the 
common precursor materials as Ca(CH3COO)2 and KH2PO4 over the control of solution pH, 
temperature and Ca:P ratio. High hydroxyl ion concentration (12.25 ≥ pH ≥ 10.5) and low 
temperature (298 K) favours isotropic non-confined spherical shape, intermediate concentration 
(9.5 ≥ pH ≥ 7.75) and low temperature (303 K) initiate the anisotropic growth of rod particles and 
low concentration (7 ≥ pH ≥ 5.25) but high temperature (353 K) accelerates the restricted expansion 
to fibroid morphology of HA. NHF has high crystallinity with compare to NHS and NHR. The 
prepared HA nanoparticles have 8 nm, 10 nm and 40 nm size for NHS, NHR and NHF, 
respectively. Vibrational spectra of HA nanoparticles reflects the presence of functional groups 
PO4
3–
 and OH
–
 of HA only. BET isotherm and specific surface area reveals the formation of high 
specific surface area of synthesized HA; highest for spherical and lowest for fibrous morphology. 
HA nanoparticles exhibits type-IV adsorption isotherm and ~2 nm nanoscale pores through BJH 
pore size distribution. Thus, the prepared three morphologies of HA nanoparticles have been 
considered for the fabrication of nanobiocomposites with gelatin and studied the BSA protein 
adsorption and release behaviour.  
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4.2 Dispersion of HA nanoparticles  
 
Dispersed nano HA particles have importance in the sense of gene carrier, protein delivery media, 
slurry for the preparation of freeze casted porous scaffold and artificial bone regrowth because of 
high absorption efficiency and binding affinity with versatile molecules [199,200]. However, 
dispersion in aqueous medium and stability of such hydrophobic nanoparticles is a challenging task. 
Most of the techniques are used to disperse HA nanoparticles such as ultrasonication and 
mechanical milling with variant dispersants [201,202]. However, the above mentioned methods 
have no prolong stability in aqueous media. Therefore, a typical dispersion mechanism has been 
adopted as followed to make silica sol from silica nanoparticles [203].  
In a similar fashion, three morphologies of HA nanoparticles are dispersed in aqueous media 
using sodium citrate as chelating agent. Na-citrate is developed from combination of citric acid and 
NaOH. The dispersed state of different HA nanoparticles in aqueous media are shown in  
Figure 4.12. In the proposed research work, HA-citrate complex is obtained at 90 
o
C and pH~7.4.   
 
 
Figure 4.12 Illustration of dispersed nano HA particles (A) NHS, (B) NHR and (B) NHF. 
 
Stability of the HA-citrate depends upon the reaction temperature and pH of the solution. Two 
molecules of citrate ions C3H5O(COO)3
3– 
are likely to interact with three molecules of Ca
2+
 of HA 
and form chelate complex (Figure 4.13). The formation of chemical bonding between nano HA and 
citrate is represented through hydrogen bonding and or carboxyl-calcium-carboxyl ((COO-)-Ca-
(COO-)) complex, which allows the homogenous dispersion of nano HA [204]. Thus, the complex 
formation and dispersion phenomenon are influenced by the available Ca
2+
 site and surface 
characteristics of particles. Prepared homogenous dispersion exhibits stability up to six months 
without appearance of the creamy layer or sedimentation on the surface of the solution.  
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Figure 4.13 Schematic for the reaction of HA-citrate complex formed between the sodium citrate 
and HA.    
4.2.1 Zeta potential measurement   
An assessment of zeta potential (ξ; mV) is essential to achieve homogenous dispersion of different 
grade HA nanoparticles. Dispersed nanoparticles exhibits stability for the extent of more than six 
months with a constant zeta potential, -19.2 mV, -17.6 mV and -15.2 mV for NHS, NHR and NHF, 
respectively. The negative zeta potential favour to form homogenous dispersion because of the 
excellent chelating ability within citrate ions and Ca
2+
 ions, which develops negative electrophoretic 
mobility of HA in citrate solution [99,205]. HA-citrate complex increases the interfacial surface 
area due to the repulsion between particles and increases the dispersibility of nanoparticles.    
4.2.2  Particle size distribution of dispersed HA nanoparticles  
Particle size distribution of the dispersed HA nanoparticles is represented in Figure 4.14. Mono 
modal size distribution of HA nanoparticles with an average size of the dispersed HA nanoparticles 
are found as 148 nm, 168 nm and 220 nm for NHS, NHR and NHF respectively as indicated in  
Table 4.4. NHS and NHF both have wider size distribution whereas NHR represents relative narrow 
distribution; although all seems in higher size range with respect to original particle size. Both NHS 
and NHR have the tenacity to coagulate within the particles because of high surface area. However, 
the particle size of relatively low surface area NHF is also shifted towards the right side after 
dispersion because of strong particle interaction associate with irregular shape and non-uniform 
stress distribution around the surface edge of elongated morphology [206]. The deviations of 
observed particle size from TEM and BET surface area analysis attribute to the tendency to form 
agglomerate within the range of 150-220 nm because of van der Waals force of attraction with 
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unsaturated citrate molecules. A representative FT-IR spectrum is further discussed the HA-citrate 
complex behaviour as follows.   
 
 
Figure 4.14 Particle size distribution of dispersed HA.   
 
Table 4.4 Zetapotential and size of the dispersed HA nanoparticles.  
 
4.2.3 Vibrational spectra of dispersed nanoparticles 
The characteristic stretching and bending vibrational spectrum of HA-citrate complex is shown in  
Figure 4.15. FT-IR spectrum of  HA – citrate complex exhibits characteristic vibrational bands of  
C – O  and spectral bands of υas (COO–) at 1619 cm–1 and υs (COO–) at 1416 cm–1, respectively 
[99,205]. Most intense and broad peak at 3458 cm
–1
 describes the presence of OH
–
 ions from citrate 
group on the HA surface. The most prominent characteristic peaks of COO
–
 and OH
–
 reveal the 
feasibility of the formation of HA citrate complex. Furthermore, the vibrational band at wave 
Samples Zetapotential (mV) Size (nm) 
NHS -19.2 148 
NHR -17.6 168 
NHF -15.2 220 
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number 1034 and 566 cm
–1
 show the characteristic stretching and bending modes for PO4
3–
 group of 
HA nanoparticles, respectively.  The spectral band difference between before and after dispersion of 
HA nanoparticles confirms the formation of HA-citrate complex.  
 
 
Figure 4.15 FT-IR of before and after dispersion of NHR nanoparticles. 
4.2.4 Conclusion  
Dispersed HA nanoparticles follow complexometric reaction with sodium citrate. The resulting HA 
citrate has homogeneous dispersibility and more than six months stability without the appearance of 
sedimentation. FT-IR analysis confirms the complexation reaction feasibility between the HA and 
the citrate ions. High negative zeta potential attributes the stability of the HA dispersion. Dispersed 
HA nanoparticles could be used for the preparation of homogenous slurry or suspension and their 
fabrication of porous scaffold with apposite solid loading, as well as protein delivery media.   
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4.3 BSA adsorption and release study on synthesized HA 
nanoparticles  
 
Hydroxyapatite is a major constituent of hard tissue, bone and teeth and hence synthetic 
biocompatible HA has clinical use as filler and delivery media [207]. A common conjecture in 
biomaterials research is the cellular interaction towards bioimplant surfaces, mediated through 
adsorbed proteins, since protein is an essential component to support cell nutrients, cell growth and 
attachment. Hence, different class of protein first adsorb on foreign biomaterial surface prior to 
initiate in vivo activity [208,209]. Serum albumin is such an essential protein ingredient for in vitro 
cell culture [210,211]. In addition, the adhesion and proliferation of osteobleast cells and 
mesenchymal cells depend on the concentration of the serum protein in culture media [160,212]. 
Osteoporosis, osteomyelitis, arthritis, etc., are bone related disease and sustain drug release at the 
bone site is desirable [209]. The bone-implant interfaces consist of bonding zone of calcium and 
phosphorus-rich proteinaceous matrix [152,213]. Serum protein adsorption onto implant materials 
form bond through interfacial film. Development of advanced materials for bone tissue 
replacement, coatings on medical prosthesis or tissue engineering applications, is needed to 
understand the mechanisms within protein–biomineral interface. In this aspect, HA could be 
considered as a reliable source as protein delivery media to the requisite site. Thus, protein HA 
interaction and their adsorption / release are important phenomena. In this backdrop, BSA has been 
considered as a model protein as it is available in a highly purified form and soluble in water. It is, 
therefore, convenient to use this protein in a series of repeated experiments comparing the 
adsorption and release behaviour of HA. Here in, synthesized HA nanoparticles are used for BSA 
protein adsorption and release study. Protein concentration, adherence on HA nanoparticles surface 
and bonding behavior are studied through UV-visible, BET isotherm, FT-IR and DSC/TG analysis.  
4.3.1 Microstructure of BSA protein 
Microstructure of the BSA is represented in Figure 4.16. SEM microstructure of BSA shows plate 
like structures with channeled pores. The sizes of the channeled pores are found in the range  
~10 µm whereas lengths are around 300 µm of BSA. The intercalating spaces assist to develop 
moderate conjugation with nano scale HA particles and its biocomposite because of the electrostatic 
interaction between the BSA protein and HA nanoparticles [214].     
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Figure 4.16 SEM microstructure of the pure BSA.  
4.3.2 Mechanism of copper complex with BSA  
The BCA™ Protein Assay is a bicinchoninic acid (BCA) reagent for the colorimetric quantification 
of protein. This method describes the well-known reduction of Cu
+2
 to Cu
+1
 process by protein in an 
alkaline medium and selective colorimetric detection of cuprous cation (Cu
+1
) using a unique 
reagent containing bicinchoninic acid (Equation xix) [215]. The purple-colored reaction product of 
this assay is the result of chelation of two molecules BCA with one cuprous ion [216]. The 
chelation product that formed with the two molecules of the BCA and Cu
+1
 is shown in Figure 4.17.  
This water-soluble complex exhibits a strong absorbance at 562 nm, which follows linear 
relationship with increasing protein concentration over a broad working range of 20-2,000 μg/ml 
[217].    
 

CuCuProtein OH2 ..........................(xix) 
N
N
N
N
Cu
Cu BCA+
COO-
COO
 -
COO-
COO-
 
Figure 4.17 Schematic of BCA Cu ion complex.   
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4.3.3 Standard curve for protein BSA determination 
The concentration of the standard BSA protein is calculated by measuring the absorbance. The 
maximum absorbance of standard BSA protein is found in the wavelength Amax ~562 nm. A 
standard plot is drawn by measuring the concentration of predetermined dilution and the maximum 
absorbance of diluted standard BSA. The dilutions with the corresponding absorbance are 
represented in Table 4.5.  
  
Table 4.5 UV-spectroscopic measurement of the maximum absorbance at A562 nm.  
No. of Vial  BSA 
(µg/ml) 
Working 
reagent (ml) 
Volume of 
sample (ml) 
Absorbance 
(A562) 
A 2000 2 0.1 2.2485 
B 1500 2 0.1 1.7655 
C 1000 2 0.1 1.4305 
D 750 2 0.1 0.8911 
E 500 2 0.1 0.5823 
F 250 2 0.1 0.3329 
G 125 2 0.1 0.1559 
H 25 2 0.1 0.0798 
I 0 2 0.1 0.0413 
 
  
Figure 4.18 BSA protein standard curve for the protein concentration determination.  
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The maximum absorbance with concentration of the known BSA protein gives linear plot as 
shown in Figure 4.18. Linear plot with the correlation factor (R
2
) 0.996 is calculated from the 
standard plot, which is latterly used for the determination of amount of BSA adsorbed by the HA 
nanoparticles and nanobiocomposite scaffold.   
4.3.4 BSA adsorption on HA nanoparticles  
BSA adsorption on HA nanoparticles phenomenon has evaluated for different time interval from 10 
to 240h as shown in Figure 4.19. UV-visible absorbance behavior of BSA adsorbed HA 
nanoparticles are observed in the wavelength region of ~560-570 nm. The maximum absorbance 
depends upon the intensity of the color developed and also the period of incubation. A rapid rate of 
protein adsorption on HA nanoparticles is found after 48 h incubation and follows steady state 
beyond this time area. Wassell et al. [218] demonstrated that BSA adsorption on HA reaches a 
steady state at very shorter time scale of around 2h. The maximum absorbance of BSA protein for 
48h is studied through UV-visible spectrometer as revealed in Figure 4.20. Absorption study shows 
that rod morphology of the HA nanoparticles adsorbes higher amount of BSA in comparison of 
spherical and fibroid morphology. A slight higher adsorption capacity of rod morphologies is 
presumed to be the reason of semicrystalline behavior, high surface area and higher Ca:P ratio 
compare to others. High degree of cationic charge prefers to interact with anionic part of protein 
molecules [219]. Adsorption isotherms of the BSA adsorbed HA nanoparticle is shown in  
Figure 4.21 The results of adsorption isotherm clearly indicates that BSA adsorption on HA follows 
the Langmuir adsorption isotherm and develops monolayer [220]. Adsorbed amount of BSA protein 
increases sharply at low solution concentration of BSA protein and levels off at higher protein 
concentration approaching a limiting adsorbed value.  The amount of adsorbed protein at the 
plateau of the adsorption isotherm is close to the closed-packed monolayer. Amount of BSA uptake 
by HA nanoparticles surfaces are 26.5 mg/g, 28 mg/g and 25.7 mg/g for NHS, NHR and NHF, 
respectively. The result shows that rod morphology of the HA nanoparticles uptake is relatively 
higher amount of BSA as compared to the counterpart spherical and fibroid morphology. 
     
Chapter 4 – Results and Discussion  
79 
 
 
Figure 4.19 Uptake of BSA by different morphologies of HA nanoparticles with incubation time.   
 
 
  
Figure 4.20 UV-visible of BSA adsorbed HA nanoparticles after 48 h studies.  
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Figure 4.21 Adsorption isotherm of BSA on HA nanoparticles. 
  
Langmuir adsorption isotherm represented as:  
 
Ce
a
Ceq
q
L


)
1
(
max
 .....................(xx)
 
Where,  
q = Amount of BSA adsorbed on HA (mg/g) 
qmax = Maximum adsorption capacity (mg/g) 
Ce = BSA concentration in solution at the equilibrium  
aL = Langmuir constant (ml/mg)  
The amount of BSA adsorbed is calculated by applying the Equation xxi. The equation can be 
represented as: 
Amount of BSA adsorbed 
M
VCC
q e
)( 0 
..........................................(xxi)
 
Where,  
Co = Initial BSA concentration  
V = Volume of BSA solution in ml 
M = Mass of HA in grams.   
 
 
Chapter 4 – Results and Discussion  
81 
 
 
Figure 4.22 Uptake of amount of BSA by HA powders calcined at 700 
o
C  
 
In a similar fashion, the protein intake is also determined for calcined HA particles to justify the 
effect on surface area and crystallinity. Figure 4.22 represents the BSA uptake content by 700 
o
C 
calcined HA nanoparticles. Amount of BSA uptakes by calcined HA nanoparticles are calculated as 
previous and found as 16 mg/g, 17 mg/g and 15 mg/g for NHS, NHR and NHF, respectively. The 
low adsorption capacity of calcined (700 
o
C) HA particles due to the low specific surface area 158 
m
2
/g, 115 m
2
/g and 20 m
2
/g against the as-synthesized HA nanoparticles for NHS, NHR and NHF, 
respectively. Hence, as-synthesized HA nanoparticles are considered for protein adsorption/release 
as well as the fabrication of scaffold. A comparison study of BSA protein adsorbed by  
as-synthesized and calcined HA represented in Table 4.6. 
 
 Table 4.6 Comparative study of protein adsorption by as-synthesized and calcined HA particles.  
 As-Synthesized HA Calcined HA 
Samples Surface area 
(m
2
/gm) 
BSA adsorbed 
(mg/gm of HA) 
Surface area 
(m
2
/g) 
BSA adsorbed 
(mg/gm of HA) 
NHS 256 26.5 158 16 
NHR 217 28 115 17 
NHF 47 25.7 20 15 
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4.3.5 BET adsorption isotherm of BSA adsorbed HA nanoparticles  
BET specific surface area plots of BSA adsorbed HA nanoparticles and the pure BSA are 
represented in Figure 4.23. The specific surface area of the HA powders is likely to be decreased 
from their corresponding initially data 256 m
2
/g, 217 m
2
/g and 47 m
2
/g for NHS, NHR and NHF 
during BSA adsorption onto the HA nanoparticles. BET specific surface area of pure BSA (sigma 
Aldrich) is 25.85 m
2
/g, whereas BSA adsorbed NHS, NHR and NHF powders has 59.74 m
2
/g, 
41.47 m
2
/g and 5.01 m
2
/g, surface area respectively. The BET plots are not linear because of the 
adsorption and existence of BSA molecules on the HA surface. Specific surface area decrement of 
the adsorbed HA nanoparticles supports the adherence of BSA particles on the HA surface. 
 
 
 Figure 4.23 BET specific surface area plots of BSA adsorbed HA nanoparticles (a) NHS, (b) NHR, 
(c) NHF and (d) pure BSA.  
 
BET adsorption isotherm plots associated with the micro pores on BSA adsorbed HA nanoparticles 
as shown in Figure 4.24. BSA adsorbed HA nanoparticles show isotherm-IV type and the saturation 
pressure starts earlier as compared to the isotherm for untreated HA. The hysteresis curve is wider 
due to the presence of micro pores on HA nanoparticles. Pore diameter in the range 1.65 nm, 1.419 
nm and 1.241 nm for NHS, NHR and NHF, and is detected by applying BJH pore size analysis 
method. Reduction of micro pores and pore volume content are attributed to the adsorption of BSA 
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on HA nanoparticles. BJH pore size distribution, surface area of pores and volume of pore are 
represented in Table 4.7.  
 
 
Figure 4.24 BET isotherm plot (A) NHS, (B) NHR and (C) NHF and their corresponding 
micropore size distribution (B), (D) and (F).  
 
Pore volume calculated from the BJH method is decreased when protein BSA conjugates with HA 
nanoparticles. The reduction of surface area, micro pore diameter and pore volume clarifies the 
feasibility of HA-BSA conjugates formation.  
 
Table 4.7 BET specific surface area and properties of the micro pores. 
Sample ID BET surface 
area of HA in 
m
2
/g 
BET surface 
area BSA-HA 
in  m
2
/g 
Pore volume 
in cc/g VBJH 
Pore diameter 
in Å (BJH) 
NHS 256 89.74 0.037 16.51 
NHR 217 41.47 0.039 14.19 
NHF 47 5.01 0.037 12.41 
BSA - 25.86 0.0047 25.12 
Chapter 4 – Results and Discussion  
84 
 
4.3.6 Mechanism of BSA- HA adsorption  
The plausible schematic representation of BSA protein adsorption mechanism on HA nanoparticles 
is illustrated in Figure 4.25. Nano HA binds the protein BSA with high affinity on its surface due to 
high surface to volume ratio. Binding is thought to depend on the interaction of calcium with 
anionic site (COO
–
) of protein whereas, the phosphate group of same HA follows a strong 
interaction with a basic moiety (–NH3
+
) of identical protein molecules [78,221]. The Ca
2+
 site of 
HA also repulse with NH3
+
 group of protein, but PO4
3–
 tends to attract toward NH3
+
. Similarly, 
anionic PO4
3–
 of HA also repulses with COO
– 
of a protein molecule and attracts with Ca
2+
 through 
electrostatic force of attraction. Thus simultaneous attraction and repulsion mechanism between HA 
and protein facilitate to make strong HA–protein conjugates. Higher molecular weight proteins such 
as fibronectin, transmembain protein, bone morphogenic protein has tendency to adsorb on HA 
surface more tightly as predicted by Rauschmann et al [222].  
 
 
Figure 4.25 Mechanism for protein BSA and HA interaction.  
4.3.7 FT- IR analysis of adsorbed BSA  
FT-IR is sensitive to secondary protein structure [223]. Secondary protein structure is nothing but a 
specific geometric shape caused by the hydrogen bonds between backbone amide and carboxyl 
groups in protein [224]. Characteristic vibrational functional groups for the BSA and BSA adsorbed 
HA nanoparticles are represented in Figure 4.26.  Different wavenumber 1654 cm
–1
, 1536 cm
–1
 and 
1441 cm
–1
 represents the vibratioanal bands for amides of the adsorbed BSA [225]. The terminal 
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alkyl –CH stretching for the adsorbed BSA is observed at wavenumber 2963 cm–1. Broad 
adsorption peaks for OH
–
 stretching vibration are resulted due to the presence of OH
–
 of HA as well 
as the adsorbed BSA. Wavenumber 1059 cm
–1
and 559 cm
–1 
represents for the characteristic 
stretching vibration for PO4
3–
 group. FT-IR result reveals that BSA protein adsorbs on the HA 
nanoparticles without any denaturation. Furthermore, the characteristic vibrational band of amide 
shows the secondary structure of BSA, as well as the BSA adsorbed on HA surface [226]. The 
nature of bonding behavior and position of vibrational wavenumbers are summarized in Table 4.8.  
 
 
Figure 4.26 FT-IR study of the BSA adsorbed HA nanoparticles (a) Pure BSA, (b) NHS-BSA, (c) 
NHR-BSA and (d) NHF-BSA.  
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Table 4.8 Characteristic vibrational bands of BSA adsorbed HA nanoparticles.  
Functional Groups BSA 
νo(cm
–1
) 
HSB 
νo(cm
–1
) 
HRB 
νo(cm
–1
) 
HFB 
 νo(cm
–1
)       Groups Mode of vibration 
  
– 
 
1038 
          Strong 
1041 
strong, broad 
1035 
strong, broad 
– 
 
553  
Weak 
545 
weak 
559 
weak 
 
 
3314 
strong 
3350 
Strong 
3320 
strong, broad  
3327 
strong, broad  
610 
weak 
605 
Weak 
603 
broad, strong 
608  
weak 
 2953 
weak 
2933 
Weak 
2960 
weak 
2951 
very weak 
  
1662 
strong 
1650 
Weak 
1658 
strong 
1654 
strong, intense 
 
1544 
strong 
1532  
Weak 
1546 
strong 
1536 
strong, intense 
  
4.3.8 Thermal analysis of BSA adsorbed HA nanoparticles  
The relevance of this study is allied with the indirect assessment about the adherence of BSA 
protein with HA nanoparticles; since high temperature will allow to remove the adsorbed organic 
molecules at elevated temperature. In this study, rod shaped HA morphology is encountered 
because it has maximum BSA protein adsorption behavior. Thermal analyses of BSA and BSA 
adsorbed nano rod HA particles are represented in Figure 4.27. Thermal analysis of BSA shows an 
endothermic peak at 90 
o
C for the presence of physical adsorbed moisture and broad exothermic 
peaks observed at 450 
o
C associate with the decomposition of amides bonds in BSA [227]. Thermo 
gravimetric analysis of the pure BSA shows mass loss of around 70% at temperature 420 
o
C and the 
remaining mass is due to the formation of some carbonaceous products [228]. Broad exothermic 
peak in the temperature range 350 to 550
 o
C is because of decomposition of pure BSA as shown in 
Figure 4.27(A). In the same time, BSA adsorbed NHR shows 22% mass loss at 450 
o
C which is 
associated with the decomposition of BSA. Differential scanning calorimetry data for the  
NHR-BSA powder shows an exothermic peak at 340 
o
C associate with decomposition of amide 
bonds of BSA as represented in Figure 4.27(B). The exothermic peak attribute to the thermal 
decomposition of BSA molecules that tightly bound with HA crystals through electrostatic force 
[229]. Thus, the thermal analysis of BSA adsorbed HA nanoparticles clarifies the adherence of BSA 
particles on the surface of the HA through electrostatic force of attraction.  
P
O
-O
O-
O-
O H
C H
O
C N
H
O
C N
H
P–O stretching  
P–O bending  
O–H stretching  
O–H bending  
C–H stretching  
Amide-I stretching  
Amide-II bending 
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Figure 4.27 Thermal analysis of BSA adsorbed HA powders (A) pure BSA and (B) NHR-BSA.  
4.3.9 BSA release study on HA nanoparticles 
Release study of the BSA loaded HA nanoparticles are also studied through UV spectrometer. The 
amount of BSA release amount percentage is plotted against the release time represented in  
Figure 4.28. The high rate of release is observed ~75% in 96h and then follows slow release 
rate.The absorbance performance of the released BSA from HA nanoparticles after 96h is shown in 
Figure 4.29. Rod morphology shows the highest absorbance followed by spherical and fibroid.  
 
 
Figure 4.28 Amount of BSA released from the loaded HA nanoparticles.  
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Figure 4.29 UV-visible release of BSA from HA nanoparticles.   
 
Mechanism of BSA release from the BSA loaded HA nanoparticle is illustrated in  
Figure 4.30. Both of BSA and phosphate ions in PBS are efficient to adsorb onto Ca-sites on HA 
[230]. However, a competition occurs between BSA and phosphate ions in PBS. Phosphate ions 
have high affinity to HA compared to BSA [114]. So, most of adsorption sites on HA are occupied 
by phosphate ions, leading to desorption of adsorbed BSA. As a result, adsorbed BSA protein 
molecules are easily released from nano HA and displaced by phosphate ions. 
 
 
Figure 4.30 Release mechanism of BSA from the HA-BSA in PBS solution  
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4.3.10 Conclusion  
Rod morphology HA nanoparticle adsorb higher amount of BSA as compare to the counterpart 
spherical and fibroid morphologies. One gram of nanorod HA particles adsorb 28 mgs of BSA. 
Higher protein adsorption capacity of nano HA has also high release rate. Slow and steady release 
of loaded BSA from HA nanoparticles is observed up to 75% within 96 h. FT-IR analysis of BSA–
HA shows the secondary structure of protein. BSA adsorbed HA nanoparticles may be used as bone 
filling material and tissue engineering. In addition, high adsorption and steady release of BSA 
protein from synthesized nano-rod are supposed to be beneficial for the delivery of protein drugs, 
treatment of cancer cells and bone related diseases.      
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4.4 Fabrication of freeze casted HA-gelatin scaffold 
 
Porous scaffold allow cell growth and their proliferation when pore diameter exist near to 100 m 
as resemble with bone morphology [231]. Scaffolds provide adequate space and effective surface 
for cell seeding into the temporary scaffold before implantation and support cells for better 
attachment and proliferation. Hence, bioactive porous HA scaffolds are considered as a large extent 
for repairing and tissue engineering because of effective nutrients transport, tissue growth and 
formation of bone – extracellular matrix to support the adequate structure [232]. Different results 
are reported for the fabrication of porous scaffolds in several ways particularly using pore formers 
[137], polymeric template [233], dual phase mixing [234], salt leaching and foaming [118,235]. In 
another end, nanoparticle has high temperature phase and morphology instability when prepared 
from Ca(CH3COO)2 and KH2PO4 [190]. Moreover, high crystallinity and less reactivity towards 
protein molecule have been observed after 700 
o
C calcination of HA nanoparticles.  In another end, 
gelatin is generally coined as the hydrolysed form of collagen and has clinical use as a drug delivery 
carrier because of its sufficient plasticity, hydrogel properties and resemble with bone matrix 
[236,237].
  
Hence, low temperature freeze casting technique has been adopted for the fabrication of 
macroporous nanobiocomposite scaffolds from as-synthesized HA nanoparticles and gelatin and 
studied their details porous architecture, pore size distribution and mechanical response of freeze 
casted HA-gelatin nanobiocomposite scaffold systematically.   
4.4.1 Interaction between polyvinyl alcohol and gelatin 
Polymeric binder polyvinyl alcohol (PVA) has terminal hydroxyl groups, and gelatin contains 
amino acid residue with terminal acidic and amino groups. Esterification process within hydroxyl 
groups of PVA and the terminal acidic groups of the amino acid residue of the gelatin favors 
formation of whitish high viscous slurry at temperature 60 
o
C [238]. The schematic for the probable 
chemical reaction likely to occur between PVA and gelatin is shown in Figure 4.31. A detail 
nanobiocomposites of HA – gelatin preparation technique has already been illustrated in the 
experimental section. The gelling properties of gelatin interact and bind with HA powder through 
covalent network to form porous scaffold.   
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 Figure 4.31 Schematic for the chemical reaction between PVA and gelatin.  
4.4.2 Vibrational spectra of freeze dried HA-gelatin scaffold  
Figure 4.32 shows the FT-IR spectrum of the freeze dried HA-gelatin scaffold. The characteristic 
stretching and bending vibration bands of HA are found at the wavenumber of 1035 cm
–1
 and 603 
cm
–1
 for PO4
3-
 and 3433 cm
–1
 and 559 cm
–1
 for the OH
–
 group, respectively [239]. Wavenumber 
2919 cm
–1
 occurs due to the stretching vibration of –CH of alkyl residue present in both of the PVA 
and gelatin [240]. The characteristic wavenumber at 1661 cm
–1
 is due to the –COO– group of the 
ester formed by the mixing of PVA and gelatin. Broad and prominent peak for OH
–
 are the result of 
an interaction between gelatin and PVA. The FT-IR spectrum analysis confirms the presence of 
pure HA as well as the gelatin.       
 
 
Figure 4.32 FT-IR study of the freeze dried HA-gelatin scaffold.   
Chapter 4 – Results and Discussion  
92 
 
4.4.3 SEM microstructure of fabricated scaffold   
As-synthesized three different spherical, rod and fibroid hydroxyapatite nanoparticles are 
considered to fabricate HA-gelatin porous scaffolds. SEM microstructure of freeze dried HA 
scaffolds is represented in Figure 4.33. The reason of optimum (40 wt.%) solid content with 
consideration of pore dimension, pore size distribution and their mechanical properties is discussed 
in next Section 4.4.5. Interconnected near circular pore morphology macro porous structure has 
seen with a pore diameter ~ 50-180 µm for NHS-gelatin (HSG) scaffold (Figure 4.33(A)) and HA 
particle dispersion is shown in Figure 4.33 (B). Similarly, the SEM result shows open macropores 
morphologies with average pore diameter in the range ~ 40-150 µm for NHR-gelatin (HRG) 
scaffold in Figure 4.33(C) and distribution of NHR particles shown in Figure 4.33 (D). Pores are 
found as circular in shape with partly interconnected structure through polymeric matrix. The SEM 
microstructure of NHF-gelatin (HFG) scaffold as represented in Figure 4.33(E) and NHF particle 
distribution is shown in Figure 4.33(F). Circular open macro pores with an average pore diameter 
varies in the range ~ 50-200 µm. HFG scaffolds has relatively larger pore diameter than the 
counterpart HRG and HSG scaffold. Different pore morphologies resulted is the replica of the 
developed ice crystal during freeze drying. Heinemann et al [138] demonstrated HA-collagen 
scaffold through freeze casting exhibits 100-200 µm pore size, 80 vol.% porosity and 0.085 MPa 
compressive strength. HRG scaffolds shows well pore size distribution with reticulated open porous 
structure as compared to HSG and HFG and hence considered for micro-CT analysis in later. Most 
of the pores are open macroporous along with elliptical shape. NHR particles are well dispersed and 
arranged within the polymer matrix as compared to the counterpart spherical and fibroid particles. 
Thus, the mechanical properties of rod morphology scaffold exhibits improved mechanical response 
relative to others.The morphologies of different pores are resulted due to the anchoring effect of the 
different morphologies of HA nanoparticles. However, freeze drying process parameter assist pore 
morphology synchronization could be considered as another futuristic challenging task to 
manipulate the mechanical properties and in vitro bioactivity.  
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Figure 4.33 Scanning electron micrographic image of the freeze dried HA-gelatin scaffold (A) 
HSG, (C) HRG and (E) HFG and their particle distribution is (B), (D) and (F) respectively.   
4.4.4 Mercury poresize distribution of HA scaffold  
Pore size distributions of all three different freeze dried scaffolds are studied through mercury 
intrusion porosimetry, as represented in Figure 4.34.  Multimodal pore size distribution is seen for 
the HSG with average pore diameter in the range ~80 µm and consist micro pores in the range ~1-
10 µm (Figure 4.34(a)). Mercury porosimetric includes both open and close pore in the range of 
pore size from 0.1 – 200 µm and, hence exhibits lower range of pore size compared to pore size 
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from SEM microstructure (Table 4.9). Apparent porosity of scaffolds is also cross checked through 
Archimedes method and total porosity by mercury porosimeter. Total volume porosity measured in 
the mercury intrusion is 74%. Figure 4.34(b) shows multimodal pore size distribution for HRG 
scaffold with the average pore diameter in the range ~ 70 µm. Some micron pores are also observed 
in the range ~0.1-1 µm with a resultant porosity of 72 vol.%. Development of micro pores due to 
the ice crystal that are grown in the walls of the pores [241]. Figure 4.34(c) shows multimodal pore 
size distribution of HFG scaffold. The average pore diameter is observed in the pore diameter ~100 
µm along with porosity of around 76%. Different gradations of micro pores are observed in the 
range of ~0.1-10 µm. Diverse pore size distribution as revealed by porosimetry from SEM 
microstructure results due to the anchoring of the HA nanoparticles with the PVA-gelatin slurry and 
the development of ice crystals during freezing at 221 K. This pore size distribution analysis 
confirms the presence of micro/macro pores in fabricated scaffolds, which is presumed to be 
excellent media for adhesion of foreign organic molecules and scaffold. 
         
 
Figure 4.34 Pore size distribution of the freeze dried scaffold (a) HSG, (b) HRG and (c) HFG.  
4.4.5 Effect of HA loading on compressive strength and porosity of 
scaffold  
Solid loading has been optimized on the support of two prime properties such as apparent porosity 
and compressive strength, which are systematically described in Figure 4.35. All scaffolds HSG, 
HRG and HFG exhibits decrement of apparent porosity and their compressive strength increment 
with increasing solid loading from 30 to 50 wt.%, although these two fundamental properties are 
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non-linearly related [242]. Reasonable compressive strength with adequate porosity of the scaffold 
is seen in 40 wt.% HA solid content. Due to the above cause, the scaffolds are fabricated by 
selective 40 wt.%  HA solid content and considered for next step compressive strength 
enhancement.  
   
  
Figure 4.35 Plots of apparent porosity and compressive strength (A) HSG, (B) HRG and (C) HFG.  
   
Stress-strain behavior of HA-gelatin scaffolds is represented in Figure 4.36. The compressive test of 
the HA-gelatin scaffold samples are studied under uniaxial compression for specifically 40 wt.% 
HA solid bearing scaffold. The scaffold shows the stress of 2.2 MPa for HRG, 2.05 MPa for HSG 
and 1.87 MPa for HFG scaffold, respectively. The result shows strain of the scaffolds at the yield 
stress ~12%. This slow strain rate confirms the ductility nature of freeze dried scaffold. Due to the 
low compressive stress with ductility, it is essential further development of stress of scaffolds by 
means of surface modification. The overall properties such as porosity, strength, elastic modulus 
and average pore diameter of the as freeze dried HA-gelatin porous scaffold is shown in Table 4.9.  
A close look on Table 4.9, reveals that HRG scaffold has comparative high compressive strength, 
elastic modulus with low porosity and average pore diameter 120 µm. Asefnejad et al. [139] 
demonstrated freeze casted  nanoHA-polyurethan composite has 50-200 µm pore size, 80 vol.% 
porosity and 0.6 MPa compressive strength.  
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Table 4.9 Properties of freeze dried HA-gelatin porous scaffold. 
Sample 
ID 
Porosity 
(%) 
Compressive 
Strength (MPa) 
Elastic modulus 
(MPa) 
Pore size 
(µm) (SEM)  
Pore size (µm)  
Hg-porosimeter  
HSG 74 ± 2 2.0 ± 0.03 64 ± 3 152 ± 4 80 
HRG 72 ± 3 2.1 ± 0.05 70 ± 2 140 ± 5 70 
HFG 78 ± 2 1.8 ± 0.02 62 ± 3 155 ± 3 100 
 
 
  Figure 4.36 Stress-strain behaviour of the prepared HA scaffolds at HA loading 40 wt. %. 
4.4.6 Conclusion  
Low temperature freeze casting favors the formation of HA-gelatin micro/macroporous scaffold 
from high viscous slurry of rod shaped HA nanoparticles and gelatin. Circular open macropores of 
scaffold has average pore diameter ~150 µm and compressive strength in the range ~2 MPa. 
Optimum strength and average pore microstructure obtains in presence of 40 wt.% HA solid 
content. Stress-strain behaviour reveals the ductile to quasiplastic nature at strain of 12%. However, 
improvement of mechanical response of high porous scaffold is always a challenging task and 
hence, it will be encountered as a next challenging tax in our research work.  
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4.5 Properties of freeze casted scaffold after cryo-treatment  
 
High porous trabecular bone has ease stress dissipation characteristic through articular contact loads 
and more compliance than cortical bone [243,244]. Porous trabecular bone resides at the ends of 
bone with 50 – 90 percentage pore volume, 100 – 400 µm pore diameter and ~2 – 10 MPa 
compressive strength [245]. Mechanical competence such as compressive strength and elastic 
modulus of this class of bone is influenced by age and initiate to fracture under stress [246,247]. In 
accordance with the previous compressive strength observation, further cryogenic treatment has 
been carried out to enhance the mechanical response of developed scaffold. Herein, freeze casted 
porous scaffolds are attempted to improve the mechanical properties under cryogenic temperature 
and discussed their phase and interfacial bonding behavior, compressive strength, pore structure, 
fracture behavior and machining capability.   
4.5.1 Chemical behaviour of polymeric matrix at cryogenic temperature  
FT-IR spectrum of freeze casted scaffold and the liquid nitrogen treated scaffold is shown in  
Figure 4.37. The absorption bands at wavenumbers 3421 and 602 cm
–1
 are associated with the 
characteristic stretching and bending vibrational modes of OH
–
, respectively. However, 1032 and 
562 cm
–1
 for the characteristic of PO4
3–
 groups of HA in HRG00 scaffold. The absorption band at 
2926 and 1558 cm
–1
 describes the C – H stretching vibration of vinyl group and N – H stretching 
vibrations of amide groups in HRG00 scaffold [248]. The bands at 1649 and 1458 cm
–1
 shows the 
stretching of carbonyl in ester groups, which confirms the esterificaiton during processing of 
scaffold. Absorption band for the same carbonyl group at 77 K is found at 1670 cm
–1
, which 
indicates the absorption at higher wavenumber with high intensity due to shorter and stronger bond 
length between the consecutive atoms. Thus, cryogenic environment weakens the thermal 
oscillation of atoms, which is leading to strengthen of hydrocarbon matrix, anchoring the HA 
nanoparticles and alteration the mechanical properties.  
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Figure 4.37 FT-IR pattern of freeze casted and liquid nitrogen treated scaffolds for 5h. 
4.5.2 Optimization mechanical properties of cryo-treated scaffolds 
In the beginning, nanorod based scaffold has been considered to optimize the cryogenic treatment 
time since nanorod HA has maximum BSA protein adsorption efficiency and their HA-gelain 
scaffold has highest compressive strength. The other relevant characterization for all other scaffolds 
is estimated only after cryotreatment process optimization. Figure 4.38 shows the representative 
compressive stress – strain curves for original and modified HRG00 porous scaffolds compliance 
within 5 – 10 % strain. The original HRG00 exhibits plastic yielding and thereby a plateau without 
linear elastic region. HRG00 are micro – buckled beyond peak stress 2 MPa; causing plastic 
collapse of the hydrocarbon matrix and hence, cell wall touched each other. The stress behavior is 
slightly improved under short time 2h liquid nitrogen treatment, but reasonably improved the 
compressive strength (∼6 MPa) for 5h treatment at 77 K. The mechanical performance of this class 
of material depends on the bonding and strengthens hydrocarbon matrix behavior. A close look on 
compressive strength data indicates that HRG05 has maximum strength among others. Two 
different regions can be observed for HRG05; an initial linear – elastic region that reaches a peak 
stress, followed by a significant stress drop after the linear – elastic region, which corresponds to 
fracture of HRG05. The initial linear elastic region corresponds to the cell walls bending related to 
reversible deformation. The plateau regimes in HRG05 are distinct due to different deformation 
mechanisms. Figure shows that HRG00 scaffold has high strain tolerance behavior compare to 
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HRG05. The strain tolerance is less consistent beyond 5h and observes gradual reduction of 
compressive strength of scaffolds [249]. The continuous increment and then decrement after 
optimum liquid nitrogen treatment is due to the change in bond behavior and internal stress 
associated with thermal conductivity mismatch at such low temperature. Thus, micro cracking is 
caused due to the generation of internal stress and mismatching of the thermal coefficient of HA 
and gelatin at 77 K. The coefficient of thermal expansion (CTE) for hydrocarbon matrix at 
cryogenic temperature should be somewhat lower than this value because thermal expansion 
coefficient is closely related to the oscillation of phonon, while the intensity of thermal oscillation 
becomes weaker as temperature decreases, leading to a lower CTE [250]. As a consequence, the HA 
nanorod shaped particles are clamped more tightly within hydrocarbon matrix at 77 K than HRG00, 
resulting in higher compressive strength at 77 K than that as such freeze casted scaffold. The 
hydrogen bond in HRG scaffold becomes stronger at 77 K due to the shorter bond length caused by 
thermal shrinkage. The free spaces and free volumes in the cured scaffold smaller at 77 K due to 
thermal shrinkage, which contributes to increase intermolecular force and higher strength at 77 K 
compared to the as – fabricated scaffold.  
 
 
Figure 4.38 Stress – strain behavior of freeze casted and liquid nitrogen treated scaffolds.  
4.5.3 Phase study of cryo-treated scaffold 
X-ray analysis of the HRG00 scaffold and HRG05 are shown in Figure 4.39. HA peaks are 
identified by referring the JCPDS file (74-0565). Cryogenic treatment alters the peak intensity of 
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hexagonal hydroxyapatite gelatin composite. The polymeric matrix of HA scaffold undergoes 
crystallized during cryogenic curing of HA-gelatin scaffold. Decrease in the crystallinity of the HA 
peaks after treatment with 5h in liquid nitrogen resulted is associate with the increase in the 
crystallinity of the polymeric matrix [251]. XRD analysis confirms that polymers present in the HA 
scaffold under a goes transformation of ductile behavior to brittle nature by inducing internal stress 
[252].   
 
     
Figure 4.39 XRD analysis of HA scaffold and N2 treated scaffold.   
4.5.4 SEM microstructure of cryo-treated scaffolds 
Hydroxyapatite nanorod ~8 nm diameter and 20 – 50 nm length powder (see Figure 4.9) has been 
used for the fabrication of HA-gelatin scaffold. Original (HRG00) and liquid nitrogen treated 
specifically 5h treated porous scaffolds are critically characterized to understand the pore 
morphology and their size distribution. Figure 4.40(A) illustrates the morphology of original 
scaffold with existence of average pore size 140 µm and transverse interconnected tiny pores. The 
pore shape, morphology and interconnectivity nature of the scaffold depends on the freezing point 
of solvent, reactivity within organic molecules, growth direction of ice crystals and temperature 
gradient during freeze drying [253]. Inset represents the development of ~2 µm interconnected 
pores along the hydrocarbon pore wall. The generations of such tiny micro pores are due to the 
gelation of gelatin [254]. The temperature gradient at the interface between solid HA and liquid 
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phase is caused the formation of many small ice crystals, which is expected to increase much 
internal stress and porosity in the cryogenic environment. Figure 4.40(B) represents the SEM image 
for HRG05 scaffold, where inset indicates the initiation of web of microcracks within hydrocarbon 
matrix due to adaptation of bonding characteristics, shrinkage and internal stress in scaffold. The 
diameter and pore struts have also been changed and expected to have an effect on the size 
distribution. The cumulative porosity increases from 75 vol.% to 80 vol.% when scaffold treated for 
5h, however, beyond this critical aging, the porosity and their distribution behavior changes 
abruptly due to the propagation of fine microcracks along the hydrocarbon matrix. The intensity of 
HA phase crystallinity in HRG00 suppresses with compare to HRG05 scaffold, which is because of 
the rapid esterification and intermolecular hydrogen bonding within – COOH of gelatin and – OH 
of PVA and their cross linking in hydrocarbon matrix. The C – H, C – O and O – H bond length 
becomes stronger at 77 K due to the shorter bond length caused by low temperature thermal 
shrinkage [255]. This phenomenon is also further confirmed by FT-IR analysis of HRG00 and 
HRG05 scaffolds. 
 
 
Figure 4.40 Scanning microscopic image of (A) freeze casted HA nanorods – gelatin scaffold and 
(B) liquid nitrogen treated scaffolds for 5h. Inset represents the behavior of micro pores in the pore 
wall, before and after liquid nitrogen treated scaffolds.   
 
Morphologies of the other two HGS and HGF scaffolds after 5h cryo-treatment are represented in 
Figure 4.41. The open pore structure of the HGS scaffold along with circular in shape and the 
average pore diameter are found ~ 170 µm (Figure 4.41 (A)) whereas 5h cryo-treated scaffold 
(Figure 4.41(B)) shows higher average pore diameter that resulted due to the shrinkage and the 
polymeric conversion of ductile to brittle. In-addition the HGF scaffold shows open circular pores 
with the average pore diameter ~180 µm (Figure 4.41(C)) whereas its liquid nitrogen treated sample 
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shows higher pore diameter with connected pores (Figure 4.41(D)). Thus, liquid nitrogen treated 
scaffold shows higher pore diameter with the interconnected pore morphologies. Polymer matrix 
more crystallizes and brittle after cryogenic treatment as revealed by XRD analysis. In cryogenic 
environment, the polymer matrix present in the strut of the pore is more crystallized and brittle 
[143].     
      
 
Figure 4.41 SEM microstructure of HA scaffolds, (A), (C) as freeze dried and (B), (D) 5h cryo-
treated scaffolds HGS and HGF respectively.  
4.5.5 Mercury pore size distribution of cryo-treated scaffold   
Pore size distribution of 5h cryo-treated HA-gelatin scaffolds is represented in Figure 4.42. Pore 
size distribution of the HSG scaffold results monomodal distribution with average pore diameter ~ 
90 µm and porosity of around ~ 82% (Figure 4.42(a)). Figure 4.42(b) shows the broad multimodal 
pore size distribution with average pore diameter ~85 µm and porosity ~ 78% resulted for HRG 
scaffold. HFG scaffold has narrow and intense multimodal pore size distribution with average pore 
diameter ~ 110 µm along with micron range pores of ~0.01-0.1 µm size and cumulative 85% 
porosity. Pores are well distributed in fibroid morphology, whereas for HSG and HRG scaffold 
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shows a gradient of pores. In liquid nitrogen, the scaffold has higher porosity and pore size 
distribution is shifted to higher pore diameter compared to the as freeze dried HA gelatin scaffold.   
 
 
Figure 4.42 Pore size distribution of N2 treated HA scaffold (a) HSG05, (b) HRG05 and (c) 
HRF05.    
 
 Table 4.10 Pore size before and after cryogenic treatment of as obtained from both SEM and 
mercury porosimetric observation 
HA-Gelatin 
Scaffold 
Freeze casted (-52
o
C) Cryotreated scaffold (-192
o
C) 
HRG 
 
 
Pore size 
(m) 
SEM 
Pore size (m) 
Hg-
Porosimetry 
Pore 
Volume 
(%) 
Pore size 
(m) 
SEM 
Pore size (m) 
Hg-Porosimetry 
Pore 
Volume 
(%) 
140 70 75 160 90 80 
 
Pore size and pore volume of as-freeze casted and 5h cryotreated HA-gelatin scaffold is shown in 
Table 4.10. Different pore size, pore content and pore morphologies are influenced by the HA solid 
content, gelatin and PVA molecular interaction phenomena during freeze casting process and 
cryotreatment, which is revealed by SEM microstructure and mercury porosimeter data. Tiny closed 
pores are difficult to encounter through SEM microstructure, but mercury porosimeter evaluates all 
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range of open and closed pores diameter (0.1 – 200 m) and cumulative pore size shifted to lower 
region. In the same time, the liquid nitrogen temperature shrinks the polymer matrix which 
enhances the ~15% pore size and ~5% pore volume. However, the cryotreated scaffold exhibits a 
high degree of compressive strength because of strong polymer–ceramic interaction assisted by the 
negative coefficient of thermal expansion at 77 K [142].    
4.5.6 Mechanical behaviour of different cryo-treated HA scaffolds   
HA-gelatin scaffold under liquid nitrogen environment shows the higher mechanical properties 
compared with the untreated HA scaffold. The stress-strain behaviour of the liquid nitrogen treated 
scaffolds is shown in Figure 4.43. The stain rate 5% is observed for both HGS05 and HGR05, 
whereas 7% strain is observed in HGF05 scaffold. Low strain rate and high compressive strength 
reveals that the scaffold has brittle nature. The brittle nature results due to the polymer gelatin and 
PVA present in the fabricated scaffold. Yang et al. [141] prepared polymers (epoxy) nanocomposite 
and observed the significant improvement of mechanical properties of composite at the cryogenic 
temperature (77 K). In addition, Chen et al. [142] also reported that cryogenic tensile strength, 
young‟s modulus, ductility and impact strength are significantly increased at the cryogenic 
environment and stronger interfacial bonding in the material at 77 K as compared to RT.  
  
  
Figure 4.43 Stress-strain behavior of 5 h N2 treated HA scaffold. 
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 The study of compressive strength of the scaffold with variation of the soaking time inside liquid 
nitrogen is represented in Figure 4.44. Compression strength of the scaffolds shows highest at 5h 
for any HA-gelatin scaffolds then after strength is further reduced due to the microcracking under 
internal stress within the polymeric matrix.  
 
  
Figure 4.44 Compressive strength of the scaffold with varying the soaking time in liquid N2.  
4.5.7 Fracture behaviour of cryo-treated scaffold  
The facture behaviour of the scaffolds under compression is shown in Figure 4.45. Longer curing in 
liquid nitrogen insists catastrophic fractured in the scaffolds. The result shows that the formation of 
zigzag microcracks around the outer edge of the HGS scaffolds (Figure 4.45(A)). The fracture 
behaviour of the HGR scaffold indicates that higher in the brittle nature scaffold. Longer uni-
directional fracture is observed in the HGR scaffold (Figure 4.45(B)) because of the highest 
ductile–brittle transition and higher crystallinity of the scaffold. The temperature gradient in liquid 
nitrogen changes the internal stress and cluster of microcracks which finally changes the pore 
morphology of HGF scaffolds. Furthermore, this nature of change in the fracture behavior of 
different morphology of HA and hydrocarbon matrix strengthening are responsible for the transition 
of ductile to brittle transformation, which has a significant effect on ultimate room temperature 
mechanical properties of such porous scaffolds. 
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Figure 4.45 Fracture behavior of N2 treated scaffold under compression (A) HSG05, (B) HGR05 
and (C) HGF05.    
4.5.8 Machining of the cryo-treated scaffold 
A macroscopic view of cryotreated HA-gelatin scaffold is shown in Figure 4.46. Machining of the 
HA-gelatin scaffold samples is done through precision lathe machine. Figure 4.46(B) shows the 
drilled (cantered) as well as machined whereas machined HA-gelatin scaffold is represented in 
Figure 4.46 (C). Such a scaffold has an excellent machinability as exhibited by turning or drilling 
performance. These cylindrical shaped scaffolds of various sizes can be produced in a reproducible 
manner using the adopted fabrication route. In particular, the scaffolds with length of up to 100 mm 
and diameter of up to 20 mm can be conveniently prepared in this adopted method. Thus, the 
developed HA-gelatin scaffold support easy machinability which will assist for the selection any 
complicated shape as a placement of cancellous bone and tissue engineering.  
 
 
Figure 4.46 Images of freeze dried and subsequent cryotreated (A), centred drilled (B) and 
machined scaffold (C).   
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4.5.9 Conclusion  
Cryogenic temperature has a significant impact to enhance the compressive strength. A prerequisite 
optimum 5h cryotreatment is needed to achieve a highest strength of such high porous scaffolds. 
The cryotreated scaffolds have a high degree of compressive strength 5.8 MPa, volume porosity 
~80% and 160 µm average pore diameter in comparison of counterpart freeze casted scaffold. At 
cryogenic environment, polymeric matrix undergoes phase transformation from ductile to brittle 
nature, which results for the higher the compressive strength, higher the porosity and the pore 
diameter in the scaffold shifted to higher region. Bond characteristics and crystallinity of 
hydrocarbon matrix have influence on the compressive strength of a porous scaffold. Excessive 
time reduces the strength of scaffolds, because of mismatch thermal expansion, results internal 
stress and spontaneous failure. High porous and reasonable compressive strength of the scaffold 
could be considered as a suitable candidate for the bone tissue engineering, formation of 
neocartilage and growth of osteoblast cells.  
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4.6 Bioactivity, biodegradability and cytotoxicity of CHAMPS  
 
The concept of bioactivity and biocompatibility, associated with a set of in vitro standardized tests, 
is introduced in order to assess the biological behaviour of synthetic scaffold materials. When 
synthetic materials are first used in biomedical applications, the only requirement is considered to 
achieve a suitable combination of physical properties to match those of the replaced tissue with 
minimal toxic response of the host. Bioactivity is the ability to interact in a biological environment 
to enhance the biological response, tissue/surface bonding and bioresorption through progressive 
degradation while new tissue regenerates and heals [178,256]. Evaluation of in vitro bioactivity of 
bioceramic scaffolds is to evaluate the apatite-formation ability of the scaffold in the SBF solution, 
and the other is to investigate in vitro bone cell response to scaffold [257,258]. Biomaterials 
combining biodegradability and bioactivity, once implanted, will help the body to heal itself. 
Details knowledge on bond and sustain capability within living bone and host material is mandatory 
to develop new bioactive ceramics for load bearing bone repair applications. Here in, in vitro 
bioactivity of scaffolds are evaluated through SBF solution whereas biodegradation has been 
studied in Tris-HCl solution. In vitro cytotoxicity and cell viability is analysed using L929 mouse 
fibroblast cells.  
4.6.1 In vitro bioactivity  
In vitro bioactivities of the fabricated cryo-treated HA-gelatin micro/macro porous scaffold 
(CHAMPS) is determined after incubation for a different period in simulated body fluid (SBF) 
solution at the temperature of 37 
o
C and pH ~ 7.4. The incubation period has a significant effect on 
the formation and deposition of apatite on porous scaffolds, which are represented in Figure 4.47. 
Interesting to note that the apatite particles concentration in presence of SBF is gradually increasing 
with time and preferably deposited around the porous region compare to continuous matrix of 
scaffolds. A comparative look within time dependent SBF treated scaffold reveals that most of the 
area is covered by apatite layer after 168h treatment and further confirmed by SEM/EDAX and  
FT-IR analysis. Spherical deposition is likely to be beginning around the pore wall and the pore 
struts. It has been observed that apatite deposition starts on the site, where the scaffold has higher 
porosity with well interconnected pores. The spherical deposition of apatite layer on the surface of 
the scaffold cross checked through EDAX of the SBF soaked HA scaffold. Combination of SEM 
and EDAX study confirms the bioaccessibility of the scaffold. In addition, nucleation of the apatite 
on HA scaffold as analysed through FT-IR is shown in Figure 4.48. The characteristic of carbonate 
bands is observed at wavenumbers 1640 cm
–1
 and 1493 cm
–1
, respectively.   
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 Figure 4.47 Apatite nucleation on the CHAMPS in SBF solution associated with EDX (A) 1 day, 
(B) 3 days and (C) 7 days. 
    
 
 
Figure 4.48 FT-IR analysis of SBF treated HA-gelatin scaffold (a) before SBF trearment and (b) 
after 7 days in SBF.  
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4.6.2 In vitro biodegradability  
Figure 4.49 shows the biodegradation study of fabricated CHAMPS in Tris-HCl buffer solution at 
37 
o
C and pH~7.4, where maximum 25 wt.% degradation is recorded for 7 days. The initial plateau 
exhibits very slow rate of degradation up to 3 days, but enhances up to 7 days and thereafter, 
follows steady state behaviour. A higher degradation of the scaffold is due to the release of 
polymeric small chains. Martinez-Valencia et al. [150] reveals a weight loss of 4% of the HA-
polyurethane biocomposite scaffold for an incubation time of 56 days in tris-buffer solution 
pH~7.4. Similarly, Gou et al. [156] measured biodegradation up to 36 wt.% of calcium deficient 
HA scaffold after 12 week in tris-HCl solution. However, surface engineering or polymer 
modification can enhance the biocompatibity, cell proliferation and low biodegradation for 
futuristic tissue engineering application.  
 
  
Figure 4.49 Biodegradation of CHAMPS studied as function of time. 
4.6.3 Cytotoxicity of CHAMPS  
In vitro cytotoxicity assessment of HA scaffolds carried out direct contact of L929 mouse fibroblast 
cells is represented in Figure 4.50. The cytotoxicity of the scaffold evaluated with following the 
ISO-10993-5 [180]. The test result performed on the extract of the HA scaffold exhibits spindle 
morphology characteristic of mouse fibroblast cell line and is analysed compared with the negative 
control (high density polyethylene) and positive control (stabilized PVC disc). The cell density on 
the negative control is very similar to the fibroblast-like morphology with cell-to-cell contact and 
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filopodia extension as shown in Figure 4.50(A). In contrast, the L929 cells undergo apoptosis and 
necrosis on positive control revealing severs toxicity as represented in Figure 4.50(B). Similar to the 
positive control, the spindle shaped L929 cells are found to adhere and expands on HA-gelatin 
scaffold (Figure 4.50(C)). The fraction of globular shaped is similar on both positive control and 
CHAMPS. Apart from the reason, like the intrinsic characteristic of the used cells lines at specific 
passage, the observation of the globular shaped L929 cells can be the result of initial degradation 
rate of the HA-gelatin scaffold and the release of the polymeric small chains. The result of the 
cytotoxicity test reveals that the extract of the HA scaffold does not affect the cell viability and 
proliferation. Oliveira et al. [152] reveals fibroblast cells (L929) partially proliferated after prolong 
72 h seeding on HA scaffold. After 24 h of contact, an almost confluent monolayer cell lines are 
observed, where improved proliferation with good morphology of the cells maintained. The results 
obtained by the extraction method indicate the viability and proliferation of L929 fibroblasts, 
clarified the well documented biocompatibility of the HA scaffold.  
 
 
Figure 4.50 Fluorescence microscopic image revealing the adhesion of cultured L929 cells after 
one day of incubation: (A) negative control, (B) positive control and (C) CHAMPS. 
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4.6.4 MTT assay of CHAMPS  
Metabolic activity of cells has been studied through MTT assay using mouse fibroblast cells and the 
difference in the cell viability index as shown in Figure 4.51. The cell viability and proliferation of 
the HA scaffold samples at different concentration is evaluated by compared to the controlled tissue 
culture plate. The MTT Assay of L929 cells after contacts with HA scaffold extract shows 40% 
metabolic activity. The amount of formazan produced is directly proportional to the number of 
mitochondrially active cells [259]. Clearly, the MTT assay results reveal that the metabolic activity 
of L929 cells decreases with the increase in the extract concentration of HA-gelatin scaffold  
in vitro, as shown in Figure 4.51. As far as the quantification of cells viability is concerned, 90% of 
the cells are viable on negative control and less than 10% cells on positive control. It is important to 
mention that at the HA-gelatin scaffold extract concentration at 12.5% and 25%, more than the  
70 % of the cells are mitochondrially viable. Although significant decrease in cell viability at 100% 
extract is recorded, at least four times on larger cells population are mitochondrially active than 
compared to positive control. In contrast with 100% concentration compared that on positive 
control. Oliveira et al.[152] measured 90% L929 cells viability at 25% extract concentration on HA 
scaffold through MTT assay. The aforementioned study and relevant data confirms the 
cytocompatibility of HA-gelatin scaffold with L929 fibroblasts cell. The scaffold surfaces are able 
to support cell proliferation because of the metabolic activity, shows a good indication to the 
futuristic application.   
 
  
Figure 4.51 MTT Assay results of various extracts of CHAMPS scaffold along with control. 
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4.6.5 Conclusion  
In vitro bio-assessment of the scaffold reveals about the deposition of apatite layers on the surface 
of the scaffold and apatite layer is completely covered in 7 days.  The carbonated apatite layer has 
been nucleated within SBF solution and confirmed by FT-IR.  Also, the biodegradation of scaffolds 
in tris-HCl solution exhibits a slow but systematic increase in weight loss over an incubation period 
up to 7 days. Spindle shaped L929 fibroblast cells are observed in the direct contact on the scaffold. 
Although higher extract concentration of CHAMPS induces toxicity to L929 cells in a statistically 
significant manner compared to positive /negative controls, lower extract concentration up to 25% 
does not cause a reduction in L929 cell viability. When compared to a negative control, the 
reduction in cell viability has been tentatively explained as a result of the release of small polymeric 
chains.  
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4.7 BSA adsorption and release on CHAMPS  
 
Bovine serum albumin (BSA) has received significant attention to reduce the dissolution of 
synthetic HA, as well as enamel demineralization in vitro [260,261]. Thus, porous HA scaffold is 
considered as a potential delivery media for protein drugs, which could improve the transportation 
mechanism and protect the drug against inactivation, degradation and metabolization phenomena 
[262,263]. BSA protein is considered as model protein for the study of adsorption and release on 
HA-gelatin scaffold [264]. Hence, the assessment of protein interaction with a scaffold is of 
significance for tissue engineering. Keeping this in view, different in vitro analysis such as 
adsorption/release of BSA protein and an attempt has been made to correlate between structure and 
properties CHAMPS. In order to characterize both quantitative and qualitative pore architecture, 
micro computed tomography (micro-CT) technique is being used extensively for protein-loaded and 
as-fabricated HA-gelatin based porous nanobiocomposite scaffolds. Although some aspects of the 
gelatin/HA scaffold are studied from the perspective of the biomedical applications as also 
summarized above, the use of micro-CT to effectively characterization of the pore 
morphology/distribution has not been made in any of the previous studies. Therefore, the internal 
porous architecture of complex nature that one can achieve in such scaffolds after cryogenic 
treatment is also not being realized. The present study, therefore, provides the first set of micro-CT 
results on this aspect. It is expected that such results will open up various possibilities for further 
study to probe into the potentiality different biomedical applications.    
4.7.1 Adsorption study of BSA on CHAMPS  
The results of UV-Visible absorption study on CHAMPS are plotted in Figure 4.52, where 
maximum absorbance of standard BSA protein is measured at the wavelength Amax ~562 nm. The 
peak position of maximum absorbance is gradually shifted towards higher wavelength for 
absorption of beyond 48h. Figure 4.53 represents the time profile adsorption behaviour of BSA on 
CHAMPS as calculated using a predetermined standard concentration – intensity calibration curve 
[265]. Initial adsorption of BSA on the porous surface of HA rapidly increases and then follows a 
steady rate. In this study, the strong adsorption phenomena of BSA on HA can be attributed to the 
electrostatic interaction between Ca
+2
 cation and PO4
3– 
anion of HA with COO
–
 anion and NH3
+
 
cation of BSA protein, respectively [266]. BSA adsorption phenomenon is rapid due to the 
hydrophobicity of the scaffold surface, which attain a steady state after 48h incubation. Under this 
circumstance, the CHAMPS adsorbs highest amount of 51 mg protein per gram of scaffold.   
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Figure 4.52 Analysis of maximum absorbance of adsorbed BSA on CHAMPS with time.  
 
Adsorption isotherm of BSA on HA scaffold is shown in Figure 4.54. Interestingly, the BSA 
adsorption isotherm followed Langmuir isotherm and monolayer adsorption behaviour [267]. The 
maximum adsorption capacity is estimated from standard Langmuir equation: q = [qmaxCe / [(1/aL) 
+ Ce]]; where, q= amount of BSA adsorbed on HA scaffold (mg/g), qmax = maximum adsorption 
capacity (51.3 mg/g), Ce= BSA concentration in solution at equilibrium, aL = Langmuir constant 
(0.213 ml/mg) and correlation factor (R
2
) ~0.9902. Kim et al.[268] demonstrated the BSA 
adsorption on collagen derived HA-gelatin nanocomposite occurs at relatively much faster rate of 
within 24h. In case of chitosan-gelatin scaffold, the BSA adsorption occurs only after prolong time 
scale and typically reached a steady state over a period of 15 days [269]. The present study confirms 
that relatively faster adsorption behaviour of BSA proteins in CHAMPS scaffold occurs within 48h, 
although the time scale for the attainment for the steady state BSA adsorption is little longer than 
that reported in another related study [268]. 
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Figure 4.53 Amount of BSA adsorbed on CHAMPS with time. 
 
 
Figure 4.54 Adsorption isotherm of BSA on CHAMPS.  
4.7.2  Microstructure after BSA protein adsorption  
The CHAMPS adsorbs highest amount of BSA protein after 48h incubation, and they are further 
considered for microscopic analysis. Figure 4.55 represents the scanning electron microscopic 
image of CHAMPS scaffold after BSA protein adsorption. Overall, the spreading of proteins on 
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CHAMPS surface can be clearly seen. The adsorbed protein form a well spread sheet like structure 
and reflects good ability of CHAMPS scaffold to adsorb BSA protein. Hence, it is expected that the 
interconnected and highly porous scaffold surface adsorb more biomacromolecules as compared to 
relatively dense surface. The interconnected porous microstructure of the fabricated scaffold would 
support for the attachment of BSA through its pore walls. Interaction of BSA with porous HA is 
likely to be the electrostatic interaction, and it occurs on the pore surface [157]. Fabricated scaffold 
has hydrophobic surfaces, which interact with the hydrophobic surface of the water soluble BSA 
protein surfaces. The hydrophobic-hydrophobic surface has greater interaction between protein and 
porous HA as compared to the hydrophobic-hydrophilic surface interactions [270]. Thus the 
interaction between protein and porous HA is hydrophobic-hydrophobic, and their conjugate has 
moderate bonding interaction.  
 
 
Figure 4.55 Typical SEM image after BSA protein absorption on CHAMPS. 
4.7.3 Micro-CT scan analysis for CHAMPS and BSA protein loaded 
CHAMPS  
In order to quantitatively and qualitatively characterize the pore architecture, micro 
computed tomography (micro-CT) technique is used extensively for protein-loaded and as-
fabricated gelatin–HA based porous nanobiocomposite scaffolds. The critical analysis of micro CT 
results are carried out in terms of the strut thickness, pore size distribution and pore volume 
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distribution across the entire  three dimensional space of the nano HA/ gelatin scaffold, before and 
after protein adsorption experiments. As far as the total open porosity is concerned, the protein 
adsorption importantly increases the volume percent of open porosity from 63.5% to 71.8%. The 
amount of closed porosity in both the cases is less than 0.1%. It is clear that the protein adsorption 
makes the scaffold more porous, and this will definitely enhance the cell adhesion and proliferation. 
This is clear from the 2D slices presented in Figure 4.56. The homogeneous 2D spatial distribution 
of HA nanoparticles has been recorded in Figure 4.56(a). After protein loading, the available pore 
spaces become much finer and more interconnected in Figure 4.56(b).  
 
 
Figure 4.56 Representative 2D micro-CT slice showing the distribution of the solid volume (HA 
nanoparticles in „a‟ and/or protein macromolecule in „b‟) of CHAMPS (a) and BSA loaded 
CHAMPS (b). The brighter contrast indicates distribution of solid elements and darker region 
indicates low density gelatin matrix. 
 
From several hundred such 2D slices, the pore size, pore wall thickness, pore interconnectivity, 
together with other parameters to describe the pore architecture are being measured. These results 
are plotted in Figure 4.57. The Gaussian fitting of the measured pore wall thickness data reveals a 
peak in distribution around 40 micron in the as processed scaffold, which is shifted to 20 micron in 
the BSA protein loaded scaffold (see Figure 4.57(b)). The overall shift of the pore wall thickness 
distribution towards left essentially reveals favorable protein absorption on the pore wall surfaces in 
a homogeneous manner. Also, the fact that the majority of the pores have pore wall thickness of 
around 40 to 50 micron reveals that such pores can support the ingrowth of biological tissues 
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neobone. Hence, in terms of more quantification of pore size analysis, the distribution in pore sizes 
obtained from extensive analysis of the entire 3-D scaffold for as-synthesized and protein loaded 
HA/ gelatin scaffolds are presented in Figure 4.58. While the shape of the curve is qualitatively 
similar, the peak of the curve is shifted more towards left after the protein loading. From the peak of 
the curve, it can be said that the average porosity in the structure is around 40 µm and around 28 
µm in the as synthesized and protein loaded HA/ gelatin scaffolds, respectively. The extended tail in 
the pore size distribution curve essentially indicates the presence of inhomogeneous pore size 
distribution with the presence of pores as large as 100 µm or larger (see Figure 4.57).  
 
 
Figure 4.57 Plot of micro–CT scan analyzed data to quantify the pore size (a) and pore wall 
thickness (b) distribution for the as-synthesized CHAMPS and BSA protein-loaded CHAMPS. 
 
More specifically, at least 6% of the total porosity has sizes of around 114 µm and at least 1% of the 
total pore volume has sizes of 228 µm, in case of as-synthesized scaffolds. Similarly, the volume 
fraction of the larger pores of 100 µm or above is around 1%. From the perspective of biomedical 
applications, the optimal pore size for bone tissue engineering scaffolds is around 40-200 µm 
[271,272]. Also, the pores of 40 µm or finer would help in the initial attachment of bone cells and 
the presence of larger pores of 100 µm would be useful for bone/ tissue ingrowth in vivo. The 
physical parameters observed from the micro-CT analysis of CHAMPS and BSA loaded CHAMPS 
are summarised in Table 4.11.   
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Table 4.11 Summary of the physical parameters describing the porous architecture of the CHAMPS 
scaffold loaded with and without BSA protein, as determined using extensive micro-CT analysis.  
 
 
 
 
Figure 4.58 Representative 3D micro–CT scan image of the as-synthesized CHAMPS (a) and BSA 
protein loaded CHAMPS (b) 
 
Since biological tissues are of different sizes, the extended tail in the pore size distribution 
of the currently investigated scaffold would be useful for better osseointegration property. As far as 
the total inter connectivity is concerned, the inter connectivity of pores increases from 528749 to 
882899 with protein adsorption. Also, the connectivity density of the as synthesized scaffolds 
Physical parameters  CHAMPS without BSA 
Protein adsorption  
CHAMPS with BSA 
Protein adsorption after 48h 
Total Porosity 63.5 (%) 71.8 (%) 
Total volume pore space 1.1 x 10
11
 (µm
3
)  1.9 x 10
10
 (µm
3
)  
Fractal Dimension  2.61 2.54 
Average Pore separation distance 86.8 µm 66.4µm 
Degree of anisotropy 5.3 2.6 
Connectivity Density 3.21 x 10
-6
 (µm
-3
) 3.30 x 10
-5
 (µm
-3
)  
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increases by one order of magnitude from 3.2 x 10
3
 /mm
3
 to 3.3 x 10
4
 / mm
3
 upon protein 
adsorption. Irregularity of the pore size can be assessed from the fractal dimensions. In the present 
case, the fractal dimension is 2.61 for as synthesized scaffolds and 2.53 for the protein loaded 
scaffolds. It is worthwhile to mention that the fractal dimension can be defined as a ratio indicating 
a statistical index of complexity as how the finer structural details in a designed object changes with 
the scale at which it the object is being characterized [273]. A more complex structure provides 
more the space filling and high value. Here, complexity of macroporous scaffold decreases from 
2.61 to 2.53 when substantial amount of protein adsorbs on the surface of porous complex structure 
[274]. As per as the complexity of the pore size distribution concerned, the present investigated 
scaffold has a highly complex pore structure distribution as can be realized from the fractal 
dimension (FD) of 2.61. It is known that for a less complex porous scaffold FD=2 and for natural 
cancellous bone, FD=2.1 to 2.3 is expected [275]. Another important factor in the context of the 
pore architecture is degree of an isotropy (DA). Higher value of DA essentially indicates the 
anisotropic of pore orientation. In case of as processed scaffold, DA=5.3 and it is reduced to 2.6 
after BSA protein absorption.  
The large interconnectivity of 3.2X10
3 
in case of as processed scaffold as well as 3.3X10
4
 for 
protein loaded scaffold indicates that pores are highly connected and in fact, protein adsorption 
through complex pore favorably increases the interconnectivity density. It is important to mention 
here that high interconnectivity density would definitely facilitate the passage of nutrients, blood as 
well as waste products from the biological cells which would find easy passage to get into the 
available pore volume because of highly favorable pore architecture. From the above, it should be 
clear that highly interconnected porous microstructure with average pore diameter in the range of 
~50-200 µm facilitated the attachment and delivery of BSA on hydrophobic gelatin-HA scaffold 
surfaces and enabled hydrophobic–hydrophobic surface conjugate interaction [270].  
4.7.4 Secondary structure determination of BSA protein through FT-IR  
 FT-IR is a useful tool to determine the secondary structure, bond behaviour and phase purity. 
Details FT-IR spectrum of pure HA and major functional groups are provided in Figure 4.59(a) and 
Table 4.12 respectively. A characteristic vibrational band is detected at wavenumbers of 1024 and 
559 cm
–1
 for PO4
3–
 and 3344 and 610 cm
–1
 for OH
–
 in as-synthesized pure HA, respectively [276]. 
The weak stretching vibrational band at 1647 cm
–1
 for C=O bond and at 1463 cm
–1
 for N – H bond 
are attributed to the presence of gelatin in CHAMPS (Figure 4.59(b)) [277]. FT-IR spectrum of pure 
BSA is included in Figure 4.59(c). The weak vibrational band is observed at 2950 cm
–1
 for –CH 
stretching in pure BSA. A broad and strong stretching band at wavenumber of 3315 cm
–1
 is 
Chapter 4 – Results and Discussion  
122 
 
associated with –OH and –NH bond stretching of amino acid of BSA protein. The band at 1654 and 
1542 cm
–1
 reflects the C=O stretching vibration for amide-I and N – H bending vibration for  
amide-II, because of α-helix structure of BSA [278]. FT-IR spectrum of adsorbed BSA on the 
surface of CHAMPS is shown in Figure 4.59(d). The adsorbed BSA on CHAMPS surface exhibits 
strong and more intense characteristic bands of N–H and C=O, which demonstrates the secondary 
structure of BSA protein without any denaturation. A strong and broad characteristic band at 3314 
cm
–1 
is associated with –OH band for both HA and BSA. Also, the band at 603 cm–1 is related to the 
bending vibration of –OH group. The stretching and bending mode of vibration for PO4
3– 
group of 
HA and CHAMPS are recorded at 1065 and 559 cm
–1
, respectively [239].  Amide- I and Amide- II 
of polypeptide linkage of protein are also detected in case of BSA adsorbed CHAMPS and these 
results together confirmed the adhesion behaviour of protein molecule on the interconnected porous 
surface of CHAMPS scaffold.  
 
 
Figure 4.59 FT-IR spectrum of (a) NHR, (b) CHAMPS (c) BSA and (d) CHAMPS-BSA. 
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Table 4.12 Characteristic FT-IR bands for different groups present in of HA, CHAMPS, BSA and 
BSA adsorbed CHAMPS.  
Functional Groups HA 
νo(cm
–1) 
CHAMPS 
νo(cm
–1) 
BSA 
νo(cm
–1) 
BSA adsorbed 
CHAMPS νo(cm
–1)       Groups Mode of vibration 
P
O
-O
O-
O-
  
1024 
strong 
1029 
          strong 
- 1035 
strong, broad 
559  
weak 
559  
weak 
- 603 
weak 
 
O H  
3344 
strong 
3350 
strong 
3315 
strong, broad  
3314 
strong, broad  
610 
weak 
605 
weak 
544 
broad, strong 
559  
weak 
C H – 2919 
weak 
2948 
weak 
2948 
very weak 
O
C N
H   
– 1647 
weak 
1654 
strong 
1654 
strong, intense 
O
C N
H  
– 1463  
weak 
1542 
strong 
1542 
strong, intense 
 
4.7.5 Release of loaded BSA from CHAMPS  
The amount of BSA released from CHAMPS in vitro is estimated using UV-visible absorbance 
measurement. A maximum absorbance peak at 562 nm is shifted towards longer wavelength beyond 
24h release time, as indicated in Figure 4.60. The initial rate of BSA release from CHAMPS is rapid 
from 6h up to 24h. However, same release remains at a steady state up to 240h, as shown in  
Figure 4.61. Overall, the BSA release kinetics analysis reveals around 60% release of BSA protein 
after 24h and this followed steady state Langmuir isotherm, as similar to protein adsorption 
phenomenon. However, the solution pH is constant for the entire release study. The release of BSA 
from CHAMPS is diffusion controlled in the first stage due to the smaller molecular weight of BSA 
[279]. The steady release rate, as recorded in the present case, might be beneficial for the 
proliferation of osteoblast cell in culture medium as well as in the drug delivery system. As far as 
the protein release is concerned, the CHAMPS scaffold clearly outperforms other biodegradable 
scaffolds as far as the BSA release over 10 days is concerned. For example, Jaklenec at al. [157] 
measured 40-50% of BSA release for PLGA microspheres loaded with 4.3% BSA in vitro over an 
incubation period of up to 10 days and BSA release does not attain the steady state even up to the 
P–O stretching  
P–O bending  
O–H stretching  
O–H bending  
C–H stretching  
Amide-I stretching  
Amide-II stretching  
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period of 20 days. In contrast, the BSA release is around 70% after 24h incubation and reaches a 
steady state behaviour of 60% BSA release over an incubation period of 2-10 days. Such ability of 
the CHAMPS scaffold to release BSA proteins over a time span of 24h indicates that these scaffolds 
can be used for protein delivery applications.   
   
 
Figure 4.60 Release of BSA from CHAMPS UV study of absorbance with wavenumber.  
 
 
Figure 4.61 Amount of BSA released from the loaded BSA CHAMPS with time  
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4.7.6 Conclusion 
HA-gelatine scaffold has higher affinity towards BSA molecules on its surface due to its porous 
structure. The result shows that 1gm of HA scaffold adsorbs about 51 mg of BSA protein. Peptide 
bond of protein remains unaltered after adherence with scaffold. Higher surface area and the 
interconnected porous structure of the scaffold facilitates the adherence of more amount of BSA 
compared to the as synthesized HA nanoparticles. BSA release is around 70% after 24h incubation, 
and reaches steady state behaviour after 60% BSA release over an incubation period of 2-10 days. 
Micro CT- analysis reveals that the inter connectivity increases with the adsorption of BSA on HA 
scaffold.    
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Chapter 5 Conclusion 
 
To fulfil the research objective, several steps have been considered and successfully executed  to 
prepare HA nanoparticles and their dispersion; HA/protein conjugate and their adsorption/release; 
freeze casted macroporous scaffold and their compressive strength enhancement by cryogenic 
treatment; in vitro bioactivity, biodegradation, cytotoxicity, cell viability study and finally BSA 
protein adsorption/ release of CHAMPS scaffolds. Cumulative findings are summarized as follows:  
 
i) Different morphologies of HA nanoparticles are synthesized through control of solution pH, 
temperature and Ca:P ratio from common precursors  Ca(CH3COO)2 and KH2PO4.  
ii) High hydroxyl ion concentration (12.25 ≥ pH ≥ 10.5) and low temperature (298K) favours 
isotropic non-confined spherical shape, intermediate concentration (9.5 ≥ pH ≥ 7.75) and 
low temperature (303K) initiates the anisotropic growth of rod particles and low 
concentration (7 ≥ pH ≥ 5.25), but high temperature (353K) accelerates the restricted 
expansion to fibroid morphology of HA.  
iii) Spherical morphology is observed with an average diameter of around 10 nm, rod 
morphology with ~8 nm diameter and an aspect ratio of ~5 whereas fibroid morphology of 
HA shows micron size length with 30-40 nm diameter.  
iv) Dispersion of HA nanoparticles prepared through the complexometric reaction with Na-
citrate are stable for more than six months without appearance of sediments. 
v) The as-synthesized nano metric HA particles are studied for the protein BSA adsorption and 
release. Rod morphology exhibits relatively higher BSA adsorption capacity compare to the 
counterpart spherical and fibroid HA nanoparticles. Higher surface area and Ca:P ratio of 
HA nanorod adsorbs 28 mg/(gm of HA) of BSA in 48h and around 75% release within 96h.   
vi) The HA gelatin scaffold is successfully fabricated through the freeze casting method. 
Circular open pores are resulted with an average pore diameter ~150 µm. Compressive 
strength of the scaffold is observed within ~2 MPa.  
vii) Compressive strength of the freeze casted scaffolds is improved by soaking in liquid 
nitrogen. The compressive strength of freeze casted high porous scaffold depends on curing 
time in liquid nitrogen environment. At cryogenic environment, polymeric matrix under 
goes phase transformation from ductile to brittle nature, which develops an optimum 
compressive strength with adequate pore diameter and pore volume.   
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viii) The combination of freeze casting and cryogenic curing for 5 h in liquid nitrogen develops 
HA-gelatin nanobiocomposite scaffolds with interconnected porosity and excellent protein 
adsorption / delivery property. Such scaffold exhibits 80 vol. % porosity with pores of 50-
200 m, moderate compressive strength 5 MPa and large strain failure up to 24%. Both the 
structure and compression response are similar to that of natural cancellous bone.  
ix) Although higher extract concentration of HA scaffolds induces toxicity to L929 cells in an 
statistically significant manner compared to positive /negative controls, lower extract 
concentration up to 25% does not cause significant reduction in L929 cell viability. When 
compared to negative control, the reduction in cell viability has been tentatively explained as 
the result of release of small polymeric chains.  
x) The biodegradation of scaffolds in tris-HCl solution exhibits a slow but systematic increase 
in weight loss over an incubation time period up to 7 days.  Also, the nanosized apatite 
nodules are extensively formed within 7 days in vitro.  
xi) HA gelatin scaffold has a higher affinity towards the adherence of BSA on surfaces due to 
its porous structure. Higher surface area and interconnected porous structure of the scaffold 
facilitates for adherence of more amount of BSA as compared to the synthesized HA 
nanopowders. One gram of the HA scaffold adsorbed 50 mg of BSA at 48h and 60 wt.% of 
release is observed in 24h of the loaded scaffold.  
xii) The protein adsorption behaviour follows the classical Langmuir isotherm and the FT-IR 
analysis confirms that the secondary protein structure is retained upon adsorption for longer 
time period.  
xiii) On the basis of the micro-computed tomography analysis, the investigated nano HA-gelatin 
scaffolds are characterized by the skewed pore size with a mean of 40 µm and an extended 
tail of up to 250 µm, as well as pore wall structure thickness varying in the range of 10-100 
µm. A systematic shift towards finer pore size / pore wall distribution with BSA adsorption 
is also recorded. Further, the superior protein adsorption / delivery are attributed to the 
unique pore interconnectivity and anisotropy in addition to desired pore distribution.  
xiv) The protein release study reveals a higher release rate of 60-70% from HA scaffolds and this 
is better than other biodegradable scaffolds. 
 
In summary, the combination of protein adsorption and release study indicates that the 
scaffolds can be used as a suitable growth substrate for anchorage-dependent eukaryotic cells as 
well as for protein delivery. Also, the present study provided first comprehensive results to confirm 
the in vitro bioactivity, biodegradability and favourable protein interaction of CHAMPS scaffold. 
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5.1 Future Work  
Apart from the brief conclusion on the current research program there are several scope for further 
improvement of performance of such nanobiocomposite macroporous scaffolds with consideration 
of following future work;  
a) Detail study of HA nanoparticle growth kinetics and their crystal structures.  
b) Protein molecule and direct cell adhesion phenomena study with respect to particle size and 
crystallinity.  
c) Fabrication of freeze casting scaffold with varying gelatin content, gelatin molecular weight 
and freeze casting parameters. 
d) Study on the effect of viscosity of slurry on pore morphologies and compressive strength.  
e) Evaluation of CTE after cryotreatment and establish the polymeric phase transformation 
mechanism at that temperature.  
f) Preparation of conjugate with other proteins (bone morphogenic protein, osteocalcine, 
human bovine serum albumin etc.) and study of their adsorption/release characteristics.  
g) In vivo assessment of the scaffold in animal model. 
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